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Abstract 
Abstract 
Rinderpest virus (RPV) is a morbillivirus which causes a highly contagious disease 
affecting members of the order Artiodactyla. The viral L protein is the catalytic 
subunit of the RNA-dependent RNA polymerase, but requires the P protein for 
activity. In previous studies it was found that, in addition to a direct L-P interaction, 
both the C and V non-structural proteins bind to L. The L proteins of morbilliviruses 
consist of three long highly conserved domains separated by short unconserved 
sequences. The interaction ofP, C and V with these three domains was studied. 
Using co-immunoprecipitation, it was shown that P interacts with the first domain, 
whilst C and V were each shown to interact with the central domain. Further 
mutational analysis using the yeast two-hybrid system (Y2HS), showed that the P 
binding site lies in the amino-proximal domain of L, between amino acids 1 and 233, 
which fits with the co-immunoprecipitation data. However, the Y2HS suggested that 
the binding site for C and V includes a region between amino acids 1 and 363 of L, 
i.e. within the first domain. These data indicate (i) that the P binding site is distinct 
from that ofC and V, and (ii) that the C and V binding site(s) may be complex. 
To search for host cell proteins with which L interacts, a library screen was 
performed using the Y2HS and a porcine macrophage cDNA library. Three host cell 
proteins were recovered from the library screen as putative L interactors. The 
interaction with one of these, striatin, was confirmed by co-immunoprecipitation, and 
co-localisation of the two proteins was observed by confocal microscopy. The L 
sequence with which striatin interacts was investigated. Like the C and V proteins, 
striatin was shown to interact with the second conserved domain of L by co-
immunoprecipitation and Y2HS data indicated that a possible second binding site for 
striatin includes a region of L sequence between amino acids 1 and 363. 
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Chapter One 
Introduction 
1.1 Rinderpest 
1.1.1 The Disease 
Chapter 1- Introduction 
Rinderpest or "Cattle Plague" is an acute, highly contagious viral disease 
affecting even-toed ungulates of the order Artiodactyla, most commonly cattle 
and buffalo. Infections are characterised by the sudden onset of clinical 
symptoms manifested in high fever, nasal and ocular discharge, severe 
gastroenteritis with inflammation and haemorrhage, resulting in constipation 
followed by diarrhoea. The disease has a high morbidity rate and an associated 
mortality rate of 90-1 00% with the more virulent strains, falling to around 20% 
with milder strains. Rinderpest was one of the first diseases shown to be caused 
by a filterable agent in 1902 by Nicolle and Adil Bey (Rossiter, 1994) and the 
infectious agent, rinderpest virus (RPV), was first grown in bovine tissue culture 
by Plowright and Ferris (Plowright & Ferris, 1957). 
The incubation period of rinderpest varies with virus strain and dosage, in 
addition to the route of exposure, and individual strains of rinderpest vary in their 
pathogenicity depending on host species and breed (Rossiter, 1994). The 
molecular factors determining variations in virulence remain unknown. Animals 
infected with rinderpest shed virus one-two days prior to the onset of clinical 
symptoms, and up to ten days following the start of pyrexia, in their nasal, oral, 
ocular and vaginal secretions and faeces (Rossiter, 1994). Rinderpest is spread 
almost exclusively by contact between infected and susceptible animals. RPV 
may also be transmitted by aerosol and it has been shown experimentally that 
RPV can be transmitted by aerosol over several hundred metres (Hyslop, 1979). 
Nevertheless, droplets are large and are only infectious for a short period of time 
thus close contact is necessary for infection (Reid, 1981). RPV has been isolated 
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from a variety of insects: yet there is no evidence for them playing a role in the 
transmission of the virus (Kahrs, 2001). 
Although rinderpest can be prevented with vaccination, it spreads easily among 
non-vaccinated herds, through livestock trade and pastoral migrations, causing 
economic hardship and widespread famine. Animals vaccinated with vaccine 
strains of rinderpest do not shed virus and this is most likely due to the low levels 
of viraemia. 
Extensive clinical depictions of rinderpest exist in the literature with the course of 
disease in both cattle and buffalo similar. In the classic acute form of the disease, 
sudden onset of fever usually occurs one to four days post exposure and lasts 
between six and eight days, known as the "prodromal phase". The affected 
animal's temperature gradually climbs over the first two to four days to between 
40 and 41.2°C. The animal is unwell, yet it lacks any symptoms of diagnostic 
value. The animal may also exhibit conjunctivitis, clear serous nasal and ocular 
discharge, anorexia, slowed rumination causing constipation and depression. 
Visible mucous membranes are hyperaemic and may be abnormally dry. It is in 
the "erosive" phase where the specific signs ofRPV are seen, characterised by the 
appearance of necrotic oral lesions lasting about five days, which start to appear 
around day four or five, after the onset of pyrexia and accompanied by excessive 
salivation. One to two days after the onset of oral lesions, when the fever begins 
to fall, diarrhoea starts. The animal has no appetite, a difficulty in breathing, is 
thirsty, restless, depressed and has a dried out muzzle. Ocular and nasal 
discharges become mucopurulent, accompanied by fetid breath. The fate of the 
animal is soon decided. It collapses, dying immediately, or remains the same for 
a few days and then dies, or the diarrhoea rapidly progresses resulting in death 
due to dehydration and malnutrition. If the animal has enough resistance to 
recover, the fever recedes, returning to normal in around two days. The oral 
lesions heal, the diarrhoea ceases and the animal regains its appetite. Abortion 
occurs in recovering pregnant animals. 
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Two variants of the disease also occur. Peracute infections are rare and usually 
occur in young calves, with the death ofthe infected host occurring in about three 
days (Anderson et al., 1996). Subacute reactions tend to have a longer 
incubation period of up to fifteen days and clinical signs are usually milder than 
those seen with the classic form of disease. Most animals with this type of 
infection survive and are normally the young and the immature adults in areas 
where rinderpest is enzootic. 
Both mild and highly pathogenic strains ofRPV share the same tissue tropism in 
vivo; however, highly pathogenic isolates such as Saudi 1181 replicate more 
rapidly in permissive cells resulting in a faster rate of disease progression and a 
wider distribution when compared to milder strains (Wohlsein et al., 1995). 
Although RPV grows in cells of very different tissue origin, it is primarily 
lymphotropic and epitheliotropic in its host (Wohlsein et al., 1993). It is the 
destruction of lymphocytes by RPV that causes the affected animal to become 
immunosuppressed, leading to secondary bacterial infections that can often be 
fatal and cause mis-diagnosis. Unlike most morbilliviruses, RPV has never been 
detected in the brain of infected animals. 
1.1.2 History of the Disease 
Rinderpest was for centuries the most feared bovine plague known, capable of 
destroying entire populations of cattle and buffalo and responsible for changing 
the course of history. Although the distribution of RPV may now be limited, at 
the start of the twentieth century it still affected cattle populations throughout 
Asia, Africa and parts of Europe, and it was the fear generated by rinderpest that 
brought about the first European veterinary colleges. The disease is thought to be 
of ancient Asiatic origin with recognisable descriptions of rinderpest dating back 
to the European epizootic of 376-386AD (Reid, 1981). Historically, outbreaks of 
rinderpest follow wars and periods of civil disturbance where there is 
uncontrolled movement ofpeopJe and troops along with live food animals, which 
can carry the virus. A recent example is that of Turkey, where the virus 
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reappeared in September 1991 as a consequence of the Gulf War and the 
displacement of the Kurdish people (Anderson et aI., 1996). 
The Great Rinderpest Pandemic of 1889-97 is widely thought to be the first major 
introduction of rinderpest into Africa, yet there still remains confusion 
surrounding the exact source of the virus that started this pandemic. The more 
popular opinion is that the virus was introduced to Eritrea by the cattle that 
accompanied the Italian army in 1887. The virus then proceeded to spread 
rapidly through Ethiopia in 1888, along the Rift Valley and into West Africa via 
. Sudan and Chad. Within five years the virus had reached the Atlantic and in less 
than a decade, the virus had crossed into South Africa. Mortality rates in cattle 
and wildlife exceeded 90%, although waterbuck and alcelaphines, such as 
wildebeest, remained relatively unsusceptible to the disease (Rossiter, 1994). 
The great pandemic was responsible for the deaths of over 5.25 million cattle and 
uncountable wildlife. Humans were affected not only financially, but also 
through collapse of the transport system and widespread famine. 
The last reported outbreaks of rinderpest in Europe were in Belgium in 1920 and 
in a Rome zoo in 1949 (Rossiter, 1994); the cause in both cases was the 
importation of infected livestock. 
1.1.3 The Eradication of Rinderpest 
Rinderpest never established itself in the Americas or AustralialNew Zealand and 
its distribution in other parts of the world is now restricted due to internationally 
co-ordinated vaccination programs. As a result, rinderpest is currently targeted 
for global eradication by 2010 (Anderson et al., 1996, Reid, 1981). If this goal is 
achieved then it will be the first time that an animal disease will have been 
eliminated worldwide and, after smallpox, the second disease eradicated in 
history. 
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In 1961 Joint Project 15 (JP15) was founded, an internationally funded and co-
ordinated mass vaccination campaign to control rinderpest in Africa using a 
tissue-culture attenuated virus vaccine. The attenuated RBOK vaccine strain of 
RPV was derived in Kenya from a virulent strain of RPV (Kabete '0') (Plowright 
& Ferris, 1962). Kabete '0' was passaged 90 times in primary calf kidney cells, 
losing the ability to induce a febrile response in all classes of cattle inoculated 
with the tissue culture adapted form. Passages 41 and 90 were tested for 
reversion to virulence by back passage in cattle. Passage 41 reverted to virulence 
by passage 2, whilst passage 90 of the attenuated virus showed no reversion to 
virulence. Virus passages 90-100 in primary calf kidney cells are used for 
vaccine production. JP15 was not only responsible for a dramatic reduction in 
the incidence of rinderpest, but in some countries the disease was even eliminated 
for several years. By the time the campaign ceased in 1976, more than 70 million 
cattle in 22 countries had been vaccinated (Masiga et al., 1988, Rossiter, 1994). 
However, due to a recession in the world economy, many countries could no 
longer afford to vaccinate their herds against rinderpest. This resulted in a 
gradual increase in the incidence of rinderpest as it spread from its endemic 
strongholds. Following the resurgence of rinderpest in Africa from 1979, a new 
internationally co-ordinated scheme was introduced to Africa in 1981 - the Pan-
African Rinderpest Campaign (PARC). The aim of this was to re-establish 
control of rinderpest, to assist veterinarians and to eventually rid Africa of this 
disease (Masiga et aI., 1988, Rossiter, 1994). 
The Global Rinderpest Eradication Programme (GREP) was founded in the 1980s 
and works together with eradication campaigns in Africa and Asia, in addition to 
other regional, national and international organisations to co-ordinate rinderpest 
eradication efforts. The GREP strategy is again based on mass vaccination, in 
addition to movement controls, surveillance and training to improve veterinary 
support services. The aim of GREP was to eradicate rinderpest by the end of 
2003 and to achieve full Office International des Epizooties (OlE) accreditation 
of freedom from rinderpest by 2010. As it currently stands, the target year of 
2010 remains achievable, with the last remaining reservoir of rinderpest thought 
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to be limited to the Somali pastoral ecosystem spanning the south and south-east 
of Somalia and north-eastern Kenya (Mariner & Roeder, 2003). 
Despite the huge successes seen over the past few years with the progress of 
eradication, caution is now necessary, as the tpajor fatal epizootics that were such 
a feature of the nineteenth century and the start of the twentieth century could 
now return. This is due to the fact that they occurred in naIve populations, much 
like those seen today where vaccination has ceased in accordance with 
eradication guidelines. Such a fear is understandable, as many cattle no longer 
have any immunity/resistance to the disease leaving numerous vulnerable herds 
and wildlife. 
1.2 Rinderpest - the Virus (RPV) 
1.2.1 Classification 
Rinderpest virus (RPV), which is closely related to the human Measles virus 
(MeV), is a member of the genus Morbillivirus, family Paramyxoviridae in the 
order Mononegavirales (Pringle, 1991, Schneemann et al., 1995); for 
classification see figure 1.2.1. In addition to RPV, the morbillivirus genus 
includes several viral pathogens of veterinary and medical importance, Canine 
distemper virus (CDV), Dolphin morbillivirus (DMV), MeV, Peste des petits 
ruminants virus (PPRV), Phocine distemper virus (PDV) and Porpoise 
morbillivirus (PMV) (Barrett et al., 1993, Cosby et al., 1988, Mahy et al., 1988). 
RPV has been proposed as the archevirus of the morbillivirus group as it reacts 
with a wide range of monoclonal antibodies produced against other 
morbilliviruses (Norrby et al., 1985). 
Over recent years the number of members of the morbillivirus genus has 
increased. Until 1988, there were only four members, CDV, MeV, PPRV and 
RPV. Since then three new morbilliviruses, DMV, PDVand PMV have emerged 
causing epizootics in aquatic mammals (Barrett et al., 1993), although DMV and 
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Bornaviridae Filoviridae 
Bomavirus "Ebola-like 
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"Marburg-like 
viruses" 
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Rhabdoviridae 
Lyssavirus Rabies virus 
Vesiculovirus Vesicular 
stomatitis virus 
Ephemerovirus Bovine 
emphemeral fever virus 
Cytorhabdovirus Lettuce 
necrotic yellows virus 
Nucleorhabdovirus 
Potato yellow dwarf virus 
N ovirhabdovirus 
Infectious hematopoietic 
necrosis virus 
Paramyxoviridae 
~ l 
Paramyxovirinae Pneumovirinae 
Respirovirus 
Sendai virus 
(mPIVI) 
Pneumovirus Rubulavirus A vulavirus Henipavirus Human respiratory 
Mumps virus NDV Hendra virus 
Morbillivirus 
Measles virus 
Rinderpest virus 
Canine distemper virus 
Phocid distemper virus 
Cetacean morbillivirus 
Pestes-des-petits-ruminants virus 
syncytial virus 
& 
Metapneumovirus 
Avian pneumovirus 
Figure 1.2.1. Classification of single-stranded monopartite 
negative sense RNA viruses. Showing the type species for all genera, 
with the exception of the genus Morbillivirus, where all known members are 
listed. Sendai virus is also known as murine parainfluenza virus type 1 
(mPIVI) and NDV corresponds to Newcastle disease virus. 
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PMV are now considered to be the same virus, Cetacean morbillivirus. Further 
to this, in 1994 a virus isolated from horses in Australia, originally called "Equine 
Morbillivirus", was tentatively classified within the genus Morbillivirus (Murray 
et aI., 1995). This virus is now known as Hendra virus (He V) and following 
genetic analysis of its entire genome is classified within a new genus, the 
Henipavirus, together with Nipah virus (NiV), within the family 
Paramyxoviridae (Harcourt et al., 2001). 
All known morbilliviruses are capable of causing severe disease in their 
respective hosts, with each virus species in general having its own host range. 
Morbilliviruses do not persist in an infectious form following an acute infection 
and recovery of the host results in life-long immunity. The virus thus relies on a 
constant supply of new susceptible hosts for its maintenance. 
1.2.2 Virus Structure and Genome Organisation 
Morbilliviruses are single-stranded monopartite negative sense RNA viruses, 
replicating in the host cell cytoplasm; they are not robust, being sensitive to heat, 
light and ultrasonic waves. Denaturation of the virus occurs in both high and low 
pH conditions and also in the presence of lipid solvents due to the fact that 
virions are enveloped (Anderson et al., 1996). The large pleomorphic virions are 
150-300nm in diameter and obtain their lipid bilayer envelope from the host cell 
during the budding process. Projecting from this envelope are the two surface 
glycoprotein spikes, F and H. The fusion (F) protein plays an important role in 
virus infectivity; it not only mediates the pH independent fusion between the host 
cell plasma membrane and the viral envelope, but F proteins expressed at the 
surface of vir ally-infected cells can also mediate cell-cell fusion resulting in the 
formation of syncytia, or giant multi-nucleated cells (Evans et al., 1990). To be 
in an active state the fusion protein must be cleaved by a host cell trypsin-like 
protease from its inactive Fo precursor state into the biologically active disulfide-
linked Fl and F2 heterodimer. The new amino terminus ofFl generated by this 
cleavage reveals the highly conserved hydrophobic fusion peptide, which is 
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believed to be involved in the fusion event. Like other paramyxoviral attachment 
proteins, the morbillivirus haemagglutinin (H) proteins of both RPV and PPRV 
have neuraminidase activity (Langedijk et al., 1997, Seth & Shaila, 2001 b). MeV 
H (Ohgimoto et ai., 2001) and RPV H (Y oneda el ai., 2002) have both been 
shown to play important roles in determining tissue tropism and recent studies 
with CDV indicate that the H protein is the main determinant of the fusion 
efficiency of the virus (von Messling et al., 2001). 
For the majority ofparamyxoviruses, both the F and H proteins are required for 
the induction of cell-cell fusion, as is the case for RPV (Das et al., 2000, Seth & 
Shaila, 2001a, Wild et al., 1991) and CDV (Bar-Lev Stem et al., 1995). The 
PPRV F protein however can alone induce fusion, in the absence of the 
haemmaglutinin protein (Seth & Shaila, 200Ia), as has been shown for some 
strains of SV5 (Ito et ai., 1997). Unlike the majority of paramyxoviruses, where 
there exists a requirement for homotypic F and H proteins to generate cell-cell 
fusion, MeV and CDV F and H proteins are able to form heterotypic interactions 
both for generating cell-cell fusion and forming viable viruses (Bar-Lev Stem et 
ai., 1995, Nussbaum et aI., 1995, von Messling et al., 2001). The same has been 
more recently shown for the two glycoproteins ofNiV and HeV (Bossart el al., 
2002). RPV and PPRV F and H proteins could not be mixed to create viable 
virus (Das et al., 2000), but in transfected cells heterotypic interactions can occur 
between the glycoproteins of the two viruses (Seth & Shaila, 2001 a). It has been 
shown that the strength of the interaction between F and H is responsible for 
modulating viral fusogenicity; the stronger the interaction, the less fusogenic the 
virus is and vice versa (Plemper et ai., 2002). Only these two surface proteins 
stimulate the virus neutralising antibody response (Belsham et ai., 1989, 
Giavedoni et ai., 1991, Schlereth el ai., 2000, Yamanouchi et aI., 1993, Vilma et 
ai., 1988) and neutralising antibodies are primarily against H (Giraudon & Wild, 
1985). 
The matrix (M) protein forms a paracrystalline layer under the viral lipid bilayer 
envelope (Bachi, 1980) and is widely considered to be the main organiser of viral 
morphogenesis. M functions to stabilise the viral structure by interacting with the 
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cytoplasmic tails of both the F and H proteins, with the lipid bilayer and with the 
nucleocapsid (N) protein (Mottet et ai., 1999, Stricker et ai., 1994). Also 
contained within the viral membrane is the nucleocapsid core, which contains the 
single-stranded RNA genome (see figure 1.2.2.1). Until recently it was thought 
that morbilliviruses, like the majority of viruses, packaged a single copy of the 
viral RNA genome into each virus particle. However, a stable MeV mutant that 
efficiently packages at least two genomes has been characterised and found to be 
fully functional, growing with comparable efficiency to an unmodified control 
MeV (Rager et ai., 2002). 
The nucleocapsid protein enwraps the genomic RNA to form the core structure to 
which the phosphoprotein (P) and large (L) proteins are attached during 
transcription and replication. It is this helical, nuclease-resistant, nucleocapsid, 
rather than naked RNA, that acts as the template for all RNA synthesis. N is the 
most abundant viral protein in RPV infected cells and the principal component of 
the helical nucleocapsids (Grubman et ai., 1988), which have a characteristic 
herringbone appearance when viewed through the electron microscope 
(Kingsbury, 1990). Using immunogold labelling, it has been shown that there are 
at least 60-70 molecules of P and 30-35 molecules of L clustered together along 
paramyxoviral nucleocapsids (Portner et ai., 1988). The helical nucleocapsid 
core ofSendai virus (SeV), a related paramyxovirus, is composed of 
approximately 2,600 nucleocapsid (N) proteins, 300 P proteins, and 50 L proteins 
associated with the viral RNA (Lamb et al., 1976). 
N proteins ofparamyxoviruses self-associate, forming organised nucleocapsid 
structures. Such interactions have been characterised for numerous 
paramyxoviruses including SeV (Buchholz et ai., 1993, Horikami et ai., 1996), 
MeV (Fooks et al., 1993, Spehner et ai., 1991), human parainfluenza virus type 2 
(hPIV-2) (Nishio et ai., 1999), Newcastle disease virus (NDV) (Kho et ai., 2003) 
and human respiratory syncytial virus (RSV) (Murphy et ai., 2003). The self-
assembly domain for SeV (Buchholz et 01., 1993, Myers et ai., 1999), MeV 
(Bankamp et ai., 1996, Liston et ai., 1997), hPIV-2 (Nishio et ai., 1999) and 
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Figure 1.2.2.1 Sche matic representation of a rinderpest 
virion. The two surface glycoproteins, the fu sion (F) prote in and 
haemagglutinin (H) protein are shown protruding fro m the host deri ved 
membra ne envelope, which is represented as a black border. Located j ust 
below the membrane envel ope, the matr ix (M) prote in is tho ught to be 
attached to the cy toplasmic tails ofF and/o r H. The RNA is depicted as 
being encaps idated wi thin num ero us co pi es o f the nucl eocapsid (N) 
pro te in , whi ch is associated with both the large (L) prote in and the 
phospho- (P) prote in. 
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NDV (Kho et a/., 2003) N proteins has been mapped to the amino-terminal two-
thirds. It is a possibility that the self-interactions ofN may form the RNA 
binding site. The carboxy-terminal region ofNDV N was found to be 
dispensable for the formation of the nucleocapsid particles and was postulated to 
playa regulatory role in N polymerisation (Kho et al., 2003), as seen for SeV 
(Curran et al., 1993) and recently with RSV (Murphy et al., 2003). 
The RPV genome is 15 882nt in length and consists ofa short 3' "leader" RNA 
region followed by coding regions for the six structural proteins. Each 
transcription unit is separated by defined stop-start sequence motifs and the 
genome ends with a short 5' "trailer" RNA region. The genome encodes, in a 3' 
to 5' order, the nucleocapsid protein, phosphoprotein, matrix protein, fusion 
protein, haemagglutinin protein and the large protein, (Baron & Barrett, 1995b), 
and this gene order is the same for all morbilliviruses (Rima et al., 1986), as 
outlined in figure 1.2.2.2. The F 5' untranslated region (UTR) located between 
the M and F open reading frames (ORFs) has been found to be GC-rich in MeV 
and RPV (Evans et al., 1990, Richardson et al., 1986). Furthermore, in 
morbilliviruses, this region has been shown to be specific to each virus type and 
is thought to be host specific (Meyer & Diallo, 1995), with evidence that it may 
function as a virulence factor in MeV (Valsamakis et al., 1998). 
In MeV, there is a transcription polarity which has been observed in vitro from 
the N gene towards the L gene meaning more copies of N are produced than of L 
(Horikami & Moyer, 1991); this has also been observed for RPV both in vivo and 
in vitro (Ghosh et al., 1996). Thus it is the position of the gene within the 
genome that determines the transcriptional level of each gene. 
12 
-w 
3' Leader 
sequence 
(55nt) 
N 
1692 
GIC rich region 
P/CIV M 
1658 1463 
F 
2370 
~ ~~\ . 
••• 
H 
1961 
L 
6646 
5' Trailer 
sequence 
(37nt) 
Figure 1.2.2.2. Diagrammatic representation ofthe genome organisation of rinderpest virus. The 
length of each gene in nuc leotides is given. The second gene is labelled P/CN, as the P gene encodes several prote ins; the P 
core protein and two non-structural proteins C and V. It should be noted that the black regions correspond to the untranslated 
sequence, which includes gene start, gene stop and intergenic motifs, these conserved motifs consist of at least 
"AAAACTTAGG(A/G)". The black regions also include poorly conserved untranslated regions at the 5' or 3' ends of each 
open reading frame . 
n 
::r' 
'" '0(0 
.., 
::s 
a 
0-
~ 
o· 
::s 
Chapter 1- Introduction 
1.3 Viral Replication 
1.3.1 Virus Entry 
Upon attachment of the virion to the host cellular receptor, mediated by the 
haemmaglutinin protein (Scheid et 01., 1972), the viral membrane fuses with the 
cellular plasma membrane at the neutral pH found at the cell surface, resulting in 
the release of helical nuc1eocapsids into the host cell cytoplasm. The H protein is 
a class II glycoprotein oftetrameric configuration, with a single N-terminal 
hydrophobic membrane anchor domain that is at exactly the same position for all 
morbillivirus H proteins (Blixenkrone-M011er et 01., 1996), a short cytoplasmic 
tail, and a large un conserved C-terminal extracellular domain, which is thought to 
playa role in host specificity (Blixenkrone-M0ller et 01., 1996). 
Until recently, little was known about the host cellular receptors of 
morbilliviruses, only the receptors for MeV were identified. SLAM (human 
signalling lymphocytic activation molecule, also known as CDwI50), has been 
shown to be a cellular receptor for Me V (Erlenhoefer et 01., 2001, Ono et 01., 
2001, Tatsuo et 01., 2000), whilst CD46, a complement regulatory protein, is the 
acknowledged receptor for vaccine strains of MeV such as the Edmonston and 
Halle strains (Dorig et 01., 1993). In contrast, recent evidence suggests that CD46 
can also act as the natural receptor for wild type MeV as primary clinical isolates 
were found to use CD46 as a receptor (Manchester et 01., 2000). The H protein 
of wild type MeV possesses CD46 binding residues and it has been postulated 
that wild type MeV interacts with SLAM with high affinity, but that it uses CD46 
as an additional low affinity receptor (Masse et 01., 2002). In a further 
development, recently published data show that MeV has as yet an unidentified 
third cellular receptor (Andres et 01., 2003, Hashimoto et 01., 2002); wild type 
MeV was shown to infect cells in the absence of SLAM and in the presence of 
CD46-blocking antibodies. In addition, subacte sclerosing panencephalitis 
(SSPE) strains of MeV have also been shown to enter cells in a SLAM- and 
CD46-independent manner (Shingai et 01., 2003). 
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It has been shown that a single codon in Me V H, an asparagine at residue 481, is 
important in determining the virus' ability to utilise CD46 as a receptor; when this 
residue changes from asparagine to tyrosine, an improvement is seen in the 
ability of the virus to utilise CD46 for entry (Schneider et al., 2002). 
Further research from the Japanese group that identified SLAM as a cellular 
receptor for MeV suggests that SLAM may act as common cellular receptor for 
the morbillivirus genus (Tatsuo et al., 2001). Three strains of canine distemper 
virus (CDV), including the Onderstepoort vaccine strain, and a strain ofRPV, 
have been shown to use SLAM as a cellular receptor. Furthermore, MeV, CDV 
and RPV were able to use SLAM of non-host species for virus entry (Tatsuo et 
al.,2001). However, data presented by this group is controversial, as wild type 
virus has not been used in these receptor studies. To truly identify 
uncharacterised receptors for viruses such as RPV and CDV, primary isolates of 
these viruses need to be studied, not viruses that have been passaged repeatedly in 
the laboratory to gain attenuation. It will be interesting to see if these results can 
be duplicated with wild type RPV and CDV. 
1.3.2 Transcription and Replication 
Both vesicular stomatitis virus (VSV) and Sendai virus (SeV) are model viruses 
used to study the transcription and replication of negative sense monopartite 
RNA viruses and are similar to RPV, except where noted. 
The initiation of both transcription and replication of negative sense monopartite 
RNA viruses requires the presence of promoter regions, which are usually 
untranslated regions at the termini of the viral genomes. Such promoter 
sequences are able to act in cis- with viral proteins of the polymerase complex to 
direct transcription and replication. The extragenic sequence at the 3' end of the 
viral genome is referred to as the leader region, whilst the sequence at the 5' end 
of the viral genome is termed the trailer region. RNA synthesis begins once an 
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active initiation complex is established at the polymerase entry site on the 3' 
terminal genomic leader region; transcription commences with the synthesis of a 
short unmodified (+)- strand leader RNA (Ghosh et al., 1996, Horikami & 
Moyer, 1991). The minimum unit with transcriptional activity is the 
encapsidated genome associated with the P and L polymerase complex for both 
VSVand RPV (Emerson & Schubert, 1987, Ghosh et at., 1995). The (+)-leader 
RNA is released at the junction of the leader region and the 3' proximal gene; and 
the polymerase resumes synthesis at the following gene start signal (Ghosh et al., 
1996, Horikami & Moyer, 1991). However recent studies with Se V and VSV 
have provided evidence to suggest that in vitro transcription and replication may 
initiate at separate sites on the viral genome (Whelan & Wertz, 2002, Vulliemoz 
& Roux 2002). 
Approximately the first sixteen nucleotides of the leader and the last sixteen 
nucleotides of the trailer are complementary (Baron & Barrett, 1995a), this is 
most likely to be due to the fact that the leader contains the viral genome 
promoter, whilst the trailer region contains the anti-genome promoter. In 
addition to these sequences, the related paramyxovirus SeV, also contains a 
promoter sequence element which is outside of the leader and trailer region, the 
"BBbox"(Blumberg et al., 1991), containing the motif (GNNNNN)J which is 
essential for replication (Tapparel et al., 1998). A similar motif has been shown 
to be important in Simian virus 5 (SV5) (Murphy & Parks, 1999) and RPV 
(Mioulet et al., 2001). 
Viral transcription units are transcribed sequentially by a stop-start mechanism 
that is guided by the conserved regions found at the start and the end of each 
transcription unit (Dickens et al., 1984); and it is the resulting mRNAs which 
direct the synthesis of each of the virus proteins. These elements include the 
gene start (GS) motif at the upstream border, the gene end (GE) motif at the 
downstream border of each gene, and the intergenic region located between GE 
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and GS. Located between the gene· boundaries are intergenic regions, which are 
highly conserved only in parainfluenzaviruses and morbilliviruses (Lamb & 
Kolakofsky, 1996) and for the genus Morbillivirus are three nucleotides in length 
and are either GAA or GCA or GAT (Baron & Barrett, 1995b). Studies using 
several members of the order Mononegavirales have shown that GE signals direct 
polyadenylation and termination of each mRNA, whilst GS signals direct 
initiation and capping (Barr et al., 1997, Hwang et aI., 1998, Kuo et a/., 1997, 
Kuo et a/., 1996, Rassa & Parks, 1999, Stillman & Whitt, 1997, Stillman & 
Whitt, 1999). It is possible for the polymerase to detach from the template when 
a gene end signal is reached. The polymerase complex must then re-attach at the 
promoter (3' end of the genome). This results in the transcription gradient seen in 
infected cells where products of distal viral genes are produced in lower quantity 
than those from genes located in closer proximity to the 3' genome terminus. 
Paramyxovirus mRNAs are capped at their 5' end and polyadenylated at the 3' 
end like eukaryotic mRNAs. Capping and polyadenylation are performed co-
transcriptionally by the VSV polymerase (Hercyk et al., 1988, Hunt et al., 1988, 
Hunt et a/., 1984); such specific functions for morbillivirus polymerases remain 
to be identified. Polyadenylation occurs through a stuttering mechanism, in 
which the polymerase slips back and copies the short polyuridylate tract at the 
end of each gene reiteratively. Reiterative copying or pseudotemplated 
transcription by the viral polymerase not only accounts for the synthesis of poly 
(A) tails but also for the different versions ofP mRNA which occur in all the 
paramyxoviruses except human parainfluenza virus 1 (hPIV -1) and the 
pneumoviruses (Hausmann et a/., 1999a, Hausmann et a/., 1999b, Lamb & 
Kolakofsky, 1996, Vidal et a/., 1990), see section 1.5. 
It was previously thought that the same polymerase complex was active in both 
transcription and replication, however it is now a more accepted view that the 
• Although it is common usage to use the term gene with these viruses for each transcription unit, 
some may find the term inaccurate as it may be thought that a gene should include a 
promoter/enhancer element, in addition to the coding region/transcription unit, while these viruses 
have a single promoter and multiple transcription units. 
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transcriptase and replicase comprise two distinct complexes composed of L-P2-3 
or L-P40r L2-Pg, and L-(N-P) (Curran etal., 1995a, Das etal., 1997, Tarbouriech 
et al., 2000a, Tarbouriech et al., 2000b). 
Once in replication mode, the polymerase synthesises without break, ignoring the 
gene stop signals, until the 5' end of the genome is reached and the polymerase 
complex is then released. Entry of the polymerase complex then occurs within 
the (+) - trailer region (i.e. the 3' end of the newly synthesised (+) (sense) copy of 
the genome) and this anti-genome serves as template for mUltiple rounds of 
genome synthesis. Newly synthesised genomic and anti-genomic RNA are never 
found as free RNA, but are always co-transcriptionally encapsidated with the 
nucleocapsid protein, forming RNAse resistant nucleocapsids (Baker & Moyer, 
1988). 
As in mRNA transcription, the minimum unit for replication is the nucleocapsid 
with attached P and L proteins (Horikami & Moyer, 1991). It has been found 
with Sendai virus (SeV) that the L does not directly interact with the 
nucleocapsid (Horikami & Moyer, 1995, Ryan & Portner, 1990), but that the P 
protein of SeV binds to the C-terminal domain ofN in order to position the 
polymerase onto the template (Buchholz et at., 1993, Curran et al., 1994, Ryan et 
al., 1993, Smallwood et al., 1994). The domains of MeV N required for 
interaction with P have been identified as two non-contiguous regions, amino 
acids 4-188 and amino acids 304-373, while deletion of amino acids 189-239 
were found not to affect N-P binding activity (Bankamp et al., 1996). Thus for 
MeV, the N oligomerisation and N-P interaction map to the same domain ofN, 
perhaps explaining why morbillivirus N proteins are so highly conserved over the 
first 400 amino acids (Baron & Barrett, 1995a, Baron & Barrett, 1995b, Diallo et 
al., 1994, Kamata et al., 1991, Rozenblatt et al., 1985). P is thought to unwind 
the N-RNA template, thereby facilitating the movement of L along the template 
RNA. Although recent research using the rubulavirus, hPIV -2, has shown both in 
vivo and in vitro that the Nand L proteins of this virus do indeed interact with 
one another, the function of this complex remains unclear (Nishio et al., 2000). 
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Studies using SeV mini-genome templates revealed that only RNA templates 
which were an exact multiple of six nucleotides in length were efficiently 
replicated (Calain & Roux, 1993). This provided functional evidence for the 
physical properties observed earlier by Egelman and colleagues (Egelman et al., 
1989), who by analysing negatively stained Se V nucleocapsids concluded that 
each N protein subunit was associated with approximately 6 nuc1eotides. "The 
rule of six" (Calain & Roux, 1993) predicts that each nucleocapsid protein 
associates with precisely six nuc1eotides and that templates are efficiently 
replicated only when their 3' ends are completely covered by terminal 
nucleocapsid proteins. Only Sendai virus genomes which are multiples of six 
nucleotides in length are found in nature (Hausmann et al., 1999a, Hausmann et 
al., 1996, Kolakofsky et al., 1998). 
The "rule of six" is also adhered to by Me V (Radecke et al., 1995, Sidhu et al., 
1995) and less stringently by the rubulavirus, Simian virus 5 (SV5) (Murphy & 
Parks, 1997). An exception to the rule for paramyxoviruses is that of respiratory 
syncytial virus (RSV), as non-hexamer genome analogs ofRSV are efficiently 
replicated by RSV polymerase (Samal & Collins, 1996). 
Encapsidation of nascent leader RNA is proposed to be the anti-termination 
mechanism that causes the polymerase to ignore the stop signal at the junction 
between the leader and the first gene (Blumberg et al., 1981). It is thought that 
the initiation of encapsidation of viral RNA by N probably involves the 
recognition of a specific leader RNA sequence (Das & Banerjee, 1992). It has 
been proposed that when unassembled N protein, which exists as a soluble N-P 
complex, accumulates in the cell the polymerase "switches" from mRNA 
transcription to replication mode (Banerjee & Barik, 1992, Blumberg et al., 1981, 
Patton et al., 1984). This idea of a "switch" is controversial and there is evidence 
with studies using RSV that an excess of un assembled N, or Nand P complexed 
together had no detectable effect upon the ratio ofmRNA transcription to 
replication (Feams et al., 1997). 
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Recent work with rabies virus has suggested that it may be the M matrix protein 
that may regulate the balance between transcription and replication modes (Finke 
et al., 2003), which contradicts a previous report of work with rabies virus that 
suggested it is N that regulates viral RNA transcription and replication, 
depending on its phosphorylation state (Yang et al., 1999). However, Wu and 
co-workers have recently shown that both transcription and replication levels are 
reduced when rabies N is not phosphorylated (Wu et al., 2002). When expressed 
alone, rabies N is phosphorylated and this is due to phosphorylation by cellular 
casein kinase II (Wu et al., 2003), which also phosphorylates VSV P (Barik & 
Banerjee, 1992). Another recently described possible mechanism for controlling 
the switch between transcription and replication involves the P protein of a 
rhabdovirus (Chandipura virus) that is closely related to VSV (Basak et al., 
2003). The proposal here is that as unphosphorylated P protein binds the nascent 
leader RNA it actively promotes readthrough of transcription termination signals 
and provides a bias for replication. This was shown when unphosphorylated P 
was overexpressed and the level of replication increased. When phosphorylated, 
the P protein is no longer able to bind to the leader RNA. The exact mechanism 
by which mRNA synthesis switches to genomic replication remains to be 
identified. 
1.3.3 Virus Assembly and Exit 
Both the F and H proteins are synthesised in the endoplasmic reticulum and 
transported via the exocytic pathway to the plasma membrane where the virus is 
assembled and from where it buds (Ali & Nayak, 2000). However, it has been 
demonstrated with Me V that the neither of these two surface glycoproteins are 
required for the budding process, with such a role proposed to be played by either 
the L, P, N or M proteins (Maisner et al., 1998). The M protein is now widely 
thought to be critical for virus assembly and budding and an important role for 
the morbillivirus M protein has been hinted at with studies using SeV. SeV M 
and hPIV-l M are known to interact with newly assembled nucleocapsids via the 
N subunit (Coronel et al., 2001, Mottet et al., 1999, Stricker et al., 1994), a 
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requirement for the incorporation of the nucleocapsid into the virion (Coronel et 
al.,2001). It has recently been shown that the M proteins of both SeV (Ali & 
Nayak, 2000) and MeV (Noll et al., 2001) interact with the glycoproteins F and H 
in the absence of any other viral proteins, demonstrating that the viral 
nucleocapsid is not an obligatory factor in Mlglycoprotein interaction. These 
data indicate that M could function as the central organiser of viral 
morphogenesis (Sanderson et al., 1994). This has now been confirmed, as 
mutations in cysteine residues of Se V M have been linked to altered viral 
morphology and disruption of the incorporation of the viral genome (Sakaguchi 
et al., 2003). Studies with SeV and MeV have shown that both F and M are able 
to drive the budding process (Cathomen et al., 1998b, Spielhofer et al., 1998, 
Takimoto et al., 2001) and that M is necessary for maturation of virus into 
particles (Inoue et al., 2003). Furthermore, it has been shown with Me V, that 
viruses lacking the M protein are severely disabled when it comes to forming 
MeV particles containing the RNP complex (Cathomen et al., 1998a), providing 
further evidence that MeV M interacts with the ribonucleocapsid, as previously 
proposed by Hirano and co-workers (Hirano et aI., 1993). In addition, more 
extensive cell-cell fusion was seen with cells infected with the M-Iess MeV 
indicating that M may playa role in regulating cell to cell fusion (Cathomen et 
al., 1998a). MeV M is thought to exert this effect through its interaction with the 
cytoplasmic tail of F, an interaction which may regulate the fusogenicity of F 
(Cathomen et al., 1998b). 
The budding of the new virus particle occurs from the apical surface of the host 
cell and it has been known for sometime that this process utilises the host cell 
protein tubulin (Moyer et al., 1986). In addition there is evidence to suggest that 
both SeV (Takimoto et al., 2001) and MeV (Tyrrell & Norby, 1978) use actin 
during the budding process. Most other cellular proteins are selectively excluded 
from the matured virions during budding, indicating that specific protein:protein 
interactions occur. 
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1.4 Phospho- (P) Protein 
The P gene of RPV encodes several proteins (Baron et al., 1993, Ghosh et al., 
1996, Haas et al., 1995 , Yamanaka et al., 1992); the P core protein and two non-
structural proteins, C and V, which are discussed in sections 1.5 and 1.6. The P 
protein is the only P gene product essential for viral RNA synthesis (Baron & 
Barrett, 2000, Radecke & Billeter, 1996, Schneider et al., 1997) being very 
versatile and playing many roles within the life cycle of the virus. The 
paramyxovirus P protein is a modular protein with two distinct functional 
domains; the carboxy-terminal domain, which is highly conserved, possesses all 
regions required for viral transcription, whilst the amino-terminal domain 
provides additional functions required for replication (Curran, 1996, Curran et al., 
1995b). Paramyxoviral P proteins are highly phosphorylated, with the maj ority 
of the phosphorylation sites of MeV P residing within the amino-terminal portion 
of the protein (Das et al., 1995). 
The P protein ofSeV has been shown to be a tetramer (Tarbouriech et al., 2000a) 
and RPV P is known to self-associate, to bind both monomeric and polymeric N 
protein to form the nucleocapsid complex (Shaji & Shaila, 1999), in addition to 
forming the polymerase with L (Sweetman et al., 2001). The interaction ofP 
with unassembled N protein prevents N from assembling into nucleocapsids in 
the absence of the nascent RNA and this function has been mapped to nine amino 
acids at the amino-terminus of Se V P (Curran et al., 1995b). Furthermore, it is 
the interaction ofP from the polymerase complex with the N component of the 
nucleocapsid that enables the binding of the polymerase to the RNA template 
(Horikami & Moyer, 1995). Many ofthe functions of P are thus mediated 
through its interaction with N. The P protein of MeV has been shown to regulate 
the efficiency with which the N protein assembles into nucleocapsids (Spehner et 
al., 1997), and N-P and Pop interactions have also been confirmed in other 
paramyxoviruses (Bankamp et al., 1996, Harty & Palese, 1995, Paul et al., 1988, 
Slack & Easton, 1998, Takacs et al., 1993). The carboxy-terminal half of the 
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morbillivirus P protein is far more conserved than the amino-terminal domain 
(Baron et al., 1993). It is therefore interesting that both the amino- and carboxy-
terminal domains of RPV P are required for interactions with N, but only the 
carboxy-domain is required for interactions with itself (Shaji & Shaila, 1999), 
mimicking earlier findings of MeV P (Harty & Palese, 1995, Liston et al., 1995). 
The carboxy terminus of Me V P is known to bind L for the formation of the 
polymerase (Liston et al., 1995) and it is thought that one of the functions of P is 
to ensure the correct folding of the L protein. A similar finding was recently 
observed for the pneumovirus, Bovine respiratory syncytial virus (Khattar et al., 
2001) and the rubulavirus hPIV-2 (Nishio et al., 2000). In contrast, the L binding 
site of rabies virus is located in the first 19 residues of P (Chenik et al., 1998). 
Furthermore, it is known that the P, N and L binding domains of Se V P do not 
overlap (Bowman et al., 1999, Smallwood et al., 1994). 
An additional function of Me V P is that it has been found to retain N in the 
cytoplasm and prevent its transport to the nucleus, as a result of specific 
interactions between itself and N; co-expression of N with either M or H resulted 
in no such cytoplasmic retention of N (Huber et al., 1991). Se V P is thought to 
act as a chaperone for the monomeric N protein during the nascent chain 
assembly step of genome replication (Curran et al., 1995b). 
1.5 Production of Non-structural Proteins, C, V and W 
The P genes of many paramyxoviruses are known to encode multiple proteins. In 
addition to the P protein, the morbilli virus P gene also produces three additional 
proteins, C, V and W. The C protein is generated from a separate translation start 
site. This is as a result of leaky scanning by ribosomes, which enables the first 
AUG codon to be skipped and the second AUG of the mRNA to be accessed, 
allowing the initiation of the translation of the C protein (Baron et al., 1993, 
Bellini et al., 1985) (see figure 1.5.1). The V and W proteins are generated by a 
pseudotemplated transcription mechanism which allows access to alternate 
reading frames within the P coding region (Cattaneo et al., 1989, Thomas et al., 
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1988). The co-transcriptional addition of one non-templated G residue at the 
editing site in the mRNA causes a frameshift within the P ORF resulting in the 
synthesis of the V protein, whilst the addition of two non-templated G residues 
results in the synthesis of the W protein (Baron et al., 1993, Ghosh et al., 1996). 
The editing site is a highly specific, conserved region of sequence located at 
approximately the centre of the P ORF, that is identical for RPV, CDV, MeV, 
DMV and PDV (Baron et al., 1993, Blixenkrone-M011er et al., 1992, Cattaneo et 
al., 1989, Ghosh et al., 1996). The V protein thus has an amino-terminus which 
is identical to that of the P protein, and a different cysteine rich carboxy-terminus 
(Baron et al., 1993) (see figure 1.5.1). The W protein, which is present in only 1-
2% of transcripts (Baron et al., 1993) consists essentially of the amino-terminal 
halfofP. 
The C, V and W proteins are termed non-structural as they have yet to be found 
in purified virions, but they could still be critical for viral replication. The V 
protein ofRPV has been shown to be distributed uniformly throughout the 
cytoplasm and nucleus in infected cells (Sweetman et al., 2001), while the C 
proteins of both MeV and RPV have been shown to co-localise with N in the 
cytoplasm of infected cells (Bellini et al., 1985, Sweetman et al., 2001). 
1.6 Possible Roles of the Non-structural Proteins 
1.6.1 Roles in Transcription and Replication 
Studies with Me V have shown that C and V are both accessory factors required 
for efficient virus replication in transgenic mice (Valsamakis et al., 1998), with 
evidence that they are likely to operate via separate mechanisms (Patterson et al., 
2000). In addition, mutant rinderpest viruses lacking both C and V have been 
shown to replicate sub-optimally (Baron & Barrett, 2000). The RPV C knockout 
virus showed impaired growth in vitro in addition to a reduction in viral mRNA 
synthesis, whilst the V knockout resulted in a virus with a large syncytium-
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inducing phenotype and it also displayed increased levels of both viral genome 
and anti-genome RNAs (Baron & Barrett, 2000). 
Previous studies have found that RPV C self-associates in high molecular weight 
aggregates independent of other viral proteins and, in addition, RPV C and V 
proteins were found to associate with L (Sweetman et al., 2001), the significance 
of which remains to be determined. Interestingly, the SeV C protein has been 
shown to inhibit viral replication in vitro, by complexing with the L protein 
subunit of the polymerase (Tapparel et al., 1997). It is therefore possible that the 
interaction between RPV C and L may playa similar role; however, it should be 
noted that there is a total lack of sequence similarity between Se V C and RPV C, 
suggesting that they may interact with L in different ways. Se V C functions as a 
promoter-specific inhibitor of viral RNA synthesis and as a fidelity factor by 
increasing the specificity of the 3' genomic promoter and, by doing so, limits the 
extent of replication (Cadd et al., 1996, Horikami et al., 1997, Tapparel et al., 
1997). More selectivity is generated as C proteins accumulate during infection, 
although this inhibitory effect of C can be reversed by the overexpression of P 
(Tapparel et al., 1997). The first 98 amino acids of Se V C have been shown to be 
unnecessary for this down-regulation of RNA synthesis (Kato et al., 2001). The 
binding of C to L does not affect L-P binding and indicates that not only are the C 
and P binding sites on L different, but that C is able to interfere with RNA 
synthesis by direct action on L (Cadd et al., 1996, Horikami et al., 1997). To 
date no specific functional region of C has been identified, although recent 
sequence analysis ofSeV C indicates that the carboxyl two thirds of the C protein 
are of functional importance (Fujii et al., 2001). 
The V protein is expressed in almost all members of the sub-family 
paramyxovirinae, unlike the C protein, which is not expressed in the 
rubulaviruses, as reviewed in (Lamb & Kolakofsky, 1996). Another distinction 
between the V and C proteins is the fact that, unlike the V proteins, which share a 
highly conserved cysteine-rich carboxy terminal domain, the C proteins share no 
conserved motifs or regions of sequence. The only exception to this appears to 
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be the C proteins of morbilli viruses which possess a conserved motif of 
approximately 15 amino acids in the central portion of the protein (M. Baron, 
personal communication). The V proteins ofRPV (Baron & Barrett, 2000), MeV 
(Patterson et al., 2000) and SeV (Kato et al., 1997) are known to be non-essential 
for virus replication and are thought to encode a "luxury function" required for 
in vivo pathogenicity. Alignment of the carboxy-terminal sections unique to 
paramyxovirus V proteins revealed that seven cysteine residues, whose positions 
are well conserved among all the V proteins, form a "zinc-finger"-like motif 
(Liston & Briedis, 1994, Nakamura et al., 1999). Further, it has been shown that 
this carboxy-terminal domain of the MeV V protein binds zinc and this metal 
binding activity is highly specific to zinc (Liston & Briedis, 1994). RPV V has 
been shown to interact with N (Sweetman et al., 2001), the function of which 
remains to be determined, but may be similar to that of Se V V (Horikami et al., 
1996) and Me V V (Tober et al., 1998) which are known to interact with 
unpolymerised N to regulate viral RNA synthesis. This interaction is hardly 
surprising as the amino terminal domain ofP, which is shared with V, contains 
the N binding site for MeV (Harty & Palese, 1995). V has been proposed to 
inhibit genome replication by interfering with either the formation or the use of 
the N-P encapsidation complex (Horikami et al., 1996), whilst Kato and co-
workers (Kato et al., 1997) have proposed that Se V V protein may function in 
conjunction with host cellular factors to regulate transcription. Alternatively, it 
may be that the recently discovered interaction of V with L is responsible for 
regulating viral transcription (Sweetman et al., 2001). 
Data therefore suggests that the roles of these accessory proteins in the viral life 
cycle are specific to each genera of virus within the sub-family paramyxovirinae. 
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1.6.2 Roles in Innate Immune Resistance 
The C and V proteins ofparamyxoviruses are known to interact with several host 
cellular proteins to modulate the host cell environment and interfere with the host 
immune response and, again, the roles of these proteins varies with the genus. 
The V proteins of the rubulaviruses SV5 (Didcock et 01., 1999b) and mumps 
virus (Kubota et 01.,2001) are known to target STAT-l (signal transducer and 
activator of transcription-I) for proteasome-mediated degradation, whilst the V 
protein of hPIV -2 targets STAT -2, rather than STAT -1 for degradation (Parisien 
et 01.,2001). The V protein of MeV also functions to inhibit the host cell IFN 
response (Takeuchi et 01.,2003), by' actively inhibiting the phosphorylation of 
both STAT -1 and STAT -2, suggesting that the effect is on a particular kinase 
rather than the STA Ts. Furthermore, the V protein of the recently emergent NiV 
was shown to counteract the host cell interferon (lFN) response (Park et 01., 
2003b), with V acting to inhibit cellular IFN responses by forming aggregates 
with, and retaining in the cytoplasm, both STAT -1 and STAT -2 (Rodriguez et 01., 
2002). More recently it has been shown that the V protein ofNDV not only 
functions as an alphalbeta interferon antagonist (Park et 01., 2003b), but that it 
also plays an important role in host range restriction by blocking innate host 
defences in a species specific manner (Park et 01., 2003a). This corroborated 
previous work with SV5 which revealed that a single amino acid substitution at 
residue 100 in V, from asparagine to aspartic acid, determined the virus' ability to 
block the IFN response in either human or mouse cells (Young et 01.,2001). 
Wild type SV5 is unable to block the IFN response in murine cells, but is able to 
block IFN signalling in monkey, human and canine cells (Didcock et at., 1999a). 
On the other hand, for SeV, it has been found that it is the C protein which 
interacts with cellular proteins to interfere with the interferon response produced 
by SeV infected cells (Garcin et 01.,2000, Gotoh et 01., 1999, Kato et 01.,2001). 
Furthermore, Kato and co-workers recently demonstrated that the amino-terminal 
portion of SeVe is not required for this function (Kato et 01., 2002), providing 
experimental data to support the hypothesis of Fuji and co-workers that the 
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carboxyl two thirds of the C protein are of functional importance (Fujii et al., 
2001). The four C proteins ofSeV all interact with STAT-I to prevent IFN 
signalling through the JAKISTAT pathway (Garcin et al., 2000). In addition to 
the V protein, the putative C and W proteins ofNiV are also known to block the 
host cell IFN response (Park et al., 2003b). 
The V protein of Simian virus 5 (SV5) is known to slow progression of the cell 
cycle, via interaction with a host cell protein (DDB1, Damaged DNA Binding 
Protein 1), showing that V, like C, appears to be a multifunctional protein (Lin & 
Lamb, 2000, Lin et al., 1998). 
1.7 Large (L) Protein 
The RNA-dependent RNA polymerase of mono partite negative-strand RNA 
viruses consists of two virus-encoded subunits, the P protein and the L protein, 
the latter being the largest virus structural protein. L is approximately 240 kDa in 
size and is the least abundant component in the nucleocapsid, with approximately 
50 copies per virion (Lamb et al., 1976), correlating with the fact that it is 
encoded by the most distal gene from the promoter. All L proteins of 
non segmented negative strand RNA viruses have a large net positive charge, are 
large in size (-245 kDa), have an unusually high leucine and isoleucine 
compostition and short regions of high basicity which may be vital for the 
interaction of L with the RNA template (Barik et al., 1990). Low levels of L 
expression are necessary for efficient viral replication, with high levels of L 
inhibiting replication in vitro for both VSV (Meier et al., 1987) and SeV (Gotoh 
et al., 1989). 
The L gene of RPV is identical in length to that of the Me V L, and sequences of 
L are highly conserved amongst members of the genus Morbillivirus (McIlhatton 
et al., 1997). Recent work with MeV L proteins from both wild type virus and 
vaccine strains of virus indicate that amino acid substitutions in the L protein may 
playa role in attenuation of the virus (Bankamp et al., 2002). This confirms 
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earlier work which looked at MeV attenuation, where they found that amino acid 
changes in the L protein and the C and V proteins were responsible for tissue 
culture attenuation resulting in impaired levels of transcription (Takeda et al., 
1998). 
The L subunit of the polymerase complex acts as a multifunctional enzyme and is 
thought to be responsible for all catalytic activities necessary for viral RNA 
synthesis (Horikami et al., 1994), including initiation, elongation, termination, 
capping, methylation and polyadenylation. Studies with VSV and SeV have 
confirmed that polyadenylation, methyltransferase, capping and kinase activities 
are associated with the L protein (Einberger et al., 1990, Gupta et al., 2002, 
Hammond et al., 1992, Hercyk et al., 1988, Horikami & Moyer, 1982, Hunt & 
Hutchinson, 1993). Formation of a complex between Land P is vital for these 
processes (Hamaguchi et al., 1983). Furthermore, a 2'-O-ribose (cap 1) 
methyl transferase domain has recently been identified in the L protein of all 
mononegavirales (Bujnicki & Rychlewski, 2002, Ferron et al., 2002). 
A difference in the properties of the polymerase complexes ofparamyxoviruses 
and rhabdoviruses is emerging in the literature. In the case of Se V (Horikami et 
al., 1992, Smallwood et al., 1994) and MeV (Horikami et al., 1994), co-
expression ofP and L in the same cell must occur for the polymerase complex to 
form, yet this is not necessary for either VSV (Canter & Perrault, 1996) or for 
rabies virus (Chenik et al., 1998). The L proteins ofSeV (Smallwood et al., 
1994) and MeV (Horikami et al., 1994) are unstable unless they are co-expressed 
with P. To form the stable polymerase complex, the amino-proximal domain of 
L is involved in the interaction with P in both Me V and SV5 (Horikami et al., 
1994, Parks, 1994), while for VSV, the carboxy-terminal domain of L is required 
for interaction with P (Canter & Perrault, 1996). 
It is widely acknowledged that there are several motifs that are unique to 
poiymerases. All polymerases which exhibit RNA template specificity have been 
shown to possess four highly conserved motif sequences designated A, B, C and 
D which define the "polymerase module" (Poch et al., 1989) and this has been 
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confinned for the RPV L protein (Baron & Barrett, 1995b). These major motifs 
include a proposed RNA binding region (Motif A), the QGDNQ-containing 
region proposed to be the active site of the polymerase and the proposed purine 
nucleotide binding site (both found in Motif C) (Poch et ai., 1990, Poch et ai., 
1989, Tordo et ai., 1988). The structural shape of a polymerase is often thought 
of as a right hand with domains that resemble the finger, palm and thumb regions 
ofa human hand. The four conserved A, B, C and D motifs ofpolymerases are 
thought to constitute the palm and part of the fingers of the polymerase active 
site, into which the template locks. As the template binds the polymerase it is 
thought that the finger and thumb regions clamp the template into position, as 
reviewed by O'Reilly and Kao (O'Reilly & Kao, 1998). 
Analysis of available RNA-dependent-RNA polymerase sequences show that 
they possess the same conserved motifs in the same order, even though the degree 
of sequence conservation along their length is poor (Barik et ai., 1990, Feldhaus 
& Lesnaw, 1988, Poch et al., 1990, Poch et al., 1989, Tordo et al., 1986, Tordo et 
al., 1988, Volchkov et al., 1999), thus indicating a common evolutionary 
ancestor. There exists a high degree of sequence conservation between 
paramyxoviral and fiIoviral L proteins (Galinski et al., 1988, Volchkov et al., 
1999), which is seen to a lesser extent with members of the rhabdoviridae family 
(Barik et ai., 1990, Le Mercier et ai., 1997). yet apart from these conserved 
motifs, no homology exists between the polymerases of the segmented 
bunyaviruses and the non-segmented paramyxoviral or rhabdoviral L proteins 
(Elliott, 1989). The QGDNQ motif is found in almost all mononegavirales 
polymerases; in NiV, HeV and Tupaia paramyxovirus (TPMV) the Q following 
the GDN tripeptide is replaced by an E (Harcourt et ai., 2001) while the 
rhabdovirus infectious hematopoietic necrosis virus (IHNV) has a V residue at 
this position (Bjorklund et al., 1995). 
Building on previous observations (Barik et al., 1990, Feldhaus & Lesnaw, 
1988), a sequence alignment and comparison study of L proteins of five 
monopartite negative-strand RNA viruses within the paramyxovirus and 
rhabdovirus families revealed highly conserved amino acids clustered into six 
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domains along the length of L, joined by variable regions (Poch et al., 1990), as 
outlined in figure 1.7.1 on seven aligned sequences. The enzymatic functions of 
the polymerase are thought to be located within the conserved domains of L, 
thereby resembling a "chain of enzymes". 
Domain I is mainly composed of hydrophobic residues, but most importantly it 
contains a very rare invariant tripeptide, "GHP", at positions 428-430, its rarity is 
due to its low frequency in the protein database, according to the Claverie and 
Bougueleret cataloguing method (Poch et al., 1990). The significance of this 
remains unknown, although the histidine residue is positioned in such a way that 
it may be involved in some enzymatic activity (McIlhatton et al., 1997, Poch et 
al., 1990). 
Domains II and III are dominated by the presence of charged amino acids and it 
is thought that this is where the polymerase module of the L protein is located 
(Muller et al., 1994, Poch et al., 1990). Domain II commences at position 578 
and from position 618 onwards it contains a central highly conserved stretch very 
rich in basic amino acids, which form a "KEKE (hydrophobic) K" motif. It is 
thought that this region may contain the RNA binding site in the form of an 
amphiphilic a-helix (Poch et al., 1990) and it is found in all L proteins of 
paramyxovirinae and filoviridae (Miihlberger et al., 1992, Takimoto et al., 2000). 
Domain III is the most highly conserved out of the six proposed domains and 
includes the fou~ highly conserved motifs as identified in Poch et al., 1989, thus 
indicating a key functional role for domain III. The conserved pentapeptide 
"QGDNQ" is known to be required for cation (Mg2+ or Mn2+ or Ca2+) co-
ordination and is similar to the "GDD" motif of other such RNA dependent 
polymerases (Blumberg et al., 1988, McIlhatton et al., 1997, Muller et al., 1994, 
Poch et al., 1990). GDD and LDD motifs are highly conserved amongst 
DNAIRNA polymerase proteins and have been postulated to form, or be part of, 
the active site of an ancestral RNA polymerase from which other polymerases 
have evolved (Kamer & Argos, 1984). 
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Domain 4 
Domain 5 
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Figure 1. 7.1. Representation of the six conserved domains of the L protein, as proposed by Poch et aI., 
1990. Positions of identity in all or most sequences are shaded red. Positions of similarity are shaded pink. The sequences shown are 
of parainfluenza virus type 2 (P12 ), simian virus 5(SY5), RPY, meas les virus (MY), CDY, SeY, human parainfluenza virus type 3 (PI3). 
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Domain IV is very rich in invariant proline residues and contains four of these, 
whilst domain V contains numerous cysteine and histidine residues, which are 
generally associated with metal-binding sites, though it has no recognisable 
motifs (Cortese et al., 2000, Poch et al., 1990). It has recently been shown that 
the amino acid residues located in domain V of Se V L are important for various 
stages of viral transcription and replication (Cortese et al., 2000). 
Domain VI is the more variable of these identified clusters and possesses a 
"GXGXG" motif, which is conserved and located at an approximate position of 
amino acids 1951-1955. Upstream of this motif there is a lysine-rich sequence 
that together with the GXGXG motif forms part of an ATP-binding site, which is 
common in protein kinases (Poch et al., 1990). It has recently been postulated 
that domain VI contains a methyltransferase domain rather than an NIP binding 
site (Ferron et al., 2002). In addition, this more variable region of the L protein 
has been proposed to contain the sequence for specialised functions developed by 
individual viruses to increase their host cell specificity and individual 
characteristics. Recent studies with SeV have shown that even a 10 amino acid 
deletion in the carboxy terminal domain of L results in defective RNA synthesis, 
with longer truncations in this region further abolishing all activity, thus 
demonstrating the essential role of the carboxy terminal domain of L for both 
RNA transcription and replication (Smallwood et al., 2002). 
The variable regions located between some of these domains are thought to have 
functions also. The region located between domains II and III, and the region 
between domains III and IV have been postulated by Poch et al. (Poch et al., 
1990) to mediate an optimal co-operation between the functional domains. It has 
also been recognised that these variable regions ofL proteins in both 
paramyxoviruses and rhabdoviruses are very similar in length. However, the 
region between domains II and III, despite always being very hydrophilic, varies 
considerably in its composition in these two families of virus (Poch et al., 1990), 
thus conservation of a function becomes less likely. Point mutations in the 
un conserved region between domains V and VI result in a series of unexpected 
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defects in the function of the polymerase (Horikami & Moyer, 1995, Hunt & 
Hutchinson, 1993). 
Extensive domain mutation analyses in Se V L have failed to identify the function 
of any individual domain (Chandrika et 01., 1995, Cortese et 01.,2000, Feller et 
01.,2000, Horikami & Moyer, 1995). Recent studies with SeV have shown that 
mutations of conserved residues in domains II and III of L do not affect P binding 
and the majority resulted in the inactivation ofSeV mRNA synthesis and leader 
mRNA synthesis (Smallwood et 01., 2002). Two of the mutations, at positions 
736 and 741, resulted in no protein being expressed at all, demonstrating that the 
stability of the protein was compromised (Smallwood et 01., 2002). 
McIlhatton and co-workers (McIlhatton et 01., 1997) investigated the L proteins 
of morbilli viruses and rejected Poch et 01. 's (Poch et 01., 1990) six domain 
hypothesis, proposing that, for this genus, there were in fact two regions of poorly 
conserved sequence along the length of L, which separated three highly 
conserved domains. These two regions were referred to as "hinges" and, like the 
variable regions located between Poch's six domains, were thought to be flexible 
and enable optimal co-operation between the conserved domains, see figure 1.7.2. 
In addition to the catalytic activities related to RNA synthesis, the polymerase of 
VSV possesses two blocks of sequence, one in domain II and the other in domain 
V, which show significant similarity to the catalytic domains of tyrosine-specific 
protein kinases (McClure & Perrault, 1989). Furthermore, the VSV New Jersey 
L protein has been shown by the analysis of A TP-binding sites present in 
transcription complexes ofVSV to possess Mg2+_ dependent ATP-utilising 
serine/threonine protein kinase activity (Hammond et 01., 1992). Like VSV L 
(Sanchez et 01., 1985), Se V L has been shown to be a specific kinase for the 
phosphoprotein (Einberger et 01., 1990), with SeV L also phosphorylating N 
(Einberger et 01., 1990). VSV L of the Indiana serotype has been shown to 
possess two consensus A TP binding sites similar to the motif found in protein 
kinases (Massey & Lenard, 1987). 
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protein as proposed by Mcllhatton et ai., 1997. Mapped on to Morbillivirus sequence alignments. 
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1.7.1 Interaction of L with Host Cell Proteins 
Both MeV Land VSV L have been shown to interact with the host cell protein 
tubulin, which is known to be required for RNA synthesis of MeV, SeV and VSV 
(New Jersey strain) (Moyer et 01., 1990, Moyer et 01., 1986). In contrast no such 
interaction was observed in similar studies using Se V L (Moyer et 01., 1990). 
Actin is known to be required for the transcription of not only hPIV-3 (De et 01., 
1993), but also RSV (Burke et 01., 1998). More recent work with RSV has 
demonstrated that another host cellular protein, profilin, is required for the 
optimal transcription ofRSV (Burke et 01.,2000), but this function ofprofilin 
required the presence of actin. 
In addition to binding tubulin, the L protein of the prototype of non-segmented 
negative strand RNA viruses, VSV, has recently been found to bind another host 
cell protein. The RNA-dependent RNA polymerase ofVSV associates with 
translation elongation factor- 1 a(3y, via the L protein, an association that is 
required for its activity (Das et 01., 1998). Prior to this finding only tubulin was 
known to be required for the RNA polymerase activity of any monopartite 
negative sense RNA viruses. 
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1.8 Aims of Project 
The aims of this study are to: 
1. Determine which of the three conserved "domains" of L interact with proteins 
P, C and VofRPV. By determining the regions ofL to which the P, C and V 
proteins bind, it is hoped that the functional regions of L will be further 
elucidated. In addition, such binding studies will serve to provide 
information of the functional basis of the interaction of both C and V with L, 
depending upon with which region of L they associate. 
2. Investigate the interaction of L with host cell proteins suspected to be 
involved in viral transcription (actin, tubulin, profilin, elongation factor-1-
alpha, guanyl-transferase). It has been postulated that the L proteins of 
members of the order monegavirales interact with host cell proteins. To 
determine if this is the case for RPV, a yeast two-hybrid library screen will be 
undertaken using L as the bait plasmid and a porcine macrophage cDNA 
library. It is hoped that any such interactions will thus be detected using this 
popular system for identifying novel protein:protein interactions. 
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Chapter 2- Methods 
For a list of all solutions used in this chapter, please refer to Appendix I, and for 
a list of all primary antibodies used, please refer to Appendix 2. In addition, all 
primers utilised can be found in Appendix 3 and plasmid maps are located in 
Appendix 4. 
2.1 Cell Lines 
2.1.1 Tissue Culture 
Vero (African green monkey kidney) cells were passaged when confluent and 
split 116. Cells were maintained using Dulbecco's modified Eagle's medium 
(DMEM) with 25mM HEPES buffer (Central Service Unit - CSU) containing 5% 
fetal calf serum (FCS), penicillin (lOOU/ml) and streptomycin sulphate 
(100J.lglml). 
Cos-1 (African green monkey kidney, expressing the simian virus 40 (SV40) 
large T antigen) cells were passaged before con fluency was achieved and split 
116. Cells were maintained as described for Vero cells. 
A549 (immortalised human type II alveolar epithelial) cells were passaged when 
confluent and split 1110. Cells were maintained as described for Vero cells and 
Cos-1 cells. 
B95a (Marmoset B-Iymphoblastoid cells transformed with Epstein Barr virus 
(EBV» cells were passaged when confluent and split 113. Cells were maintained 
using RPMI 1640 medium with Glutamax-l and 25mM HEPES buffer (GIBCO-
Invitrogen), containing 10% FCS, penicillin (lOOU/ml) and streptomycin sulphate 
(lOOJlglml). 
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2.1.2 Bacterial Cells 
Either E.eoli JMI09 (genotype: e14-, (MerA-), reeAI, endAI,gyrA96, thi-l, 
hsdRl7, (rK- mK+), supE44, relAI, t1(lae-proAB), [F', traD36,proAB, 
lacflZLiM15]) or E.coli DH5a. (genotype: deoR, endAl, gyrA96, hsdR17(rk-mk +), 
recAI, relAI, supE44, thi-l, t1(lacZYA-argFVI69), ~O&'acZt1MI5, F, A) 
bacterial cells were used for all transformations except where specified, and 
cultured in Luria Bertani broth (LB). E.coli BNN132 (genotype: (Cre+ strain), 
endAl, gyr96, thi, hsdR17, supE44, relAI, Li(lac-proAB), (F', traD36,proAB+, 
laclqUM15), (A., Kan-Cre)) bacterial cells were used to prepare the plasmid form 
of the pig macrophage cDNA library by in vivo recombination. Bacterial cells 
were stored as glycerol stocks at -70°C. 
Either E.coli KC8 (genotype: hsdR, leuB600, trpC9830, pyrF::Tn5, hisB463, 
lacLi¢74, strA, ga/U, galK) electrocompetent bacterial cells (BD-Clontech) or 
E.coli HBIOI (genotype: F, hsdS20, (rB-, mB-), thi-l, supE44, aral4, ga/K2, 
lacYl,proA2, rpsL20, (StrR), xyl-5, mtl-l, recA13, mcrB, leuB6) were used for 
attempts on the cloning of plasmid DNA isolated from yeast AH109 cells. The 
HB 101 cells were stored as glycerol stocks at -70°C, whilst electrocompetent 
KC8 cells were stored at -70°C in I OOJ..lI aliquots, as supplied by Clontech. 
2.1.3 Yeast Cells 
Either the Y190 ( genotype: MA Ta, ura3-52, his3-D200, lys2-80 1, ade2-1 01, 
trpl-901,leu2-3, 112,gaI4.1.,ga/80.1., URA3 :: GALluAS-GALlTATA-lacZ, eyhT2, 
L YS2 : : GALuAs-HIS3TATA-HIS3) (Flick & Johnston, 1990, Harper et al., 1993) 
or AHI09 (genotype: MATa, trpl-901, leu2-3, 112, ura3-52, his3-200,gaI4.1., 
gal80.1., LYS2: : GALl uAs-GALlTATA-HIS3, GAL2uAs-GAL2TATA-ADE2, 
URA3 : : MEL! uAs-MELl TATA-lacZ) (James et al., 1996) strains of 
Saccharomyces cerevisiae cells were used for all yeast transformations and 
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cultured using YEPD broth. Yeast strains were stored as glycerol stocks at -70°C 
and propagated on YEPD agar plates at 30°C when required for use. 
2.2 DNA Techniques 
Standard DNA techniques were perfonned according to methods found in 
Sambrook et al., third edition (Sambrook & Russell, 2001), except as specified 
here. 
2.2.1 Polymerase Chain Reaction (PCR) 
2.2.1.1 Plu peR 
Pfu, a proof-reading enzyme, was the enzyme of choice when the PCR product 
generated was to be used in the production of a new construct. The exact 
sequence was therefore vital and no errors were pennitted. 
Into a sterile 0.5ml microfuge tube, the following components were placed and 
the final volume made up to 50111 with DEPC-treated water: 
5111 of lOX Pfu buffer (Stratagene) 
1111 of each of the required primers (1 Opmol/Ill) 
1111 of 10mM dNTP's (1 OmM in each dNTP) 
0.5111 of Pfu enzyme (Stratagene) 
lOng of template DNA 
The program below was followed for the generation of desired coding regions of 
RBOK sequence. 
Step 1 
Initial denaturation at 95°C for 1 minute 30 seconds 
Step 2 
Denaturation and disruption at each cycle at 95°C for 30 seconds 
Step 3 
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Annealing of the melted primers to the template DNA at 50°C for 30 seconds 
Step 4 
Extension time at 72°C. The time depended upon the length of the desired 
sequence being amplified (approximately 1 minute 30 seconds for each kb). 
Step 5 
29 times to step 2 
Step 6 
Cooling of PCR product to 4°C for 10 minutes 
Step 7 
End of PCR run 
PCR products were checked on an analytical 0.8% agarose gel in TBE buffer 
(45mM tris-borate, 2mM EDTA), to ensure that the correct size of product had 
been amplified. Reaction products were stored at -20°C until required. 
2.2.1.2 Taq peR 
Taq polymerase was used for PCRs where the absolute accuracy of the product 
generated was not critical, for example during the screening of yeast colonies 
from the yeast two-hybrid system library screen. In this instance we were only 
verifying that there was a plasmid present in the crude DNA preps. In addition to 
this, PCR with Taq is more resistant to any contaminants present in the DNA 
preps and also to a higher load of DNA than PCR with Pfu. 
For all Taq reactions the same conditions were used as for Pfu reactions, the only 
difference being the actual components within the reaction tube and an annealing 
temperature of 55°C was used in place of the 50°C used with Pfu; this was due to 
the different primers being used. Into a sterile O.5ml microfuge tube, the 
following components were placed and the final volume made up to 50J.11 with 
DEPC-treated water: 
5J.11 of lOX Taq buffer (Invitrogen) 
1.5 J.1150mM MgCh (Invitrogen) 
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2~1 of each of the required primers (lOpmoV~1) 
1~1 ofl0mM dNTP's (10mM in each dNTP) 
0.5~1 of Taq enzyme (Invitrogen) 
1 ~l yeast plasmid DNA (prepared as in section 2.4.5) 
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The PCR products were then checked on an analytical 0.8% agarose gel in TBE 
buffer, to determine the size of product amplified. Reaction products were then 
stored at -20°C until required. 
2.2.2 Restriction Digests 
For each analytical digest 2~1 of "mini-prep" DNA was taken and digested by 1 
unit of the appropriate restriction enzyme(s) in a final volume of I O~l, using an 
appropriate buffer for the enzyme or enzyme combination being used. The 
reaction mix was incubated for a period of 1 hour at the optimum temperature for 
the restriction enzyme used, normally 37°C. The total digest volume, with 2~1 of 
5X loading buffer (20% (w/v) Fico1l400, 5mM EDTA, 0.05% bromophenol blue, 
0.03% xylene cyanol), was then run on a 0.8% agarose gel in TBE buffer for 1 
hour at 120 volts to analyse the products of digestion. 
For each preparative enzyme digest, 3-5~g of DNA were taken into a final 
volume of 50~1 containing 10 units of the appropriate restriction enzyme, the 
appropriate enzyme buffer (l X) and BSA (I ~g1~I). The reaction mix was 
incubated for a period of at least 3 hours at the optimum temperature for the 
restriction enzyme(s) used. After this incubation period, 1.5 ~l of the digest were 
run on a 0.8% agarose gel in TBE buffer for 1 hour at 120 volts to confirm 
complete digestion. Digested DNA fragments, with shrimp alkaline phosphatase 
(2.2.3) treatment where required, were purified on a 0.8% low melting point 
(LMP) agarose gel in T AE buffer (40mM tris-acetate, 1 mM EDTA) overnight at 
20 volts. 
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2.2.3 Shrimp Alkaline Phosphatase (SAP) Treatment 
Plasmid vectors required for ligations needed to be treated with shrimp alkaline 
phosphatase after digestion. This was to prevent re-circularisation of the plasmid 
by removing the phosphate group present at the 5' ends of the freshly digested 
DNA. After the preparative digest was checked on a 0.8% agarose/TBE gel, 
there were 48.5).11 of the digest left. To this remaining volume IJll of SAP (l U) 
and 5.5 Jll of lOX SAP buffer were added. The reaction mix was incubated at 
37°C for 20 minutes and then at 65°C for 20 minutes. The vector was purified on 
a 0.8% LMP agarose gel in T AE buffer overnight at 20 volts. 
2.2.4 Extraction of DNA from Agarose Gels 
Restriction digests of DNA were run on a preparative 0.8% LMP gel. The 
required DNA band was excised from the gel, using a sterile scalpel, and 
transferred into a sterile microfuge tube. DNA was extracted from the agarose 
using one of the two methods described below. 
2.2.4.1 "Freeze-Squeezing" DNA 
The bands of DNA were placed at -70°C for at least 20 minutes. The gel slice 
was "smashed" using an oocyte smasher and 400).11 of buffer-saturated phenol 
(BioGene Limited) added. The sample was vortexed for at least 30 seconds to 
produce an emulsion. The gel matrix had to be thoroughly collapsed at this stage. 
The mixture was quick frozen at -70°C for at least 10 minutes and centrifuged 
for 15 minutes at room temperature at 13 200rpm (using an Eppendorf5415D 
centrifuge with a F45-24-11 rotor). The top aqueous layer was next transferred to 
a fresh microfuge tube and phenol extracted once more, by adding an equal 
volume of buffer-saturated phenol. The sample was then extracted once using an 
equal volume of phenol-chloroform. The DNA was precipitated by adding 1I1Oth 
volume of 3M sodium acetate (pH 5.2) and 2.5 volumes of ethanol (-20°C) and 
leaving on ice for at least 10 minutes. The sample was centrifuged for 15 minutes 
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as before and the pellet washed with Iml of70% ethanol, before being re-spun 
for 5 minutes. The ethanol was removed and the pellet dried. The pellet was 
resuspended in -20ll] TEg (IOmMTris/CI pH 8.0, ImM EDTA pH 8.0) and the 
DNA quantitated, as in section 2.2.5, on an analytical 0.8% agarose gel in TBE 
buffer. 
2.2.4.2 DNA Extraction Using Purification Columns 
DNA was extracted from agarose using GFX columns from the "GFX PCR DNA 
and Gel Band Purification Kit" (Amersham Biosciences). Extractions were 
carried out according to the manufacturer's protocol and guidelines. 
2.2.5 Ligations in Agarose 
LMP agarose slices containing the vector and insert required were melted at 70°C 
for 10 minutes in a waterbath. 2JlI of molten agarose from each sample was run 
on a 0.8% agarose/TBE gel and quantitated by comparing the brightness of bands 
achieved alongside AlII DNA markers (EcoRIIHinDIII digested). A molar ratio 
of 3: I, insert:vector, of the DNA fragments in molten agarose was combined at 
37°C, with sterile distilled water where required, in a total volume of 10Jll. This 
was then made up to a final volume of20JlI in IX ligase buffer (Prom ega) 
containing I unit ofT4 DNA ligase. These 20Jllligations were then incubated 
overnight in a 15°C waterbath. 
2.2.6 Ligations of Extracted DNA 
DNA was extracted from LMP agarose as described above. Eluted DNA (2Jll) 
was quantitated on a 0.8% agarose/TBE gel and quantitated by comparing the 
brightness of bands achieved alongside AlII DNA markers (EcoRIIHinDIII 
digested). A molar ratio of3:1, insert:vector of the DNA fragments was 
combined, with sterile distilled water where required, in a total volume of 10Jll. 
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This was then made up to a final volume of201l1 in IX ligase buffer (Prom ega) 
containing 1 unit ofT4 DNA ligase. These 20lliligations were then incubated 
overnight in a 15°C waterbath. 
2.2.7 Preparation of Competent Bacterial Cells 
A modification of the technique described by Chung and Miller (Chung & Miller, 
1988), was used for this method. 
A 2ml culture of bacterial cells was grown up overnight in SOB at 37°C. This 
culture was then diluted 11200 with LB and incubated until the required 00600 
was achieved (0.1-0.15 for DH5as and HB101s, and 0.25-0.35 for JM109s). 
Cells were harvested by centrifugation at 2 500rpm for 10 minutes (using an IEC 
Centra GP8R centrifuge with a 218 rotor), the supernatant discarded and the 
pellet resuspended in 1I10th original volume of TSS (LB broth containing 10% 
PEG 3350 or 8000, 20mM MgS04, 5% tissue culture grade DMSO). The 
bacterial cells were left on ice for at least an hour, after which they were ready for 
transformation. 
2.2.8 Transformation of Competent Bacterial Cells 
The 20lliligations were heated at 70°C for 10 minutes (if ligations were 
performed in agarose), diluted to 200lli with 1.1 X TCM (11 mM TrislCI pH 7.5, 
11 mM MgCh, 11 mM CaCh) and chilled on ice. Competent cells (200IlI) were 
added to each ligation. The ligation components were mixed gently by flicking 
the microfuge tube and incubated on ice for one hour after which time the cells 
were heat shocked for 2 minutes in a 45°C waterbath. The samples were returned 
to ice for 5 minutes before adding O.6ml SOC (SOB containing 20mM glucose) 
to each tube. The tubes were then incubated at 37°C, with shaking, for one hour 
and the 1ml final volumes were plated out on LB/amp (lOOIlg/ml ampicillin) 
selection plates and incubated at 37°C overnight. 
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2.2.9 Transformation of E.coli Bacterial Cells with Extracted Yeast 
Plasmid DNA 
2.2.9.1I1BI0l Cells 
Glass bead/phenol-chloroform extracted AHI 09 DNA (5JlI), as described in 
section 2.4.5, or "Yeastmaker" extracted AH 109 DNA (1 JlI), as in section 2.4.6, 
was placed in a sterile ice-cold 15m} centrifuge tube (Falcon). To each tube, 
100Jl} of competent HB 10 I cells (prepared as 2.2.7 or gift of L. Goatley) were 
added and mixed gently by pipetting up and down. Samples were incubated on 
ice for 30 minutes and then heat shocked for 90 seconds at 42°C, before 
incubating on ice for a further 2 minutes. SOC (900JlI) was added to each tube 
and samples incubated at 37°C, on a shaker set at 200rpm, for 1 hour. Samples 
were then spun for 5 minutes at 2 500rpm (using an Eppendorf 5415D centrifuge 
with a F45-24-11 rotor), the supernatant discarded and cells were resuspended in 
200JlI of I X M9 salts, thereby removing all residual traces of leucine. The total 
volume was plated out onto M9 salts -Leucine/amp (ampicillin at 50Jlg/ml) agar 
selection plates and incubated for 2-S days at 37°C. 
2.2.9.2 DHSa Cells 
Either SJlI of glass bead/phenol-chloroform extracted AHI 09 DNA or IJlI of 
"Yeastmaker" extracted AHI 09 DNA were transformed using chemically 
competent (TSS method) DHSa cells. The yeast plasmid DNA was made up to 
200JlI with 1.1X TCM and the transformation protocol followed was identical to 
that described in section 2.2.8. The DH5a's were prepared as described in 
section 2.2.7. 
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2.2.10 Preparation of Electrocompetent Bacterial Cells 
Two 250ml cultures of the required cell type were grown up in LB at 37°C on a 
shaker until an OD600 of 0.5-0.6 was obtained. Cells were chilled on ice for 15 
minutes and spun in a pre-chilled centrifuge at 6 OOOrpm for 20 minutes (using a 
Sorvall SLA 1500 GSA rotor). The supernatant was discarded and cell pellets 
washed twice with 250ml ice cold double distilled water (DDW). Cell pellets 
were harvested by discarding the supernatants and resuspended in 50ml ice cold 
sterile 10% glycerol and spun as above for 10 minutes only. The supernatant was 
then discarded and final cell pellets resuspended in 500J..lI ice cold 10% sterile 
glycerol. The final cell mixtures were ali quoted out into 40J..lI volumes and stored 
at -70°C until required. 
2.2.11 Transformation of Yeast Plasmid DNA Using 
Electrocompetent Bacterial Cells 
The required number of electrocompetent cell aliquots were thawed on ice, 1 
aliquot was required for each transformation for the home-made electrocompetent 
cells. For the electrocompetent KC8 cells (Clontech), 1 aliquot was sufficient for 
5 transformations and the Clontech electroporation protocol guidelines were 
followed in full. Final celVDNA mixes were plated out on LB/amp (ampicillin at 
100J..lg/ml). To electroporate the HBI0l cells we used a BioRad electroporator 
set at 2SJ..lF, IS00hm and 2.SkV using cuvettes with a 2mm gap. The cuvettes 
and pipette tips used were all pre-chilled. To the aliquot ofHBl0ls, the required 
amount of DNA was added and mixed by gently pipetting up and down. The 
contents were then electroporated and immediately after pulsing, 0.9ml of SOC 
was added to the cuvette, which was placed on ice. Total transformation mixes 
were incubated for one hour on an orbital shaker set at 37°C, before being plated 
out onto M9 salts -Leucine/amp (ampicillin at SOJ..lg/ml) plates and incubated for 
2-5 days at 37°C. 
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2.2.12 Plasmid Mini-Preps 
The technique used here was a modification of the technique described by Zhou, 
(Zhou e/ al., 1990). 
Using a sterile cocktail stick, a single colony was picked from the LBI Amp agar 
selection plate and used to inoculate a 2ml LB/amp overnight culture (ampicillin 
at 1 OO~glml). One ml of this overnight culture was transferred to a sterile 
microfuge tube and spun at 13 OOOrpm for 30 seconds (using an Eppendorf 
5415D centrifuge with an F45-24-11 rotor). All but approximately 80~1 of the 
supernatant was removed and the bacterial cell pellet resuspended by vortexing. 
After this, 300J,l1 of TENS solution (1 OmM TrislCl, 1 mM EDT A, 0.5% SDS, 
0.1 M NaOH) were added and the samples were vortexed for at least 5 seconds. 
This was followed by the addition of 150111 of 3M sodium acetate (pH 5.2), after 
which the sample was again vortexed for at least 5 seconds. The samples were 
centrifuged at 13 OOOrpm for 3 minutes, as above, and the supernatant transferred 
to a fresh microfuge tube. One ml of ethanol (-20°C) was added and the samples 
were re-spun at 13 OOOrpm for 3 minutes. The supernatant was removed and the 
resulting pellet washed with 70% ethanol and vacuum dried. The final pellet was 
dissolved in 40J,l1 ofTEg containing RNAse A at a final concentration of 25J,lglml 
and either analysed immediately or stored at -20°C until required. 
2.2.13 Plasmid Midi-Preps 
30ml cultures of the required transformed bacteria were grown up in selective 
medium (LB/Amp - ampicillin at a concentration of 1001lglml) on a 37°C shaker 
overnight. Cultures were then harvested and the "Qiagen midi-prep kit" used 
according to the manufacturer's protocol and guidelines. 
49 
Chapter 2- Methods 
2.2.14 Plasmid Maxi-Preps 
200ml cultures of the required transfonned bacteria were grown up in selective 
medium (LBI Amp - ampicillin at a concentration of lOOflglml) overnight. The 
following morning, cultures were centrifuged in 250ml Sorvall pots for 10 
minutes at 7 OOOrpm (using a Sorvall RC5B+ centrifuge and a Sorvall SLA 1500 
GSA rotor). The supernatant was discarded and the resulting bacterial cell pellet 
resuspended in 10ml of maxi-prep solution 1 (TEg) and left at room temperature 
for 5 minutes. Maxi-prep solution 2 (O.2M NaOH, 1 % SOS) was then added 
(20ml), the preparation mixed gently and incubated on ice for 5 minutes. After 
this, 15ml of maxi-prep solution 3 (for 100ml: 60ml5M potassium acetate, 
11.5ml glacial acetic acid, 28.5ml ~OW) were added, followed by incubation on 
ice for 15 minutes. Preparations were centrifuged at 15 OOOrpm for 10 minutes 
(using a Sorvall RC5B+ centrifuge and a Sorvall SLA 1500 GSA rotor). The 
supernatant was decanted through a layer of Miracloth (Calbiochem) into a fresh 
centrifuge pot and 40ml of isopropanol added. After being left at room 
temperature for 20 minutes, DNA was pelleted by centrifugation for 10 minutes 
at 15 OOOrpm, as before. Supernatants were discarded and the resulting pellets 
washed with 70% ethanol. The wash was then removed and the pellet re-
dissolved in 8ml ofTEg. 
To this TEIDNA mix, exactly 8g ofCsCI were added and dissolved. Ethidium 
bromide (400fll at 10mglml- Sigma) was then added to each preparation and the 
whole volume transferred to a 5/8" x 3" polyallomer "QuickSeal" tube 
(Beckman). The DNA solutions were overlayed with mineral oil, balanced and 
heat-sealed. The tubes were then either centrifuged overnight at 55 OOOrpm, at 
20°C, or they were centrifuged over the weekend at the same temperature, but at 
a speed of 50 OOOrpm (using a Beckman L8-70N ultrafuge and a Beckman 70.1 ti 
rotor). 
After ultracentrifugation the CsCI gradients were unloaded by clamping the tube 
and using an 18g needle and a 2ml syringe to remove the lower red band of DNA. 
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This band of DNA was transferred to a 15ml Falcon tube and made up to a 
volume of 2m I with TE8. DNA was extracted 4-6 times, or until the aqueous 
phase was clear, with equal volumes of isoamyl alcohol to remove the ethidium 
bromide. After the last extraction, the aqueous layer was removed from under the 
. isoamyl alcohol layer and transferred to a 50ml Falcon tube. DDW (6ml) and 
ethanol (16ml) were then added to each sample. Samples were then left at -20°C 
for at least an hour before being centrifuged at 2 500rpm for 30 minutes (using an 
IEC Centra GP8R centrifuge with a 218 rotor). The supernatant was discarded 
and the resulting pellet washed with 70% ethanol and re-centrifuged at 2 500rpm 
for 30 minutes, as before. The supernatant was again discarded, the pellet dried 
and re-dissolved in 200JlI of TEg• 
The concentration and purity of the DNA produced was then measured by taking 
a series of OD readings on the spectrophotometer, at wavelengths of 260, 280 and 
320nm. The 260:280 ratio provided a measure of the purity of the DNA 
obtained, whilst the 260 reading provided the amount of ON A produced, once 
mUltiplied by the dilution factor, and then multiplied by 50 (as 1 00260 is equal to 
50Jlg/mlofDNA). 
2.2.15 Sequencing 
Sequencing of ON A was performed using either T7 polymerase or by cycle 
sequencmg. 
2.2.15.1 Sequencing Using T7 Polymerase 
Sequencing of DNA with T7 polymerase was performed using the dideoxy-
mediated chain termination method as originally described in (Sanger et al., 
1977). This technique was then modified as described in (Kristensen, 1988) and 
as outlined below. 
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For each reaction 2-3J.lg of plasmid DNA, in a volume of 18J.lI, were denatured 
using 2J.lI of 2M NaOH at room temperature for 5 minutes. DNA was 
precipitated by the addition of 75J.lI 100% ethanol and 3J.l14M NH4Ac (pH 5.2). 
The sample was incubated on ice for a minimum of 10 minutes and centrifuged 
for 10 minutes in a microcentrifuge at 4°C, at 13 OOOrpm. The supernatant was 
aspirated and the pellet washed with 100J.lI 70% ethanol. The sample was 
centrifuged for 5 minutes in a microcentrifuge at 4°C, at 13 OOOrpm. The 
supernatant was then aspirated and the DNA pellet dried. The pellet was 
dissolved in a mix of 1 OJ.lI water, 2J.lI annealing buffer (1 M Tris/CI pH7.6, 
100mM MgCh, 160mM DTT) and 2J.lI primer (5pmoVJ.lI) and incubated for 30 
minutes at 37°C to anneal the primer and DNA. The sample was then briefly 
centrifuged to collect all of the reaction in the bottom of the tube. To the 
annealed primerlDNA, 6J.lI of the following reaction mix were added: 2J.lI diluted 
T7 polymerase (1:4 dilution using manufacturer's enzyme dilution buffer), 3J.lI 
'A' labelling mix (1.375J.lM each dCTP, dGTP, and dTTP, 333.5mM NaCl) and 
1 J.lI diluted e5S] dA TPaS label (approximately 5J.lCi/J.lI, a I: 1 dilution with 
water) and incubated at room temperature for 5 minutes. During this 5 minute 
incubation period, 4 x 4.5J.lI of the reaction mix were transferred into separate 
wells on aU-bottomed 96 well plate. Then 2.5 J.lI of the appropriate termination 
mix (either A, C, G or T) were placed on the side of each well. The plate was 
sealed and centrifuged until a speed of 2 OOOrpm was reached and then 
immediately stopped. The plate was incubated for 5 minutes at 37°C. Then, to 
each well, 5J.lI of stop solution (0.3% each bromophenol blue and xylene cyanol 
FF, 10mM EDTA pH 7.5, 97.5% deionised formamide) were added and the plate 
tapped gently on the bench surface to ensure that the contents were mixed and the 
reaction stopped. 
Samples were either stored at -20°C until required, or immediately heated at 
75°C for a period of 3 minutes prior to being loaded onto a 6% acrylamide/8M 
urea gel. For each sequencing reaction, 1.5J.lI were loaded per 3mm well and IX 
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TBE was used as buffer. Electrophoresis was carried out at 72 watts for 2-3 
hours. The gel was dried and exposed directly to X-ray film. 
2.2.15.2 Cycle Sequencing 
These sequence reactions were performed using the "CEQ 8000 Dye Terminator 
Cycle Sequencing with Quick Start kit" according to the manufacturer's protocol 
and guidelines (Beckman Coulter). Reactions were analysed on a CEQ 8000 
Capillary sequencer, using the Beckman Coulter software for base calling. 
2.2.16 Transfections 
Eukaryotic cells were grown overnight in six well plates at the required seeding 
density (Vero cells at 3x105/well, Cos-I and A549 cells at 5xl05/well and .B95a 
cells at a 113 split from confluent). 
2.2.16.1 Using Transfast Transfection Reagent· 
For each 35mm well, 0.7ml ofOptimem I (GIBCO) was used in addition to the 
relevant amount of plasmid DNA being transfected and the corresponding 
quantity of Transfast (TF) reagent. TF reagent was used according to the 
manufacturer's protocol (Promega). For Cos-I, A549 and B95a cells, 3J..lI ofTF 
reagent were used for every microgram of plasmid DNA used, whilst for Vero 
cells, 6J..lI ofTF were used for every microgram of plasmid DNA. 
TFIDNAlOptimem I mixes were made up in 7ml polystyrene bijoux, vortexed 
thoroughly and incubated at room temperature for 15 minutes. During this 
incubation period, the cells were washed twice with I ml per well of Optimem I. 
After the removal of the final wash, the TFIDNAlOptimem I mix was added to 
the cells and incubated at 37°C for 2 hours. After this, l.3ml of pre-warmed 
complete medium were added to each 35mm well and the cells incubated at 37°C 
for 48 hours. 
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2.2.16.2 Using Lipofectin Transfection Reagent 
This protocol was usually used after the cells had first been infected for one hour 
with either fowlpox T7 virus or vaccinia vTF7-3 virus, see 2.2.17. 
For each 35mm well, 10JlI of lipofectin were combined with 90JlI of Optimem I 
and incubated at room temperature for 45 minutes. The relevant amount of 
plasmid DNA was then diluted in Optimem I to a final volume of 100Jll. The 
DNA mixture was combined with an equal volume of LipofectinJOptimem I mix, 
mixed thoroughly by pipetting up and down, and then incubated for 10 minutes at 
room temperature. After this incubation period, the mixture was added to the 
required well and 0.5ml of Optimem I added. Cells were incubated at 37°C for 
between 5 and 6 hours after which time 2ml of the relevant pre-warmed medium 
were added to each 35mm well. Cells were then incubated for either 18 or 42 
hours at 37°C. 
2.2.17 Transient Expression System 
Cells were grown overnight in six well plates at their required seeding densities. 
The cells were washed once using 1 ml Optimem I per 35mm well. Each well 
was infected using 40JlI offowlpox T7 virus (FPT7: titre 10-7.9 TCID50/mi on 
chick embryo fibroblasts) in 400JlI ofOptimem lor 55JlI vaccinia vTF7-3 (108 
TCIDsolml on baby hamster kidney cells) in 500JlI of serum free DMEM and 
incubated at 37°C for 1 hour, with rocking at 10 minute intervals. The inoculum 
was removed from the cells, which were then treated as in the transfection 
protocol, except that cells were used after overnight incubation where vTF7-3 had 
been used. 
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2.3 Protein Techniques 
2.3.1 Immunofluorescence 
The required cells were grown overnight on coverslips, seeded at their relevant 
density. Cells were transfected using the desired method with the constructs of 
interest. Either one or two days after transfection, the cells were washed three 
times using 2ml PBS-E (Ca/Mg free PBS) and fixed using 2m13% 
paraformaldehyde (PFA), incubating for a period of20 minutes at room 
temperature in a tissue culture cabinet. Cells were washed a further three times 
with 2ml PBS-E. At this point, the PFA was quenched with 2ml50mM NH4CL 
in PBS-E for 10 minutes at room temperature. Again the cells were washed three 
times using 2ml PBS-E. After this stage, the cells were opened for internal 
staining using 2ml 0.5% Triton X-IOO in PBS-E (5 minutes at room temperature). 
The cells were then washed three times with 2ml PBS-E and either incubated in 
2ml 0.2% PBS-gelatin for a period of 5 minutes, or 2ml 0.2% PBS-gelatin 
containing 5% normal goat serum for 30 minutes, to block non-specific binding. 
The cells were now ready for staining with the primary antibody, which was first 
diluted to the correct concentration in blocking solution. The diluted primary 
antibody (25J..lI) was placed on a strip of para film, which was located in a moist 
chamber. The coverslip was then placed cell side down on top of this drop of 
antibody for 30 minutes at room temperature. At the end of this incubation 
period, excess PBS was pipetted under the coverslip in order to break the surface 
tension thereby allowing the coverslip to float up. The coverslip was transferred 
to either fresh PBS-gelatin or PBS-E and left for 5 minutes at room temperature. 
Cells were washed twice for a period of 5 minutes each using 2ml PBS-E before 
a final 5 minute wash using 2ml PBS-gelatin, or washed for 5 minutes four times 
with 2ml PBS-E. The secondary antibody was then diluted to the correct working 
concentration in blocking solution, and the coverslip was incubated in the moist 
chamber as described for the primary antibody. 
55 
Chapter 2- Methods 
After this incubation with the secondary antibody, cells were washed twice for 5 
minutes with PBS-E. Again the cells were washed, using 2ml PBS-E containing 
2J..ll Hoechst 33258 stain (O.5mglml) before being washed once more using 2ml 
PBS-E for 5 minutes. 
Coverslips were rinsed in DDW, excess water removed with pieces of Wh atm an 
No 1 filter paper and the coverslips mounted on slides using 20J..lI of Mowiol 
(Calbiochem). Alternatively, after the secondary antibody incubation, cells were 
washed four times for 5 minutes each with PBS-E and mounted using Vectashield 
mounting medium with DAPI stain (Vector Labs). 
Mowiol mounted slides were allowed to set at room temperature for at least 45 
minutes before being viewed under the microscope using the relevant 
magnification and filters. For epifluorescence microscopy, images were captured 
using a Nikon Eclipse E800 microscope together with Openlab softwar« 
(lmprovision) and for confocal microscopy, single slice images were captured 
using a Leica SP2 confocal microscope and the Leica software provided with the 
microscope. 
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2.3.2 Preparation of SDS-PAGE Gels 
2.3.2.1 Laemmli Gels 
These gels were run using the buffer system as described in (Laemmli, 1970). 
Resolving Gel Stacking Gel 
8% 12% 
40% (w/v) Acrylamidelbis 
37:1 ratio (Sigma) 8ml 12ml 2ml 
3M Tris pH 8.8 5.6ml 5.6ml 
1M Tris pH 6.8 Iml 
Water 26ml 22ml 12.8ml 
TEMEO 20/l1 20/l1 8/l1 
10% SOS O.4ml O.4ml 160/l1 
20%APS 100J.lI 100/l1 60/l1 
Using the above table, gel mixes (acrylamide/waterlbuffer/TEMEO) for the 
relevant percentage gel and the stacking gel were made simultaneously. APS and 
SOS were added to the resolving gel mix and poured into a casting tank to the 
desired level. Water-saturated N-butanol (l00/ll) was added to each side of the 
gel to form an overlay, which kept the surface of the resolving gel flat. The gel 
was allowed to set at room temperature for one hour. Once set, the N-butanol 
was poured off and the gel surface rinsed thoroughly with water. SOS was then 
added to the stacking gel mix, swirled to mix, and 500J.lI of this were used to give 
the top of each running gel a final rinse. APS was added to the stacking gel mix, 
the solution swirled once more to mix contents and the gel mix added to fill the 
space above the running gel to the top of the casting tank. Combs were inserted 
and the gel left to set for a further hour at room temperature. 
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Once set, the combs were removed and excess stacking gel removed with a 
scalpel. Wells were rinsed thoroughly with water and the gel(s) placed in a 
running stand and the running buffer (0.1 % SDS (w/v), 1.44% glycine (w/v), 
0.3% Tris base (w/v)) added. Gels were run at a constant current of 18rnA per 
gel until the dye front had run off the bottom of the gel. 
2.3.2.2 Tricine Gels 
Tricine gels were run using the buffer system as described in (Schagger & von 
Jagow, 1987). 
40% (w/v) Acrylamidelbis 
37:1 ratio (Sigma) 
3M Tris/CI buffer pH 8.4S 
Water 
TEMED 
Glycerol 
10% SDS 
20%APS 
Resolving Gel 
7.62Sml 
10ml 
8.01Sml 
lOJlI 
4g 
O.3ml 
SOJlI 
Stacking Gel 
1.2Sml 
3.1ml 
7.96Sml 
10JlI 
0.12Sml 
SOJlI 
Using the above table, gel mixes (acrylamide/waterlbuffer/TEMED) for a 10% 
tricine resolving gel and stacking gel were made simultaneously and gels were 
made as described in section 2.3.2.1. Gels were run using different buffers for 
the anode (0.2M Tris, pH 8.9) and the cathode (1% SDS (w/v), O.IM Tris, O.1M 
Tricine, pH 8.2S). Gels were first run for one hour at 30 volts and 70rnA, and 
then at ISO volts and 30mA until the dye front was about a em from the bottom of 
the gel. 
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2.3.3 Western Blot 
Prepared protein samples were run on either Laemmli gels or Tricine gels as 
described above. After running the relevant gel, the stacking gel was removed 
from the resolving gel using a scalpel and the proteins transferred to Immobilon-P 
membrane (Millipore) using the method of (Towbin et at., 1979). Following 
transfer, membranes were blocked in blocking solution (5% (w/v) Marvel in Tris-
buffered saline containing 0.1 % Tween 20 (w/v) (TBS-T» either at 4°C 
overnight, or for 1 hour at room temperature on a rocker in an open topped box. 
The membranes (protein side in) were then placed in a 50ml Falcon tube with the 
relevant primary antibody at the current working concentration in 5ml blocking 
solution and incubated for 1 hour at room temperature on a Spiramix (Denley). 
After this incubation period with the primary antibody, membranes were washed 
twice for 30 seconds and twice for 10 minutes in TBS-T in an open box with 
agitation at room temperature. Membranes were then incubated with the required 
secondary antibody, as described for the primary antibody. Secondary antibodies 
were HRP-conjugated sheep anti-mouse, or donkey anti-rabbit 
(AmershamlPharmacia). At the end of this one hour incubation period, 
membranes were washed as before in TBS-T. The membranes were then 
incubated for 5 minutes at room temperature with "SuperSignal West Pico 
Chemiluminescent Substrate" (Pierce), before being exposed to photographic 
film. 
2.3.4 Metabolic Labelling of Transfected Cells and 
Immunoprecipitation 
Transfected cells were washed once using MetlCys-free Eagle's medium and 
starved for two periods of 30 minutes using 2ml pre-warmed MetlCys-free 
Eagle's medium at 37°C. Cells were labelled at 37°C, for one hour, in O.5ml (per 
35mm well) ofMetlCys-free Eagle's medium containing 5-10J..lI eSS]-Promix 
(Amersham). Label was removed from the cells and the cells washed once with 
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MetJCys-free medium without label. All liquid waste was disposed of as 
radioactive waste in the appropriate manner. Labelled cells were lysed for 5 
minutes in 0.5ml per well NP40 lysis buffer (1 % NP40, O.l5M NaCI, 50mM 
Tris/CI pH 7.5, 2mM EDTA) containing either 0.5mM PMSF or protease 
inhibitor cocktail set III (Calbiochem) at a final dilution of 11200. Celllysates 
were transferred to sterile microfuge tubes and spun at 13 OOOrpm for 30 minutes 
at 4°C. Supernatants were then transferred to fresh tubes and incubated with the 
required amount of the appropriate antibody overnight at 4°C, with rotation. 
The following morning, 30111 of protein G-Sepharose were added to each tube 
and incubated at 4°C, with rotation for 30 minutes. All tubes were then briefly 
microfuged at 6 500rpm (Eppendorf 5415D centrifuge, F45-24-11 rotor), to 
harvest the agarose. Supernatants were stored at -20°C in fresh tubes for possible 
further extractions. The resulting agarose pellets were washed four times with 
0.5ml wash buffer A (0.2% NP40, 10mM Tris/Cl pH 7.5, 150mM NaCl, 2mM 
EDTA) and once with O.5ml of wash buffer C (lOmM Tris/Cl pH 7.5). 
After the final washing, 40111 ofSDS-PAGE sample buffer were added to each 
sample. This buffer consisted of: 16.5111 3X sample buffer (New England 
Biolabs), 5111 0.5M DTT (dithiothreitol) and 18.5111 DDW, per sample. Samples 
were immediately vortexed and heated for 5 minutes at 95-100°C. All samples 
were re-vortexed and microfuged briefly at 6 500rpm (as before), to pellet the 
agarose. 
At this stage samples were either stored at -20°C until required for loading onto a 
gel, or 15111 of each sample was immediately run on the appropriate type ofSDS-
PAGE gel (Laemmli or Tricine) as described above. The SDS-PAGE gel was 
then soaked in 1 M sodium salicylate (50mt) for 20 minutes and then placed on 
3MM Whatmann filter paper and dried. Once dry, the gel was exposed either to 
photographic film (Kodak) at -70°C overnight in a lightproof cassette, or to a 
phospho-imaging screen in a lightproof cassette for 3 hours at room temperature. 
After exposure, either the film was developed, using a Compact X4 X-Ograph, or 
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the phospho-imaging screen scanned with a personal molecular imager FX (Bio-
Rad). Ifweak signals were obtained then the exposure times were increased 
accordingly. 
2.3.5 Yeast Protein Isolation 
Transformed yeast cells were set up as I.Sml cultures, under selection for the 
plasmid of interest, for 2-3 days at 30°C, on a shaker set at 2S0rpm. Cells were 
microfuged at 2 600rpm for S minutes, and the resulting cell pellet resuspended in 
0.2SM NaOWl % 2-mercaptoethanol (1 ml) and chilled on ice for 10 minutes. 
Trichloroacetic acid (0.16ml of a 50% stock solution) was then added to each 
sample, the contents mixed by vortexing and the samples were again chilled on 
ice for 10 minutes. Samples were then centrifuged for 5 minutes at 14 OOOrpm 
(Eppendorf 541SR centrifuge, F4S-24-11 rotor) and the supernatant discarded. 
Ice cold acetone (1 ml) was then added to each sample and the cell pellet 
resuspended by vigorous vortexing. The samples were microfuged once more at 
14 OOOrpm for 5 minutes, the supernatant was removed and the pellet left to air 
dry. The resulting pellets were resuspended in 200111 of SDS sample buffer 
(114111 DDW, 661l13X SDS sample buffer (New England Biolabs), 20111 O.SM 
DTT). Samples were immediately vortexed and heated for IS minutes at 9S-
100DC. All samples were re-vortexed and microfuged briefly at 6 SOOrpm, to 
place the contents at the bottom of the tube. Samples were then used for Western 
blot analysis, as in section 2.3.3. 
2.3.6 In vitro Transcription/Translation 
These reactions were performed using the "TNT Quick Coupled 
Transcription/Translation System" kit (Promega) according to the manufacturer's 
protocol and guidelines. 
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2.3.7 Dual-Luciferase Reporter Assay System 
Reactions were performed using this reporter assay kit (Promega) according to 
the manufacturer's protocol and guidelines. 
2.4 Yeast Two-Hybrid System 
2.4.1 Growing Stocks of Pig Macrophage cDNA Library 
The porcine macrophage eDNA library was converted from A ACT into plasmid 
form by automatic subcloning (in vivo recombination) using 10xP/cre-
recombinase technology (Durfee et al., 1993, Elledge et al., 1991). Cre 
recombinase fuses together 10xP sites (ere recognition sites) that flank the 
plasmid portion of A ACT when transferred to ere-expressing E.coli BNN132 
cells. 
BNN132 cells were plated on LB/Kanamycin (Kanamycin at 25~g/ml) and 
incubated overnight at 28°C. The next day, a 20ml culture of the fresh BNN132 
cells in LB + 40~g/ml kanamycin, 0.2% maltose, 10mM MgClz, was set up and 
incubated on a shaker at 28°C overnight. The overnight culture was spun down 
at 1 800rpm for 5 minutes (using an IEC Centra GP8R centrifuge with a 218 
rotor) and cells re-suspended in 1 ml 10mM MgClz. The 00600 was measured and 
the culture diluted with lOmM MgClz to an OD600 of 0.5. The main part of the 
porcine macrophage library (341 ~l) and 198J.11 of the second part of the library, 
were placed in a 50ml Falcon tube and 4ml diluted cells added. This was 
incubated at 30°C, without shaking, for 30 minutes. LB (4ml) was added and the 
mix incubated at 30°C, with shaking, for 1 hour. The mix was diluted with LB to 
produce a total volume of 24m!' To check the transformation efficiency a serial 
dilution up to 10.7 was made from this 24ml and plated out on LBI Amp plates 
(ampicillin at 50~g/ml), after which 1.5ml of the remaining 24ml culture was 
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plated out onto each of 16 large (245 x 245 x 25mm) LBI Amp plates (ampicillin 
at a final concentration of 50Jlglml) and incubated overnight at 37°C. 
Cells were scraped from each of the large LB/Amp plates and the harvested cells 
combined and added to a total of eight x 500ml of terrific broth (450ml terrific 
broth base, 50ml terrific broth buffer), so that every 500ml of terrific broth 
contained cells harvested from two plates. Each of the preparations was then 
shaken at 37°C, at 200rpm, for 5-6 hours until stationary phase was achieved. 
The 500ml cultures, in 250ml Sorvall pots, were then centrifuged at 7 OOOrpm for 
10 minutes (using a Sorvall RC5B+ centrifuge and a Sorvall SLA 1500 GSA 
rotor), and pellets resuspended with 20ml TEg containing 5mglmllysozyme and 
incubated at room temperature for 5 minutes. Maxi-prep solution 2 (as in section 
2.2.14) (40ml) was added, the bacterial suspension mixed by repeated inversion 
and incubated for 5 minutes on ice. M~xi-prep solution 3 (as in section 2.2.14) 
(30ml) was added, the contents mixed by inversion and incubated for 15 minutes 
on ice. Preparations were centrifuged at 15 000 rpm for 10 minutes (using the 
same rotor and centrifuge as before), the supernatant decanted into a clean pot 
through a layer of Mirac10th (Calbiochem) and 80ml of isopropanol added. After 
being left at room temperature for 20 minutes, the DNA was pellcted by being 
centrifuged at 15 OOOrpm for 10 minutes ( as before). Supernatants were then 
discarded and the resulting pellets washed with 70% ethanol. The final DNA 
pellet was re-dissolved in 8ml of TEg. 
The rest of the protocol followed was identical to that of the maxi-prep of 
plasmid DNA, as previously described in section 2.2.14, from the set up ofCsCl 
gradients onwards. 
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2.4.2 Preparation of Competent Yeast Cells and Small-Scale 
Transformation 
A culture of either Yl90 or AHI 09 yeast cells was set up using 3-5 single 
colonies to inoculate 50ml YEPD broth. The culture was vortexed briefly to 
disperse any clumps and incubated overnight at 30°C. The next morning the 
OD6oo of the yeast culture was measured and the culture diluted to produce an 
OD600 of 0.2 in 300ml YEPD broth. The culture was incubated at 30°C, on a 
shaker set at 250rpm, for 3 hours. Cells were centrifuged at 1 800rpm for 5 
minutes (using an IEC Centra GP8R centrifuge with a 218 rotor), the supernatant 
discarded and the cells resuspended in 25ml sterile DDW. The cells were re-
centrifuged and resuspended in 1.5mliX TE/LiAc (O.IM lithium acetate (LiAc), 
10mM Tris pH 7.5, ImM EDTA pH 8.0) and kept on ice until required. Prior to 
use, carrier DNA (sheared salmon sperm DNA (GIBCO)) was boiled for 7 
minutes and chilled on ice for 2 minutes. For each transformation, 200ng of each 
of the required plasmid DNAs and O.lmg carrier DNA were placed in a 
microfuge tube. One hundred III of the TE/LiAc/cell mix were added to each 
tube and mixed well with the DNA by vortexing. Sterile LiPEG (0.1 M LiAc, 
40% PEG3350) (600Jll) was then added to each tube and vortexed at high speed to 
mix. Each tube was incubated at 30°C, on a shaker set at 250rpm, for 30 minutes. 
To each tube, 70JlI of sterile DMSO was added and the contents mixed by gently 
swirling the tube. The samples were heat shocked for 15 minutes at 42°C and 
kept on ice for 2 minutes. After chilling, samples were microfuged for 5 seconds 
at 14 OOOrpm and the supernatant removed. Cells were re-suspended in 250111 IX 
TEs and the total volume was plated on the relevant type of synthetic complete 
(SC) selection plate and incubated at 30°C. 
For selection of double transformants, cells were plated out on synthetic complete 
plates lacking leucine and tryptophan (SC-L-T plates). For selection of cells 
positive for the ADE2 gene product (adenine biosynthesis), on SC plates lacking 
leucine, tryptophan and adenine (SC-L-T -Ade), and for selection of cells positive 
for the HIS3 gene product (histidine biosynthesis), cells were plated out on SC 
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plates lacking leucine, tryptophan, histidine, and containing 15mM 3-AT (3-
amino-I, 2, 4- triazole) (SC-L-T-H+lSmM 3-AT). 3-AT is used to counteract 
leaky expression from the HIS3 reporter gene by competitively inhibiting the 
HIS3 gene product. The amount of 3-A T used is dependent upon both the strain 
of yeast used and the bait protein used. The lowest possib Ie concentration of 3-
AT was used to minimise any negative effect that the 3-A T may exert on the 
transformation efficiency (Bai & Elledge, 1997). 
2.4.3 Large-Scale Yeast Transformation for Library Screen 
A 150ml culture of AHlO9 yeast cells in YEPD broth was set up and incubated 
overnight at 30°C. The next morning the OD600 of the yeast culture was 
measured. The culture was diluted to produce an OD60o of 0.2 in 1 litre YEPD 
broth and incubated at 30°C, on a shaker set at 250rpm, for 3 hours. Cells were 
centrifuged at 1 800rpm for S minutes (using an IEC Centra GP8R centrifuge 
with a 218 rotor), the supernatant discarded and pellets resuspended in SOOml 
sterile DDW. The cells were re-centrifuged and resuspended in 8ml sterile IX 
TE/LiAc and kept on ice until required. For each transformation, 1 mg bait 
plasmid DNA (pAS2/L), SOOJ..lg library plasmid DNA and 20mg sheared salmon 
sperm DNA (GIBCO) were placed into a sterile 500ml conical flask (prior to use, 
the carrier DNA was boiled for 7 minutes and then chilled on ice for 2 minutes). 
To this flask, 8ml of the TE/LiAC/cell mix were added and the contents mixed 
well by vortexing. Sterile LiPEG (60ml) was then added to the flask and the 
contents vortexed at high speed to mix. The flask was incubated at 30°C, on a 
shaker set at 250rpm, for 30 minutes. After this incubation period, 7ml of sterile 
DMSO were added to the flask and the contents mixed by gentle swirling. The 
contents were then divided into 2 sterile SOml Falcon tubes, heat shocked for 15 
minutes at 42°C and chilled on ice for 2 minutes. During the heat shock period, 
the tubes were mixed occasionally by gentle swirling. Samples were centrifuged 
at room temperature for 5 minutes at 1 800rpm (as before) and the supernatant 
removed. Cells were re-suspended in 1 Oml1 X TEs. 
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One hundred J..ll of the final cell suspension were used for a serial dilution (10-1 -
10-6), with which to determine the transformation efficiency, to be calculated on 
day five. A 100J..lI aliquot of each dilution was plated out on small SC-T-L 
selection plates and incubated at 30°C. Of the remaining cell suspension, 1ml 
was plated out onto each of 10 large SC-T-L-H+15mM 3-AT bio-assay selection 
plates and incubated at 30°C for a period of 10 days. 
2.4.4 Beta-Galactosidase Assay 
Colonies resulting from co-transformations plated out on SC-L-T plates were 
picked, resuspended in nnw and used to inoculate SC-L-T grids. SC-L-T grids 
were SC-L-T plates with a grid drawn on the bottom of the plate. This enabled a 
large number of colonies to be cultured and assayed at anyone time. Grids were 
incubated overnight at 30°C. 
The following morning, colonies were adsorbed to Hybond-C Extra nitrocellulose 
membrane (Amersham) by placing the membrane on top of the colonies, and then 
lysed by placing the membranes colony-side up into a liquid nitrogen bath for a 
period of 30 seconds. A piece of filter paper (Whatman 3 MM) was pre-soaked in 
developing solution (3ml buffer Z (60mM NazHP04, 40mM NaZP04, 10mM KCI, 
I mM MgS04), 8.1 J..lI 2-mercapto-ethanol and 30J..lI 1 OOmg/ml X-gal stock 
solution). The frozen membrane was then placed on top of the pre-soaked filter 
paper, colony side up, in a petri dish and allowed to thaw at room temperature. 
The lid was then placed on top of the petri dish, which was placed in a 30°C 
incubator. The membrane was checked every hour until blue colour had 
developed on the positive controls. 
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2.4.5 Isolation of Yeast Plasmid DNA Using Glass Beads and 
Phenol-Chloroform 
SC-L cultures (Sml) were set up from positive colonies from the library screen 
and incubated at 30DC, on a shaker set at 2S0rpm, for 3-S days. One and a half 
mt of culture were transferred to a microfuge tube and centrifuged at 14 OOOrpm 
for 1 minute. The supernatant was removed and the cell pellet resuspended in the 
residual liquid by vortexing. To each tube, 200JlI of yeast lysis solution (2% 
Triton X-IOO, O.1M NaCl, lOmM Tris-CI pHS.O, 2.SmM EDTA pHS.O), 200Jll of 
phenol-chloroform and O.3g of acid-washed glass beads were added and the tubes 
vortexed for 2 minutes. The samples were centrifuged at 14 OOOrpm for S 
minutes and the aqueous phase transferred to a fresh microfuge tube. DNA was 
precipitated by adding 0.6 volumes of isopropanol and incubating at room 
temperature for 20 minutes. Samples were centrifuged at 14 OOOrpm for 20 
minutes to collect the DNA, and the DNA pellet was washed with 70% ethanol. 
The final DNA pellet was left to air dry and was resuspended in IOJlI of sterile 
DDW. Yeast DNA was stored at _20DC until required. 
2.4.6 Isolation of Yeast Plasmid DNA Using "Yeastmaker" Yeast 
Plasmid Isolation Kit 
DNA was isolated using the "Yeastmaker" yeast plasmid DNA isolation kit 
(Clontech) according to the manufacturer's protocol and guidelines. 
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Chapter Three 
Investigating Protein:Protein Interactions of RPV L with 
Rinderpest Viral Proteins P, C and V using the Mammalian Two-
Hybrid System (MTHS) 
3.1 Introduction 
3.1.1 The Mammalian Two-Hybrid System (MTHS) 
The mammalian two-hybrid system, a recent modification of the yeast two-hybrid 
system, is used to assess protein:protein interactions in transiently transfected 
mammalian cells and, like the yeast two-hybrid system (Fields & Song, 1989), 
artificially mimics the natural process of transcription, building on observations 
that transcriptional activators can be separated into discrete regions 
corresponding to DNA-binding domains and transcriptional activation domains 
(Brent & Ptashne, 1985, Hope & Struhl, 1986). Therefore like the yeast two-
hybrid system, the MTHS analyses interactions between proteins that are 
localised in the nucleus. 
The MTHS works by expressing each of the two proteins of interest 'X' and 'Y' 
as fusions with a GAL4 DNA binding domain and the mammalian transcriptional 
activation domain of the VP16 protein from Herpes simplex virus 1. In both types 
of fusion protein, there is an in-built nuclear localisation signal. The reporter 
vector, pG5luc, is co-transfected with both of the fusion constructs into 
mammalian cells and contains 5 GAL4 DNA binding sites upstream of a minimal 
TAT A box which, in tum, is upstream of the reporter gene. If there is any 
interaction between 'X' and 'Y', the DNA binding domain ofGAL4 and the 
transcriptional activation domain of VP16 will be brought into close proximity 
and the reporter gene will be expressed from pG5luc (see figure 3.1.1). In this 
case the reporter gene is that of firefly luciferase, expression of which can be 
easily assayed. The luciferase assay is known to be highly sensitive and thus 
allows analysis of weak promoters and the use of smaller amounts of DNA and 
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cells in transfection studies. In order to normalise transfection efficiency and 
minimise experimental variability, an internal control reporter gene is expressed 
from the pBIND vector, that ofrenilla luciferase. Measurements of both types of 
luciferase can be made in the same reaction tube. 
In order to study protein:protein interactions of specific "domains" of L with P, C 
and Y, it was initially proposed to use the Promega Checkmate mammalian two-
hybrid system. This should have allowed an understanding of the way these 
proteins interact with each other during infection due to the fact that the proteins 
of interest are expressed in mammalian cells, so the intracellular environment will 
be more like that normally encountered by the viral proteins. 
There are several possible advantages that the MTHS has over other methods 
which are used to detect protein:protein interactions. For example co-
immunoprecipitations, GST pull-down assays and far-Western blotting all enable 
the assessment of the ability of one protein to interact with another; however, 
these methods do not show under which conditions these interactions occur and 
require relatively stable interactions. Weak or unstable interactions may 
therefore not be detected and such techniques also require additional manual 
processing, which would be time-consuming when compared to the MTHS 
luciferase assays. Although the Y2HS also enables the identification of 
protein:protein interactions, any interaction detected within this system must also 
be confirmed using at least one additional method, due to the fact that the Y2HS 
is known to generate false protein-binding partners. Furthermore any interactions 
characterised using the Y2HS are hard to quantitate, as a result of the type of 
reporter genes utilised within the system. The MTHS however permits the 
analysis of such protein:protein interactions in the more physiological context of 
the intact cell and allows the quantification of results obtained in the form of 
firefly luciferase readings, thus enabling the determination of the relative strength 
of protein:protein interactions investigated within the system. Another theoretical 
advantage of the MTHS over the Y2HS is that interactions can be confirmed 
rapidly, with the luciferase assays ready in minutes. The Y2HS however is a 
time-consuming method with which to investigate protein:protein interactions 
70 
Chapter 3- Mammalian Two-Hybrid System 
due to the nature of the yeast cells themselves which require several days to grow 
up post-transformation and which then have to be re-cultured under the relevant 
selective conditions for the reporter gene being used. 
The MTHS was thought to be suitable for this part of my PhD project as the 
physical interaction of native L with P, C and V was already proven (Sweetman 
et ai., 2001). A rapid system was therefore required with which to map the 
interacting domains of L with P, C and V. Since sub-domains of a protein may 
interact with binding partners more weakly than the whole protein, a sensitive 
system such as the MTHS was an ideal choice. 
3.2 Results 
3.2.1 Preparation ofMTHS Constructs 
PCR amplification using a proof-reading polymerase with mutagenic primers, 
using specific restriction sites (see appendix 3) generated the appropriate coding 
regions from existing laboratory plasmids, enabling production of protein 
encoding constructs (pACT and pBIND). The N coding region was obtained 
from pKSN (Baron & Barrett, 1997), the P and C coding regions from pKSP 
(Baron & Barrett, 1997) and the coding region for V from pKSV (pBluescript 
KS(+) containing a cDNA of V-type mRNA). The ORFs for the N, P, C and V 
proteins were all cloned into both pACT and pBIND vectors (MluIlNotI cut) and 
the 5' sequences at the fusion protein joins confirmed. The production of these 
constructs was fairly easy, but this was not true of the two constructs containing 
L. Due to its large size, it was difficult to produce a large yield of L PCR 
product, despite adaptations to the PCR program. Eventually L was removed 
from an existing laboratory plasmid, pGempol (Baron & Barrett, 1997), by 
designing a set of overlapping linker primers which created a new San site just 
upstream of L. This allowed the L ORF to be excised as a San- EagI fragment 
and should have enabled easy ligation into the pACT and pBIND vectors (SalIl 
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NotI cut). However before this was possible, problems became apparent with this 
system (as described in sections 3.2.3 and 3.2.4). 
3.2.2 Investigating Known RPV Protein:Protein Interactions Using 
theMTHS 
Experiments could now be undertaken to reconfirm findings of (Sweetman et a/., 
2001) with initial experiments focusing on N-N and N-P interactions in order to 
get the system estab lished. Transfections using Vero cells were set up using 1 Jl,g 
of each plasmid DNA per 35mm well, as in section 2.2.16.1. The cells were then 
incubated at 37°C for two days and luciferase measurements taken (as described 
in section 2.3.7). Renilla luciferase measurements were used to normalise 
transfection efficiency. 
Two positive control vectors, pBIND-Id and pACT-MyoD, containing GAU:Id 
and VP16:MyoD respectively, are fusion proteins known to interact with each 
other and were used as a positive control. To enable background levels of firefly 
luciferase to be determined, pBIND and pACT vectors were co-transfected. 
N-N and N-P interactions were investigated, and each of the plasmid constructs 
tested was also co-transfected with its relevant negative counterpart. For example 
for N-N interactions, 3 reactions would be set up: pACTN co-transfected with 
pBINDN, pACTN co- transfected with pBIND and pBINDN co-transfected with 
pACT, thus showing that any increase in firefly luciferase expression was as a 
result of genuine interactions between fusion proteins and not the insertion of a 
particular coding region into pACT or pBIND. Despite the fact that both the 
positive and negative controls worked well, no interaction between N and P was 
observed. There was also poor reproducibility of trans feet ion efficiency between 
the various reactions (data not shown). 
To assess control parameters, transfections were set up which examined 
concentrations of the reporter plasmid pG5luc at O.35Jl,g, O.7Jl,g and 1.05Jl,g 
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amounts of plasmid DNA with the two positive control vectors, pACTmyoD and 
pBINDld. No significant difference was observed in the results, thus concluding 
that the amount of reporter gene used is not a limiting factor of luciferase 
expression (data not shown). 
After optimisation, it was decided that 0.35J.lg ofpG5luc would be used and 
O.4J.lg of each of the two plasmids being tested for interactions would be used. 
This yielded similar results to those of previous experiments. A strong positive 
control was obtained, but no N-N, N-P, or N-V interactions were seen, all of 
which are known rinderpest protein interactions and the N-N and N-P interactions 
are required for viral nucleocapsid formation (figure 3.2.2.1). The renilla 
luciferase measurements showed that the transfections had worked in each case, 
although there was still considerable variability in what should have been a more 
or less constant value. 
The amount ofpG5luc used in tr~nsfections was increased to IJ.lg and in addition, 
a new molar ratio of2:1:1 was used (pACT: pBIND:pG5Iuc) as described by 
(Fotin-Mleczek et at., 2000). Despite a stronger positive control being produced 
(figure 3.2.2.2), it was still not possible to detect the expected N-N and N-P 
interactions with this system. Renilla luciferase measurements, meant to allow 
normalisation of transfection efficiency, were still problematic due to the amount 
of variability observed between pairings of constructs. 
After several sets oftransfections and luciferase assays, no N-N, N-P, P-N or N-
V interactions were seen with the pACT and pBIND constructs, despite obtaining 
good interaction with the two positive control constructs, pACTmyoD and" 
pBINDId. Rather than simply abandon this work, efforts were made to determine 
why the system was failing to show even known protein:protein interactions. 
This was in case some simple problem existed with the pACT and pBIND 
constructs that had been made, which could then be corrected. 
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3.2.3 Expression of Fusion Proteins from MTHS Constructs 
There are several possible reasons for the MTHS constructs appearing not to 
interact as expected. It was possible that, although the sequence at the fusions of 
the GAlA DNA binding domain and the VP16 transcription activation domain to 
the RPV sequences had been checked, that there was a problem with the 
expression of one or more of the constructs. In order to try and eliminate this 
possible cause of failure, it was decided to assess whether the expected proteins 
were being expressed from the MTHS constructs. 
Constructs of interest were transfected into Cos-l cells (as in section 2.2.16.1), 
cells were metabolically labelled with esS] amino acids and celllysates 
immunoextracted using the appropriate rabbit polyclonal antibody (as described, 
2.3.4). MB2 was raised against a mixture of pep tides covering the carboxy-
terminal 100 amino acids of the RPV N protein, MB 18 against a peptide 
representing the carboxy-terminal 15 amino acids of the RPV P protein, while 
MB38 was raised against a bacterially expressed GST fusion protein containing 
the whole of the RPV C protein. The samples were run on a 12% acrylamide 
Laemmli gel (figure 3.2.3.1). 
The expected sizes of the protein fusion constructs were calculated and not all 
matched the size of the proteins pulled down with the antibody used. ACTN (the 
fusion protein expressed from pAC TN) was calculated to migrate at a size of 
67.2 kDa, but was shown instead to have an increased mobility, migrating further 
distance than the 66 kDa marker, at approximately the same size as the BINDN 
fusion. Yet the BINDN fusion, with a calculated size of74 kDa, was expected to 
migrate even less distance than the 66 kDa marker. In addition ACTC was 
expected to migrate at a size of29 kDa, but was actually shown to migrate with a 
reduced mobility when compared to the 30 kDa marker. BINDC was expected to 
run at an approximate size of 35.5 kDa and this does look like the case on the 
SDS-PAGE gel (figure 3.2.3.1). ACTP was calculated to migrate at an 
approximate size of 65 kDa, whilst BINDP was expected to show a size of 
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3 4 5 6 
Figure 3.2.3.1. Immunoextraction ofN, P and C fusion 
proteins from Cos-l cells transfected with mammalian 
two hybrid constructs. Ce lls were transfected with 51lg of the 
relevant MTHS construct; two days post transfection , ce ll s were 
label led with [35 S] amino acids for one hour and lysed with 1 % NP40. 
Samples of Iysates were immunoextracted with 1111 of the appropriate 
rabbit po lyc lo nal antibody and immunoprec ipita ted prote ins were 
analysed on a 12% ac rylamide Laemmli gel a longside [14C] labelled 
molec ul ar we ig ht markers ( M). The ize of each expected fu sion 
prote in is g ive n in brackets. Track 1= pACTN (67.2 kDa), 2= pBINDN 
(73.8 kDa), 3= pACf C (2 8.9 kDa), 4= pBINDC (35.5 kDa), 5= pA CTP 
(65.3 kDa) and 6= pBINDP (7 1. 9 kDa). ACTN and BINDN were 
immunoex tracted with M B2; ACTP and BI NDP with MB 18 ; A TC and 
BINDC wit h MB 38. 
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approximately 72 kDa, both fusions however migrated at the same size, just 
above the 66 kDa molecular weight marker. 
From these observations it would appear that the BINDP and BINDC fusion 
proteins were expressed as expected, while the ACTP and ACTC constructs, 
which contain the same RPV sequences as their BIND counterparts, were shown 
to migrate with less mobility than expected on SDS-PAGE gels. 
Although enquiries made directly to Promega failed to provide any information 
regarding the expected migration of BIND and ACT fusion proteins, the VP16 
activation domain in ACT fusions is relatively acidic (14 acidic residues out of 
46) which would tend to lead to slower migration on SDS-PAGE gels than for a 
neutral protein. This could therefore provide a possible reason as to why the 
pACT constructs (VPI6 fusions) all migrated with less mobility than was 
expected. 
Both the BINDN and ACTN constructs migrated faster than expected. DNA 
sequencing showed that the amino-terminus of the N ORFs in each construct was 
correct, and correctly joined to the ACT and BIND components. In addition, 
since the proteins are precipitated by MB2, they must contain at least part of the 
carboxy-terminal 20% of the N protein. The fusion proteins were therefore 
thought to be either truncated at their extreme carboxy-terminus (due to cellular 
proteases, or PCR error) or to have an internal deletion (due to a PCR error). 
While PCR error was unlikely based on previous laboratory experience with the 
Pfu proof-reading polymerase, it was only possible to eliminate this option by 
sequencing these constructs in their entirety. 
The N ORF of the pBINDN construct was therefore sequenced and found to be 
correct (data not shown). There were therefore no mutations present due to PCR 
error, neither were there any internal deletions within the N ORF itself. The 
anomalous migration of these fusion proteins is thus not due to an error with the 
construct itself. Only the pBINDN construct was sequenced due to the fact that 
the fusion protein expressed from this construct migrated the furthest away from 
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its expected size, when compared to pACTN. BINDN should have migrated at 
73.8 kDa and ACTN was expected to migrate at 67.2 kDa, however as previously 
mentioned both fusion proteins migrated faster than the 66 kDa marker. 
In addition, the possibility of degradation by cellular proteases was tested by 
expressing the proteins in vitro, using a coupled transcription/translation system, 
since the pACT and pBIND plasm ids have T7 RNA polymerase promoter 
sequences upstream of the fusion proteins, no difference in the size of fusion 
proteins expressed from any of the MTHS constructs was detected (data not 
shown) .. 
Since there did not seem to be any errors in the sequence of the N plasm ids, or a 
problem with either degradation or mutation of the expressed proteins, the 
anomalous migration of BIN ON and ACTN must be due to some property of the 
N protein sequence. 
3.2.4 Detection of the Cellular Distribution ofMTHS Fusion 
Proteins by Immunofluorescence 
From the immunoprecipitation data, it was clear that all the constructs were 
expressing fusion proteins of at least approximately the expected size. It was 
therefore necessary to determine whether or not these fusion proteins were in fact 
being localised to the nucleus as is a requirement for the functionality of the 
MTHS. This is due to the fact that the MTHS, like the YTHS, requires nuclear 
localisation of protein constructs in order for the reporter gene to be expressed. It 
could be that this was not happening, or was inefficient with these MTHS 
constructs. It is important to note that each of the two fusion proteins for the 
MTHS possess inbuilt nuclear localisation signals (NLS); ACT has the simian 
virus 40 (SV 40) large T antigen nuclear targeting sequence fused downstream of 
the VP16 domain (Prom ega) and BIND (the GAU DNA binding domain) has 
been found to possess a NLS 74 amino acids in length (Chan et al., 1998). 
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Another possible explanation could be that steric hindrance might playa role in 
preventing interactions between these viral proteins. 
Immunofluorescence of the MTHS constructs was used as a quick method to 
determine where the proteins localise once made in the cell. MTHS constructs 
were transfected (as in 2.2.16.1), using 5Jlg of plasmid DNA, into Cos-l cells 
growing on glass coverslips in 35mm wells, incubated for 2 days and the cells 
fixed and then treated with the appropriate antibodies at the current working 
dilution (section 2.3.1). Cos-l cells were used in place ofVero cells as it was 
thought that these would be good for immunofluorescence studies and that 
increased levels of protein expression would be seen in the transfected cells. 
This experiment yielded interesting data. Both pACTC and pBINDC (figure 
3.2.4.1) showed good expression ofC fusions and, more importantly, images 
showed clear nuclear localisation of the C protein fusions. Whilst C was 
distributed to a certain extent throughout the cell, it was definitely concentrated 
within the nucleus, as it should be. pACTP and pBINDP (figure 3.2.4.2) 
produced P fusion proteins which were found mainly in the host cell cytoplasm, 
with possibly a low level of expression in the nucleus which was just detectable 
over background staining ofuntransfected cells. This would require confocal 
microscopy to confirm, as it might just be protein in the cytoplasm above or 
below the nucleus. 
Constructs pACTV and pBINDV produced differing results (figure 3.2.4.3). 
Whilst ACTV was found in the majority oftransfected cells to be localised in the 
cytoplasm of the cell, BINDV was distributed throughout the cell and in some 
cases was found to be more concentrated in the nucleus than in the cell 
cytoplasm. 
ACTN and BINDN (figure 3.2.4.4), like the P protein fusions, appeared to be 
excluded from the host cells' nuclei. In only one pACTN transfected cell, was 
there a slight speck of N protein within the nucleus of a cell and this was 
observed on the confocal microscope, so it can be said with certainty that the 
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Figure 3.2.4.1 Immunofluorescence microscopy of cells 
transfected with MTHS C constructs. Cos-I cells were 
transfected with pACTC (A, B, C) or pBINDC (D, E, F). Two days post 
transfection, cells were fixed, and permeabilised with 0.5% Triton X-I 00 
before staining with antibody. Cells were reacted with rabbit (l -RPVC 
(MB38, at 1/400), and the primary antibody visualised with Texas Red (l-
rabbit JgG (at 11200, A & D). Band E show nuclei of cells counter-stained 
using Hoechst 33258. Overlay of the two stains is shown in C and F. 
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Figure 3.2.4.2 Immunofluorescence microscopy of cells 
transfected with MTHS P constructs. Cos-l cells were 
transfected with pACTP (A, B, C) or pBINDP (D, E, F). Two days post 
transfection, cells were fixed, and permeabilised with 0.5% Triton X-tOO 
before staining with antibody. Cells were reacted with rabbit a. -RPVP 
(MB 18, at 11300), and the primary antibody visualised with Texas Red 0.-
rabbit IgG (at 11200, A & D). Band E show nuclei of cells counter-stained 
using Hoechst 33258. Overlay of the two stains is shown in C and F. 
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Figure 3.2.4.3 Immunofluorescence microscopy of cells 
transfected with MTHS V constructs. Cos-l cells were 
transfected with pACTV (A, B, C) or pBINDV (D, E, F). Two days post 
transfection, cells were fixed, and perrneabilised with 0.5% Triton X-tOO 
before staining with antibody. Cells were reacted with rabbit a -RPV V 
(a -V 2' at 116(0), and the primary antibody visualised with FITC a -
rabbit IgG (at \1220, pACTV) (A) or Texas Red a -rabbit IgG (at \1200, 
pBINDV) (D). B and E show nuclei of cells counter-stained using 
Hoechst 33258. Overlay of the two stains used is shown in C and F. 
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Figure 3.2.4.4 Immunofluorescence microscopy of cells 
transfected with MTHS N constructs. Cos-I cells were 
transfected with pACTN (A, B, C) or pBINDN (0, E, F). Two days post 
transfection, cells were fixed, and penneabilised with 0.5% Triton X-I 00 
before staining with antibody. Cells were reacted with mouse a-RPVN 
(C39, at 1/50), and the primary antibody visualised with Texas Red a -
mouse IgG (at 11200, A & D). Band E show nuclei of cells counter stained 
using Hoechst 33258. Overlay of the two stains is shown in C and F. 
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protein was in the nucleus, though in extremely limited quantities. Further, the N 
protein which was found within the cytoplasm oftransfectcd cells had formed 
aggregates which were "worm-like" in appearance. Thus, it would appear that 
this aggregation somehow overrides the nuclear localisation signals, as the small 
quantity of N found within the nucleus of that one cell did not appear to be in an 
aggregate. 
It is interesting to note that the expre·ssion levels of the N fusion proteins seen in 
the immunofluorescence images appear to be a lot higher than the amount of 
expression suggested by immunoprecipitation. A possible reas0!1 for this 
observation could be that aggregates ofN seen in the cytoplasm of trans fee ted 
cells, by immunofluorescence, could somehow block the binding domain of the 
anti-N antibody used for the immunoprecipitation work. It is also possible that 
aggregates ofN, due to their presumably large size, are pelleted with cell debris 
from lysates prior to being immunoextracted. It is therefore also possible that, 
during immunoprecipitation, full-length N fusions were not being 
immunoextracted. 
3.2.5 Investigation of RPV C-C Interaction 
As the two C fusion proteins were shown to localise to the nuclei of transfected 
cells, experiments could be performed using these constructs. Earlier work has 
shown that RPV C self-associates (in the Y2HS) and forms high molecular 
weight aggregates even in the absence of other viral RPV proteins (Sweetman et 
al.,2001). On the othe'r hand, GST-C failed to bring down C when the two 
proteins were co-expressed (Sweetman, 2000). As this interaction had already 
been seen in infected mammalian cells (Sweetman et aI., 2001), the MTHS was 
used to potentially further characterise this interaction. 
Transfections (2.2.16.1) were performed using Cos-I cells and the previously 
used 2:1:1 ratio of pACT: pG5luc: pBIND was used, plus pG51uc (0.8Jlg) per 
35mm well. Transfast (6JlI) was used per Jlg plasmid DNA to be transfected. The 
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cells were then incubated at 37°C for two days and luciferase measurements 
taken (as described in section 2.3.7). As previously described, Renilla luciferase 
measurements were used to normalise transfection efficiency (see figure 3.2.5.1). 
Despite strong positive controls no C-C interaction was found within this system 
(see figure 3.2.5.2). It could be that the C-C interaction seen during previous 
work in the laboratory was an aggregation rather than a functional interaction. If 
this is the case then such aggregates may not allow the function ofVPl6 and 
GAlA, which would explain why this interaction remains undetected in the 
MTHS. 
3.3 Discussion 
The MTHS should have allowed the rapid and quantitative analysis ofRPV 
protein:protein interactions within a cellular environment that closely mimics the 
native protein environment. However, this did not prove to be the case with the 
constructs produced for this study. To investigate possible causes for the failure 
of this system, the size and cellular distribution of fusion proteins was 
investigated. The MTHS constructs used were found to generate fusion proteins 
that migrated approximately as expected on SDS-PAGE gels. However, both the 
N fusions were found to migrate in an anomalous fashion. ACTN and BINDN, 
which were expected to migrate at around 67.2 kDa and 74 kDa respectively, 
were both found to migrate faster than the 66 kDa marker, at approximately the 
same size as each other. To determine if any mutations or internal deletions were 
present in the N ORF of the MTHS N constructs, the N ORF of the pBINDN 
construct was sequenced in its entirety and found to be correct. The anomalous 
migration ofthe N fusion proteins was therefore found to be not due to an error 
with the construct itself. 
When the nuclear localisation of these constructs in transfected cells was 
investigated, not all the fusion proteins were found to nuclear localise. In 
particular, the N fusions were all cytoplasmic, and initial characterisation of the 
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system had been carried out with several N-X pairs of proteins. Although the N 
constructs were not necessary for this study, both the P fusions and the ACTV 
fusion, which were vital for this work, were found to be very inefficient in going 
to the nucleus oftransfected cells. If the L constructs had been made and tested 
than it may very well have been that these constructs might also not have gone to 
the nucleus. This is despite the fact that each of the vector-encoded fusion 
proteins for the MTHS possesses in-built nuclear localisation signals. These 
signals must somehow be over-ridden or be inefficient with the constructs 
generated using the RPV coding sequences. It is interesting to note that in a 
recent literature search only one group has published work using the Prom ega 
Checkmate MTHS (De Jong et aI., 2002), which could indicate that this has not 
been one of Prom ega's more successful kits. Furthermore, in previous work 
qsing the Y2HS, the majority of the constructs containing the same RPV coding 
sequences were found to go to the nucleus, indicating that the Y2HS is less 
sensitive to difficulties in translocation than the MTHS. 
After several unsuccessful attempts to confirm previously characterised 
rinderpest protein:protein interactions within this system, efforts were channelled 
towards setting up another system. To determine which conserved domain of the 
L protein interacts with P, C and V it was decided to next use co-
immunoprecipitation studies. 
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Chapter Four 
Investigating the Interaction of RPV L with Rinderpest Viral 
Proteins P, C and V using Co-Immunoprecipitation studies 
4.1 Introduction 
Due to the problems encountered with the MTHS, co-immunoprecipitation 
studies were used to evaluate the interactions of L with the viral proteins P, C and 
V. Even ifthe MTHS had worked, further investigations with another technique 
such as co-immunoprecipitation would have been required to confirm any 
preliminary data. Co-immunoprecipitations (co-ips) have been in use for over 
two decades and provide a direct method of establishing protein:protein 
interactions both in vitro and in vivo. Co-ips may be used to not only prove if a 
specific interaction occurs between two known proteins, but to also isolate novel 
protein-binding partners of a known protein of interest. In either case, the 
principle behind co-immunoprecipitation is the same and straightforward: an 
antibody for a known protein is used, resulting in the immunoprecipitation of that 
protein along with any associated proteins, from either virally infected cells, or 
cells transfected with plasmids expressing proteins of interest. 
However, like all systems, there are some disadvantages to using co-ips for the 
analysis ofprotein:protein interactions, for example an interaction needs to be 
stable ifit is to be successfully detected by co-ip. Furthermore, it is not possible 
to quantitate the strength of an interaction demonstrated by co-ip and another 
possible drawback is that the process is time consuming, with a lot of "hands on 
time" required following the point oftransfection. 
For this part of the study, constructs encoding the desired proteins were 
transfected into mammalian cells. The transfected cells were then radio labelled, 
harvested and lysed under non-denaturing conditions, thereby preserving any 
protein:protein interactions which may occur within the intact cell. Using an 
antibody specifically raised against one of the proteins of interest, the protein is 
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immunoextracted from the cell lysate and analysed on an SDS-PAGE gel. Any 
other proteins associated with the protein of interest may be visualised on the gel, 
either by Western blot or, in the case of radio labelled cells, by autoradiography 
(see figure 4.1.1. for a diagrammatic overview of the system). 
4.2 Results 
4.2.1 Preparation of Constructs for Co-Immunoprecipitation Studies 
In order to perform co-immunoprecipitation studies, new constructs were made 
containing the desired protein ORFs, including an HA-tagged version of L 
(HAL), which was made due to the lack of a suitable anti-L antibody. The L 
protein was HA-tagged at its amino terminus, thus enabling L, and any deleted 
forms of L, to be recognised by commercially available monoclonal antibodies 
raised against the HA tag from influenza virus. The other advantage of using an 
epitope tag is that anti-tag antibodies should not interfere with protein:protein 
interactions, whereas an antibody to the protein of interest may bind to and block 
the binding/interaction site. The L coding region was cut from an existing 
laboratory plasmid, pGempol (Baron & Barrett, 1997), using Eco521 and then 
inserted into a modified pcDNAlHA plasmid (Noll cut). This modified plasmid 
was derived from pcDNAlHAlNac, which was a kind gift from L. Goatley 
(Department of Molecular Biology, Institute for Animal Health, Pirbright, Surrey, 
UK). Prior to the insertion ofRPV L, the plasmid was digested with EcoRI and 
XhoI to remove the unnecessary coding sequence for the Nac protein, and a NotI 
site was re-introduced using a set of specifically designed overlapping primers 
(Hains 1 and Hains 2, see appendix 3). It was this plasmid (pcDNAlHAlNot) 
which was then digested with NotI and into which the RPV L ORF was cloned as 
described above. 
Constructs containing N, P, V and C were also made, each being inserted into 
pcDNA3.1 + (Invitrogen), a plasmid containing both the CMV and T7 promoters. 
It was originally intended to use solely the CMV promoter of this plasmid, as 
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Figure 4.1.1. Diagrammatic representation of the analysis of 
prote in :protein interactions usi ng co-im munoprecipi tation. 
Mamma li an ce lls are transfected with pl asmid constructs encoding the proteins 
of interest. One or two days post transfection , transfected ce ll s are labell ed 
with [35 S] amino acids and lysed Celllysa tes are immunoextracted with the 
relevant antibody and immunoprecipi ta ted proteins ana lysed on SDS-PAGE 
gels . 
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previous studies using vaccinia T7/T7 promoter-driven expression resulted in the 
degradation of the C protein (Sweetman et al., 2001). The coding regions for C 
and V were obtained from existing laboratory plasm ids, C from pC2C and V 
from pKSV, whilst the coding region for P was acquired from pKSP (Baron & 
Barrett, 1997), all of which were digested with EcoRI and then cloned into 
pcDNA3.1 + (EcoRI cut/SAP). The N coding region was obtained by digesting 
pKSN (Baron & Barrett, 1997) with NotI and was then cloned into pcDNA3.1 + 
(NotI cut/SAP). 
All constructs were confirmed by sequence analysis of the 3' and 5' ends of the 
inserted sequence. A functional assay of HAL was not performed, as a 
recombinant RPV has been rescued containing an HA-tag at exactly the same 
location as the pcDNA/HAL construct used during these studies (M. Baron, 
personal communication). 
4.2.2 Optimisation of Protein Expression from Constructs 
Following production of these constructs, protein expression was analysed using 
immunoprecipitation studies. Expression of proteins from the majority of these 
constructs was easy to obtain when driven from the CMV promoter. However, 
the HA-tagged L construct took a lot of effort to get good levels of protein 
expression. To confirm protein expression from these constructs, Cos-I cells 
were transfected using 5Jlg of plasmid DNA of each of the constructs of interest 
(as in section 2.2.16.1), radiolabe Bed, lysed and then immunoextracted using 1 JlI 
of the appropriate antibody (figure 4.2.2.1). Clear expression ofN (expected size 
---60.5 kDa), P (expected size -59 kDa, P is known to migrate slower than 
expected) and C proteins (expected size -22 kDa) was seen. However it was 
noticed that degradation of the C protein still occurred, despite using the CMV 
promoter in place of vaccinia T7/T7 promoter-driven expression. Although C 
should migrate at -22 kDa, the majority of protein expressed from pcDNAIC 
appeared to be in a degraded form migrating at -15 kDa. 
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Figure 4.2.2.1. Immunoprecipitation of proteins 
expressed from peDNA constructs. Cos-I cells were 
transfected with pcDNNN ( I) , pcDN NC (3) or pcDN A/P (5), o r 
le ft untransfected (2, 4, 6). T wo days post transfection, ce ll s were 
labelled with [35S] amino acids fo r one hour and lysed with 1% 
NP40. Sampl es of lysates were immunoextracted with MB2 (anti -
N) (1 &2), MB38 (anti-C) (3&4) or MB 18 (anti-P) (5&6). 
Immunoprecipitated proteins were analysed on a 12% acrylamide 
Laemml i ge l alongside [1 4C] labell ed molecul ar we ight markers 
(M). 
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To further check the expression of the pcDNA constructs and to determine ifco-
immunoprecipitations could be performed using TNT lysates, in vitro 
transcription-translation reactions were set up. This also enabled the expression 
of V from pcDNAN to be confirmed, as this construct was not tested by 
immunoprecipitation due to a shortage of a-RPV V antibody. Using an 
incubation time of the recommended 60 minutes, it was shown that a product of 
the expected size of each protein was produced from each of the pcDNNC, 
pcDNNP, pcDNAN (-34.5 kDa) and pcDNNN constructs (see figure 4.2.2.2). 
Unfortunately the system was unable to produce HAL (-240 kDa) from 
pcDNNHAL and it would appear that the size of the protein was too great for the 
system. The results were validated as both the negative control, containing no 
DNA, and the positive control worked well. The positive control included 0.5Jlg 
of luciferase control plasmid DNA, which produces a monomeric protein 61 kDa 
in size. To confirm that the size of L was too great for the system, a further TNT 
reaction was set up using pcDNNHAL and the two control reactions, but this 
time an extended incubation period of 120 minutes was used. The same result 
was obtained as with the 60 minute incubation period (data not shown). The 
TNT system was therefore not useable for co-expressionlco-immunoprecipitation 
studies. 
It was noticed when the pcDNNP and pcDNNV TNT reactions were analysed 
on Laemmli gels that they appeared to produce a protein the same size as C, in 
addition to P or V (see figure 4.2.2.2). Furthermore, all three plasmids (P, C or 
V) produced a protein larger than C (-24 kDa) (figure 4.2.2.2). To investigate 
whether C was being expressed from the pcDNNP and -N constructs, an 
experiment was set up to try to immunoprecipitate C from celllysates transfected 
with pcDNAIP using MB38 (a rabbit polyclonal a-C antibody). A series of 
controls were also performed; pcDNNN was used as a negative control to show 
that MB38 is specific to C, while pcDNNC was used as a positive control (figure 
4.2.2.3). As the figure shows, pcDNNP does also produce C, and it is therefore 
reasonable to conclude that the small protein seen expressed from pcDNAN by 
TNT was also C. The -24 kDa protein was not seen in immunoprecipitation with 
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Figure 4.2.2.2. in vitro transcription-translation 
reactions of all pcDNA constructs. TNT reactions were 
set up using O.5J.lg plasmid DNA and incubated for 60 minutes at 
30°C and products analysed on a 12% ac rylamide Laemmli gel 
with [1 4C] labelled molecular weight markers (M) . Track 1= 
pcDNAlHAL , track 2= pcDNAlV, track 3= pcDN AlN, track 4= 
pcDNAlC, track 5= pcDNAIP, track 6= negative control 
containing no DNA and track 7= the positive control containing 
luciferase control plasmid DNA. 
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p + + 
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Figure 4.2.2.3. Immunoextraction with MB38 
(a-C) of celllysates transfected with either 
pcDNAlC, pcDNAIN or pcDNAIP constructs. 
Cos-l cells were transfected with different peDNA 
constructs. Two days post infection, cells were labelled 
with PSS] amino acids for one hour and lysed with 1 % 
NP40. Lysates were then treated with rabbit polyclonal a-C 
(MB38) and analysed on a 12% acrylamide Laemmli gel 
alongside [l4C] labelled molecular weight markers (M). 
Lysate from cells transfected with nothing (I); 5J.1g 
peDNAlC (2); lOJ.1g peDNAlC (3); 5J.1g peDNNN (4); IOJ.1g 
peDNAIN (5); 5J.1g pcDNAIP (6) and IOJ.1g pcDNAIP (7). 
The position of full-length C protein is arrowed. 
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anti-C antibody in these or any other experiments. The origin of this protein in 
the TNT reactions is unclear. 
Initial experiments resulted in a failure to detect HAL expression from the 
pcDNAlHAL construct, despite previous immunofluorescence data confirming 
expression of HAL (data not shown). It was therefore decided that expression of 
HAL, by immunoprecipitation, would be checked using a transient fowlpox T7 
(FPT7) expression system, as in section 2.2.17. Cos-l cells were infected with 
FPT7 and then transfected with 5Jlg pcDNA/HAL or as a positive control, with 
5Jlg ofpGempol (a laboratory plasmid containing full-length L, which is known 
to express well), and each lysate preparation treated with MB41, a rabbit 
polyclonal a-RPV L antibody or rat monoclonal a-HA antibody (Roche) (figure 
4.2.2.4). In addition, both antibodies were used to treat non-infected, non-
transfected cells to demonstrate that they did not pull down a protein of similar 
size to L from the untransfected cell lysate. All controls worked as expected and 
good expression of HAL was shown from pcDN AlHAL when driven by the T7 
promoter (figure 4.2.2.4). It was now clear that HAL could be detected by 
immunoprecipitation, as it was being expressed, just in very low amounts when 
governed by the weaker CMV promoter. 
A series of experiments were set up in Cos-l cells to optimise HAL expression 
when driven by the CMV promoter. To begin with 5J1g, 7.5J1g and lOJ1g amounts 
of pc DNA/HAL were transfected but produced no detectable levels of HAL 
expression (data not shown). Less DNA was then transfected into Cos-I cells, 
resulting in the observation that either 1 Jlg or 2Jlg of transfected plasmid DNA 
produces a higher level of HAL expression than 3J1g, 4J1g or 5J1g of transfected 
plasmid DNA (figure 4.2.2.5). It is unclear why HAL should express efficiently 
when less DNA is transfected. 
In an effort to increase the levels of HAL protein expression when driven from 
the CMV promoter, several CMV promoter enhancers were investigated. Some 
evidence exists in the literature that sodium butyrate can act as a chemical 
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Figure 4.2.2.4. Transient expression of 
pcDNAIHAL in Cos-l ceUs. Cos- I cells were infected 
with fowl pox TI for one hour and transfected with 5J-lg 
pcDNAIHAL (1 & 4), or 5J.lg pGempol (2). Two days post 
transfection, cells were labelled with PSS] amino acids for one 
hour and cells were lysed with 1% NP40. Samples of lysates were 
immunoextracted using rat monoclonal a-HA (Roche) (4 & 5) or 
rabbit polyc1onal a-L, MB41 (1,2 & 3). Immunoprecipitated 
proteins were analysed on an 8% acrylamide Laemmli gel. Where 
M= [14C] labelled molecular weight markers, 1= pcDNAIHAL, 
MB41, 2= pGempol, MB41, 3= untransfected, MB41, 4= 
pcDNAIHAL, rat a-HA and 5= untransfected, rat a-HA. 
220~ 
kDa 
M 2 3 4 5 6 
Figure 4.2.2.5. Optimisation of pcDNAIHAL 
expression. Cos-I cells were transfected with varying amounts 
of pcDNAIHAL; two days post transfection, the cells were 
labelled with PSS] amino acids for one hour and lysed with 1 % 
NP40. Celllysates were then treated with 1 J.1l rat monoclonal a-
HA antibody (Roche). Immunoprecipitated proteins were analysed 
on an 8% acrylamide Laemmli gel, alongside [14C] labelled 
molecular weight markers (M). Track 1 = I J-lg pcDNAIHAL, 2= 
2J.lg pcDNAIHAL, 3= 3J-lg pcDNAIHAL, 4= 4J.lg pcDNAIHAL, 
5= 5J-lg pcDNAIHAL and 6= lysate from untransfected cells. 
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enhancer of CMV promoter activity (Gorman & Howard, 1983). At first sodium 
butyrate was used at a final concentration of I .S mM, and was either added to the 
Transfast transfection mix only, or to the pre-warmed medium added post 
transfection, or to both the transfection mix and medium added post transfection 
using 2~g pcDNA/HAL and Cos-I cells (as in section 2.2.16.1). It was 
demonstrated that when sodium butyrate was added to only the medium added 
post transfection expression of HAL was slightly improved for I Jlg transfected 
plasmid, although levels of HAL expression were still poor (see figure 4.2.2.6). 
The experiment was then repeated using final concentrations of sodium butyrate 
at l.SmM, SmM, 7.SmM, IOmM and 12.SmM in only the medium added post-
transfection. However, no improvement was seen in the level of HAL protein 
expression as detected by immunoprecipitation (data not shown). 
Protein expression driven by the CMV promoter can be increased by a number of 
chemical stimuli. These function by activating the transcription factor nuclear-
factor-kappa B (NFKB). NFK'B then binds to four NFK'B binding sites present in 
the CMV promoter sequence which activates CMV promoter dependent 
transcription in cells (Wilkinson & Akrigg, 1992). Other known chemical 
stimulators of the CMV promoter include forskolin (713-Acetoxy-1 a ,613,9a-
trihydroxy-8,13-epoxy-Iabd-14-en-ll-one), from Coleusforskohiii, and a 
combination ofphorbol myristate acetate (PMA) and phytohaemagglutinin 
(PHA) (Clesham et ai., 1996, Wilkinson & Akrigg, 1992). Therefore, forskolin 
(Sigma) was used (at a final concentration of 10Jlmol/L), or PMA (gift from M. 
Denyer, Department of fmmunology, Institute for Animal Health, Pirbright, 
Surrey, UK) (at SOng/mt) and PHA (Sigma) (at 4~g/ml) were used together, or 
alternatively, all three were combined and utilised simultaneously. To determine 
if HAL expression could be increased in the presence of any of these known 
CMV promoter enhancers, each of the above combinations were included in the 
pre-warmed medium added to the cells post transfection, as described in 
(Wilkinson & Akrigg, 1992) and (Clesham et ai., 1996). In each case IJlg 
pcDNA/HAL plasmid DNA was transfected using Transfast (as in section 
2.2. 16.1) and, as a control, pcDNA/HAL was transfected in the absence of any 
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Figure 4.2.2.6. The effect of sodium butyrate (1.5mM) 
on HAL expression. Cos-I cells were transfected with either 1 ~g 
or 2~g pcDNAIHAL and the cells were treated with sodium butyrate as 
described beloW; two days post transfection, cells were labelled with 
PSS] amino acids for one hour and lysed with 1 % NP40. Samples of 
Iysates were immunoextracted with 1 J1l rat monoclonal a-HA antibody 
(Roche) and immunoprecipitated proteins were analysed on 8% 
acrylamide Laemmli gels alongside [l4C] labelled molecular weight 
markers (M). Where 1 = I ~g pcDNAIHAL, no sodium butyrate, 2= 
2~g pcDNAIHAL, no sodium butyrate, 3= untransfected cell lysate, no 
sodium butyrate, 4= I ~g pcDNAIHAL, sodium butyrate in transfection 
mix only, 5= 2~g pcDNAIHAL, sodium butyrate as for 4, 6= 
untransfected cell lysate, sodium butyrate as for 4, 7= I ~g 
pcDNAIHAL, sodium butyrate in medium added post transfection, 8= 
2~g pcDNAIHAL, sodium butyrate as for 7, 9= untransfected cell 
lysate, sodium butyrate as for 7, 10= I~g pcDNAIHAL, sodium butyrate 
in transfection mix and medium added post transfection, II = 2J.lg 
pcDNAIHAL, sodium butyrate as for 10,12= untransfected cell lysate, 
sodium butyrate as for 10. 
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chemical enhancers of the CMV promoter to establish the level of HAL protein 
expression in the absence of any enhancers. The level of HAL expression from 
pcDNAlHAL was shown to decrease in the presence of forskolin alone, but was 
shown with PMA and PHA, or in the presence of all three chemicals, to be the 
same as pcDNAlHAL transfected alone, that is, in the absence of any chemical 
enhancer of the CMV promoter (see figure 4.2.2.7). 
Therefore efforts to boost HAL expression levels when governed by the CMV 
promoter using known chemical stimulators of the CMV promoter resulted in no 
increase being observed, and in one case HAL expression was seen to be reduced. 
As none of the known enhancers ofCMV promoter activity tested produced an 
increase in the level of HAL expression, another possibility was explored. A 
commercially available plasmid, pAdVAntage (Prom ega), was tested next as it 
had previously been shown to enhance levels of protein expression from 
transfected cells (Terenzi et aT., 1999). This plasmid encodes the gene for the 
Adenovirus virus-associated I (VAl) RNA; when co-transfected with plasmid 
constructs of interest, it acts to enhance transient protein expression by increasing 
translation initiation within mammalian cells. This is possibly due to the fact that 
VAl RNA is able to block the activation of the cell protein kinase R (PKR) by 
complexing with it. PKR is an enzyme involved in the host cell's antiviral 
defence system which phosphorylates the translation initiation factor eIF-2, 
thereby preventing host cell translation and consequently protein production. 
PKR is thought to be activated by dsRNA generated as a result of the transfection 
process. To determine ifpAdVAntage could increase HAL expression in 
transfected Cos-l cells, 1 Ilg of pAdV Antage was co-transfected with 1 Ilg 
pcDNAlHAL; in addition to the co-transfection ofpcDNAIHAL with 
pAdV Antage, the media added post transfection contained PMA and PHA. 
When pcDNAlHAL and pAdVAntage were co-transfected in the absence of 
PMA and PHA, a minor increase in HAL expression was observed (figure 
4.2.2.8). 
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Figure 4.2.2.7. Effect of CMV promoter 
chemical enhancers on the expression level of 
HAL from pcDNA/HAL. Cos- I cells were 
trans fected with I~.g pcDN AlHAL; two days post 
trans fection, the cell s were labelled with [35S] amino ac ids 
for one hour and lysed with 1% NP40. Celllysates we re 
then immunoextracted with I ~1 of rat a-H A monoclonal 
antibody (Roche) and immunoprecipitated proteins we re 
analysed on an 8% ac rylamide Laemmli gel alongside 
[1 4C] labelled molecular weight markers (M). Track 1= 
I~.g pcDN A/HAL, 2= I ~g pcDN AlHAL with PMA, PHA 
and forskolin , 3= I ~.g pcDNAlHAL with PMA and PHA, 
4= I ~I.g pcDN AlHAL with forskolin , 5= lysate fro m 
untransfected cells . 
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Figure 4.2.2.8. pAdV Antage increases the level of 
HAL expression in transfected cells. Cos-I cells were 
transfected with the constructs on interest; two days post 
transfection, the cells were labelled with [35S] amino acids for one 
hour and lysed with 1% NP40. Celllysates were then treated with 
I III of rat a-HA monoclonal antibody (Roche) and 
immunoprecipitated proteins were analysed on an 8% acrylamide 
Laemmli gel alongside [14C] labelled molecular weight markers 
(M). Track I = I Ilg pcDNNHAL, 2= Illg pcDNN HAL with Illg 
pAdV Antage, 3= Illg pcDNNHAL with Illg pAdV Antage, with 
PMA and PHA and 4= lysate from untransfected cells. 
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Before the utilisation of pAd VAntage could be optimised, it was observed that 
co-transfection of HAL with RPV N resulted in significantly boosted levels of 
HAL protein expression, even more than that seen with pAdVAntage (figure 
4.2.2.9; note in tracks 2, 3 and 6 there is a background band which migrates just 
above the expected position ofN, see tracks 4 and 5). This apparent increased 
level of HAL protein expression was not due to the co-transfection with an 
additional pcDNA construct, as co-transfection ofpcDNAlHAL with pcDNAIP 
did not result in an increased level of HAL expression (data not shown). To 
determine ifN was exerting this effect on HAL expression by acting to stabilise 
the HAL protein, a pulse-chase experiment was performed. Levels of protein 
expression were then quantitated using a phosphorimager screen, which was 
scanned using a BioRad Personal Molecular Imager FX scanner and protein 
quantification was performed using BioRad Quantity One Quantification 
software. N was demonstrated not to stabilise HAL, as HAL was shown to 
degrade at the same rate in the presence ofN, as when HAL was expressed alone 
(see figures 4.2.2.10 and 4.2.2.11). 
In addition to obtaining good expression of HAL, un degraded expression of C 
was also problematic. Previous work in the laboratory had shown that transiently 
transfected cells using vaccinia T7/T7 promoter-driven expression resulted in the 
majority of the C protein being expressed in a degraded form, unlike C expressed 
in infected cells (Sweetman et 01.,2001), which is why the CMV promoter was 
utilised. Despite driving the expression of C from pcDNAIC using the CMV 
promoter, the majority of C was still expressed in a degraded form (see figure 
4.2.2.1). To address this problem several different cell lines were utilised to 
determine if the degradation of transiently expressed C protein was a common 
event in transfected cells. In addition to Cos-l cells, Vero cells and A549 cells (a 
gift from Dr. S. Moyer, Department of Molecular Genetics and Microbiology, 
University of Florida, Gainesville, Florida, USA) were also tested, however none 
of these cell lines conferred any protection to the expressed C protein. Lysis 
buffers with varying concentrations of protease inhibitors were tested also and 
cells were lysed on ice to minimise any degradation. All failed to yield 
undegraded C protein (data not shown). 
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Figure 4.2.2.9. The effect of RPV N on HAL expression. 
Cos-I cell s were transfected with 2J..lg o f each o f the construct 
indicated. Two days post trans fecti on, cell s were labell ed with [35S] 
amino ac ids fo r one hour and lysed with 1% NP40. Sample of ly ates 
were iml11unoex tracted wi th the relevant antibody and 
immunoprecipitated proteins were analysed on 8% acrylamide Laemmli 
ge ls alongside [1 4C] labe lled molecul ar weight markers (M). Track 1= 
pcDNAlHAL, rat monoclonal u-HA antibody (Roche), 2= 
pcDNA/HAL and pcDN AlN , with rat u -HA, 3= untransfected ce ll 
lysate, rat a-HA, 4= pcDN AlN, rabbit polyc\onal u-RPV N antibody 
(MB2), 5= pcDNAlHAL, pcDN AIN, MB2 and 6= untran fec ted cell 
lysate, MB2. 
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Figure 4.2.2.10. RPV N does Dot appear to stabilise HAL. 
Three batches of Cos-l celts were transfected with 2~g of each of the 
desired constructs (as indicated) in duplicate; two days post transfection 
celts were labelted with PSS] amino acids for one hour. After labelling, 
one batch of cells was lysed with 1 % NP40 (panel A), the two remaining 
batches of celts bad 2ml of whole medium added to each 35mm welt and 
were incubated at 37°C for either 1 hour (panel B) or 3 hours (panel C) 
before lysis with 1% NP40. Samples oflysates were immunoextracted 
with 1~ rat anti-HA monoclonal antibody (Roche) and 
immunoprecipitated proteins were analysed on 8% acrylamide Laemmli 
gels. 
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Figure 4.2.2.11. RPV N does not stabilise HAL. The Laemmli 
gels from figure 4.2.2. 10 were exposed to a phosphorimager screen and the 
screen was scanned using a BioRad Personal Mo lecular fm age r FX canner 
and the anlount of HAL protein present in each sample was quantitated 
using BioRad Quantity One Quanti ficatio n so ftware. The amount of 
labelled HAL is expressed as a percentage of that present at time=O. Each 
data point represents the ave rage value of each set of duplicates. 
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The coding sequence for RPV C was examined in an attempt to explain the 
results obtained to date with the pcDNNC construct. It was thought possible that 
the 15 kDa band seen in both immunoprecipitations and TNT reactions could be 
an additional small protein produced from an extra A TG which resides in the C 
ORF and therefore not actual degradation of the C protein. It could be that this 
smaller protein was being preferentially made over the full-length C protein and 
to determine if this was the case, a new pcDNNC construct, pcDNNnewstartC, 
was made (using Pfu PCR and the primers NewCstart2 and C end primer, see 
appendix 3). This created a construct which changed the C ATG to the optimal 
sequence for initiation by eukaryotic ribosomes, as identified by Kozak (Kozak, 
1986). This new C construct was transfected alongside pcDNNC in Vero cells 
and expression tested by immunoprecipitation. No difference was observed in 
the level of full-length C protein seen and it is therefore likely that the C protein 
really was being degraded (figure 4.2.2.l2). 
Previous work in the laboratory had shown that full-length C protein could be 
obtained from infected cells (Sweetman, 2000, Sweetman et af., 2001). In order 
to test the lysis and immunoprecipitation reagents, expression of C in Vero cells 
and B95a cells infected with RPV (RBOK strain) was compared. B95a cells 
were chosen due to the fact that this is the cell line normally used in the 
laboratory for studies of RPV. RBOK infected Vero celllysates produced 
degraded C protein; however, under identical conditions, un degraded C protein 
was obtained from B95a cells (see figure 4.2.2.13). These observations 
suggested that it was not the expression method that was leading to C 
degradation, but the cell line. To confirm this, B95as were infected with vaccinia 
vTF7-3 and pcDNNC (5J.lg) was transfected, using either Transfast or lipofectin 
as the transfection reagent. As was seen in infected cells, undegraded expression 
ofC was obtained (figure 4.2.2.14). Consequently the optimisation of HAL 
expression from the CMV promoter was no longer necessary and all further 
transient protein expression work was performed using the vaccinia T71T7 
promoter-driven system using B95a cells. 
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Figure 4.2.2.12. Comparison of C protein expression 
by immunoprecipitation from pcDNA/C and 
pcDNA/newstartC constructs. Vera ce ll s were tran fec ted 
with either pcDNA/C (tracks 1 and 2) or pcDN AInewstartC (tracks 
3 and 4); one day post transfectio n, ce ll s we re labelled with [35S] 
amino ac ids for one hour and lysed wi th 1% NP40. Track 5 
represents non-transfected (no DNA) contro l celllysates. Samples 
ofl ysates were immunoextracted with rabbit a-C antibody (MB3 8) 
and immunoprecipitated prote ins analysed on 12% acrylamide 
Laemmli ge ls. 
110 
Chapter 4- Mapping of P, C & V Binding Domains on L 
Veras B95as 
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Figure 4.2.2.13. Undegraded expression of C protein 
from RPV infected cells. In dupli cate, e ither Vero cell s we re 
infected using 25 ~1 o fRBOK per 35 mm di sh (+) or B95a ce ll s were 
in fected using 40~1 of RBOK per 35 mm di sh (+) and nonin fected 
cell s (-) were used as a negati ve contro l; 3 days post in fec ti on, ce ll s 
we re labelled with [35S] amino acids fo r one hOllr and lysed with 1 % 
NP40 buffe r containing protease inhibitor cocktail set III 
(Calbiochem) at a fin al concentration of 11200. Samples of lysates 
we re immunoextracted with MB38, a rabbit polyclonal a -RPV C 
antibody, and immunoprecipitated proteins were analysed on 12% 
acrylamide Laemmli ge ls. 
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Figure 4.2.2.14. Undegraded expression of C protein 
from cells transfected with pcDNA/C using vaccinia 
T7/T7 promoter expression. 8 95a cell s we re in fec ted with 
vTF7-3 and transfected with 5 ~g pcDN NC in duplicate, using 
either Transfast or lipofectin as the trans fection reagent. In both 
cases a negative control sample was included which contained no 
DNA. One day post transfection, cells were labell ed with [35S] 
amino acids for one hour and lysed with 1% NP40. Samples o f 
Iysates were immunoextracted with MB38, a rabbit polyclonal u-
RPY C antibody, and immunoprecipitated proteins were analysed 
on 12% ac rylamide Lae mmli gels. 
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For the remainder of these studies, transfections were performed using lipofectin 
transfection reagent (section 2.2.16.2) and B95a cells, and proteins were 
expressed using the vaccinia T7/T7 promoter-driven expression system (section 
2.2.17). 
4.2.3 Co-Immunoprecipitation of Full-Length L with P, C and V 
To show that this system was fully functional, co-immunoprecipitations (co-ips) 
using full-length HA-tagged L together with P, C or V were performed to confirm 
that these three viral proteins each co-ip L. In each case 5J.lg pcDNAlHAL was 
co-transfected with either pcDNAIC (5J.lg), pcDNAIP (5J.lg) or pcDNAIV (5J.lg) 
and proteins transiently expressed using B95a cells. One day post transfection, 
cells were radiolabellcd and lysed (as described in section 2.3.4). Celllysates 
were immunoextracted using the rat a-HA monoclonal antibody, MB38, a rabbit 
polyclonal a-RPV C, 2-1, a mouse monoclonal a-RPV P or U32, a mouse 
monoclonal a-RPV P antibody which had been found to recognise an epitope 
common to P and V (for the detection of V). Immunoprecipitated proteins were 
analysed on either 8% or 12% acrylamide Laemmli gels. The C and P proteins 
were both shown to co-immunoprecipitate full length HA-tagged L, expressed 
from pcDNAlHAL (figure 4.2.3.1), showing that this system was functional and 
confirming these previously identified interactions. However, the V protein 
failed to co-ip HAL (see figure 4.2.3.2). 
To confirm the L-V interaction by co-ip, an existing laboratory construct 
expressing a glutathione-S-transferase (GST)-tagged version of V, pGSTV 
(Sweetman et al., 2001) (5J.lg), was co-transfected with pcDNAlHAL (5J.lg) into 
B95a cells. The transfected celllysates were extracted using either rat a-HA or 
MB38 since this antibody was raised against a GST-fused C protein and will thus 
recognise all GST fusions and can be used as an a-GST antibody. This GST-
tagged form of the V protein migrates at ~66 kDa (true size 59 kDa) and was 
shown to co-ip full length L in this system (figure 4.2.3.2). Earlier work in the 
laboratory had shown that GST did not interact with full-length L (Sweetman, 
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Figure 4.2.3.1. P and C co-immunoprecipitate full-
length L expressed from pcDNAIHAL. B95a cells were 
infected with vTF7-3 and traosfected with the desired constructs 
(as indicated); one day post traosfection. cells were labelled with 
[35S] amino acids for one hour and lysed with 1 % NP40. Samples 
of lysates were immunoextracted with the appropriate antibody 
(see above) and immunoprecipitated proteins were analysed on 
either 8% (for pcDNAIP and pcDNAIHAL) or 12% (for pcDNAlC 
and pcDNAIHAL) acrylamide Laemmli gels. 
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Figure 4.2.3.2. V -L co-immunoprecipitation could 
be shown using GST -tagged V, but not V itself. B95a 
cells were infected with vTF7-3 and transfected with the desired 
constructs (as indicated); one day post transfection, cells were 
labelled with PSS] amino acids for one hour and lysed with 1 % 
NP40. Samples oflysates were immunoextracted with the 
appropriate antibody (see above) and immunoprecipitated proteins 
were analysed on 8% acrylamide Laemmli gels. 
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2000); pGSTV was therefore used in place ofpcDNAIV for the remainder of 
these L binding studies. The most likely explanation for the failure of V to co-ip 
L is that the anti-V antibody which was utilised (U32) was displacing the L 
protein. 
In all experiments, P, C or GSTV were shown to co-ip HAL but in the majority of 
cases the reverse co-ip was not seen (data not shown). In addition when it was 
possible to show HAL co-immunoprecipitating a protein, the protein co-
immunoprecipitated was always brought down in small quantities, especially 
when compared to the amount of HAL that was brought down by the protein in 
question (data not shown). This inefficiency of co-ip when using HAL or other 
HA-tagged proteins was seen throughout this work, though the underlying cause 
was never determined. 
4.2.4 Preparation of HAL Domain Constructs 
Initially three L domain constructs were generated, each of which contained one 
of the three conserved domains, as identified by McIlhatton and co-workers 
(McIlhatton et al., 1997), with the relevant hinge region(s) (see figure 4.2.4.1). 
Each of the three inserts was produced using PJu PCR, with pcDNAlHAL as the 
. template DNA. The first construct, pcDNAlHAL1, encompasses the first of the 
three conserved domains of L in addition to the first of the two proposed hinge 
regions, spanning the first 1950 base pairs (bp) of L. pcDNAlHAL2 (3333bp in 
size) consists of the second of the three conserved domains of L and each of the 
two proposed hinge regions, covering 1820-5152bp of L. pcDNAlHAL3 
(1527bp in size) comprises the third and final conserved domain of L as well as 
the second ofthe two hinge regions, covering 5084-661Obp of L. pcDNAlHALl 
was generated using the primers HALl start and HAll end, pcDNAlHAL2 using 
primers HAL2start and HAL2end, whilst pcDNAlHAL3 was made using the 
primers HAL3start and Lend (from the MTHS work, see appendix 3 for primer 
sequences). Each domain was cloned into pcDNAlHAINot with the re-
introduced NotI site (NotV XhoI cut) (as described in section 4.2.1.) for co-
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Figure 4.2.4.1. Diagrammatic representation of the three initial L domain constructs prepared for 
co-immunoprecipitation studies. The L proteins of morbilli viruses have been shown to consist of two regions of poor 
sequence identity (binge regions) , which separate three highly conserved domains along the length of the L protein, To identify 
which domain of L interacts with P, C and V these three sec tions were cloned separate ly , fusing their coding sequence to that of 
the HA epitope tag, as described in the text. 
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immunoprecipitation studies. Thus each domain was HA-tagged at the amino-
terminus of the inserted region of the L protein, enabling the use of the rat a-HA 
monoclonal antibody from Roche, as previously used in these studies. 
All three constructs were sequenced at the 5' and 3' ends of the inserted coding 
region, for confirmation purposes. 
4.2.5 Verification of Protein Expression from HAL Domain 
Constructs 
To confirm protein expression from each of these three constructs, 2Jlg plasmid 
DNA was transfected into B95a cells using the vaccinia T7/T7 promoter-driven 
expression system (as in section 2.2.17). Celllysates were immunoextracted 
using rat monoclonal a-HA antibody and immunoprecipitated proteins were 
analysed on 8% acrylamide Laemmli gels. Expression of each of the three 
domain constructs was seen, with proteins migrating as expected, HALl 
(~71.5 kDa), HAL2 (-122 kDa) and HAL3 (~56 kDa). Expression of these 
constructs was roughly optimised by transfecting varying quantities of each of the 
three domain constructs. Both HALl and HAL3 were transfected using 3Jlg, 5Jlg 
or 7.5Jlg amounts of plasmid DNA, whilst O.5Jlg, IJlg and 2Jlg amounts ofHAL2 
were used. Lower amounts ofpcDNNHAL2 were used as, when expression of 
these three constructs was initially tested, HAL2 was expressed at a higher level 
than either HALl or HAL3. All constructs were transiently transfected into B95a 
cells using vaccinia T7/T7 promoter-driven expression and levels of protein 
expression were determined by immunoprecipitation (as in sections 2.2.17 and 
2.3.4, see figure 4.2.5.1). It was decided that 5Jlg plasmid DNA would be used 
for transfections of either HALl or HAL3, and that 2Jlg of plasmid DNA would 
be used for transfections ofpcDNNHAL2 when using the transient T7 
expression system. 
During the optimisation of protein expression from these L domain constructs, it 
was observed that the HALl protein migrated as a doublet. However, this 
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Figure 4.2.5.1. Expression optimisation of 
pcDNA/HAL domain constructs. 8 9Sa ce lls were 
infected wi th vTF7-3 and transfected wi th the desired con tructs; 
one day po t transfection, cells were labe lled wi th [35 ] amino 
acids for one hour and lysed with 1 % P40. Samples of lysate 
were immunoextracted with 1 pI rat monocl onal a-HA ant ibody 
and immunopreeipitated proteins were analy ed on 8% 
ac ryl amide Laemmli ge ls alongside [1 4 ] labe lled molecular 
we ight marker (M). peON HALl was transfected using either 
3pg ( \ ,2), Spg (3, 4) or 7.S pg (S , 6) amount o f plasmid DNA. 
peDNAlHAL2 was transfeeted us ing either O .S ~tg (7, 8), \ pg (9 , 
10) or 2pg (II , 12) amounts of plasmid D A. pcDN HAL3 
wastransfeetedu ingeither 3pg( 13, 14),S pg( IS, 16)or 7.S pg 
(17, 18) amou nt of plasmid D A. 
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appears to have been an artefact of some kind, as, in all later experiments, HAll 
was seen to migrate as a single band. 
4.2.6 Identification of the Different Domains of L which Interact 
with the P, C and V Proteins 
As it had previously been shown that GST did not interact with full-length L, it 
was expected that GST would not interact with any of the HAL domain 
constructs. To confirm that this was the case, transfections were set up for each 
of the HAL domain constructs with pGST using the vaccinia T7 expression 
system. One day post transfection, cells were radiolabelled and lysed (section 
2.3.4). Celllysates were then immunoextracted with either rat a-HA (l JlI) or 
rabbit a-GST (MB38, 1 JlI) and immunoprecipitated proteins were analysed using 
10% acrylamide Laemmli gels. It was found that, as expected, GST does not 
interact with any of the HAL domain constructs (figure 4.2.6.1), thereby enabling 
the use ofpGSTV for this part of the study. 
To identify the region of the L protein to which the P, C and V proteins bind, 
each HAL domain construct was co-transfected with pcDNNP, pcDNNC, or 
pGSTV and transfected cells radiolabelled and lysed (as in section 2.3.4) one day 
post transfection. Celllysates were then immunoextracted with the relevant 
antibodies and immunoprecipitated proteins analysed on the relevant 
percentage acrylamide Laemmli gel. For pcDNNP, pcDNNC and pGSTV, 5Jlg 
plasmid DNA was co-transfected with 5Jlg of HAll or HAL3, or with 2Jlg of 
HAL2. 
When pcDNNP was co-transfected with each of the three HAL domain 
constructs, it was found that P co-immunoprecipitated HAll, but not HAL2 or 
HAL3 (see figure 4.2.6.2). Unfortunately the reverse co-ip (that is, HAll co-
immunoprecipitating P) could only be shown on one occasion out of four (data 
not shown). P therefore interacts with the first conserved domain of the L 
protein. The C protein on the other hand was shown to co-immunoprecipitate 
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Figure 4.2.6.1. GST does not bind to any of the L 
subdomains. B95a cells were infected with vTF7-3 and tnmsfected 
with the desired constructs (as indicated); one day post transfection, cells 
were labelled with PSS] amino acids for one hour and lysed with 1 % 
NP40. Samples oflysates were immunoextracted with the appropriate 
antibody (see above) and immunoprecipitated proteins were analysed on 
100/0 acrylamide Laemmli gels. 
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P + + + + 
HALl + + + + 
aP + + + + 
aHA + + + + 
p -+ 
HALI-+ 
P + + + + 
HAL2 + + + + 
aP + + + + 
aHA + + + + 
HAL2-+ 
p-+ 
p + + + + 
HAL3 + + + + 
aP + + + + 
aHA + + + + 
p -+ 
HAL3-+ 
Figure 4.2.6.2. Co-immunoprecipitations of P with 
pcDNAIHAL domain constructs. B95a ceLIs were infected with 
vTF7-3 and transfected with the desired constructs (as indicated); one day post 
transfection, cells were labelled with rSS] amino acids for one hour and lysed 
with 1 % NP40. Samples oflysates were immunoextracted with the appropriate 
antibody (see above) and immunoprecipitated proteins were analysed on 8% 
acrylamide Laemmli gels. 
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HAL2, and not HALl or HAL3 (see figure 4.2.6.3) and the reverse co-ip was 
demonstrated, that is HAL2 was shown to co-ip C. GSTV, like C, was shown to 
co-ip HAL2 and the reverse of this interaction was also seen to a lesser extent 
(see figure 4.2.6.4). As was shown for full-length HAL, the HAL domains were 
shown to co-ip lower levels of P, C or GSTV, than the levels of HAL (lor 2), 
that each ofP, C or GSTV co-immunoprecipitated. These results were 
reproduced on at least three separate occasions . 
. Whilst performing these binding studies it was found that GSTV migrates at 
exactly the same position as HALl on Laemmli gels (figure 4.2.6.4). It was 
therefore impossible at this stage to eliminate V binding to HALl. As a result, it 
was necessary to produce a further V construct. A construct was designed that 
would express a V protein tagged at the amino terminus with the short c-Myc 
epitope, thereby creating a V protein that would migrate at a faster rate than 
HALl, enabling the determination of whether V interacts with HALL To 
generate the c-Myc tagged V construct the existing pGSTV plasmid was 
manipulated. pGSTV was digested with EcoRI and NcoI to remove the unwanted 
GST tag and a c-Myc tag (amino acid sequence, from Invitrogen: Glu GIn Lys 
Leu lIe Ser Glu Glu Asp Leu) was inserted using specifically designed 
overlapping kinase-treated primers, cmycfor and cmycrev (see appendix 3 for 
primer sequence). The resulting pGemlc-MycV construct was confirmed by 
sequence analysis ofthe inserted c-Myc tag sequence. Whilst confirming the 
sequence of the construct, it was noted that one of the primers had been mis-
synthesised by the manufacturer. Fortunately the error in the primer sequence did 
not affect the c-Myc tag, nor the reading frame of the construct (see figure 
4.2.6.5). 
To confirm that the construct was expressing a c-Myc tagged version of V, 
expression was checked by immunofluorescence microscopy. pGem/c-MycV 
(5Jlg) was transiently expressed using vaCcinia r7 in B95a cells (as in section 
2.2.17). One day post transfection, cells Were fi~ed and permeabilised with 0.1 % 
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C + + + + 
BALI + + + + 
aC + + + + 
aHA + + + + 
BALI--+ 
C--+ 
C + + + + 
BAL2 + + + + 
aC + + + + 
aHA + + + + 
HAL2 
C-.... I_-
C + + + + 
HAL3 + + + + 
aC + + + + 
aHA + + + + 
HAL3--+ 
C 
Figure 4.2.6.3. Co-immunoprecipitations of C with 
pcDNAIHAL domain constructs. B95a cells were infected 
with vTF7-3 and transfected with the desired constructs (as 
indicated); one day post transfection, cells were labelJed with [35S] 
amino acids for one hour and lysed with 1 % NP40. Samples of 
Iysates were immunoextracted with the appropriate antibody (see 
above) and immunoprecipitated proteins were analysed on 12% 
acrylamide Laemmli gels. Gels shown have been split to save space. 
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GSTV + + + + 
HALl + + + + 
aGST + + + + 
aHA + + + + 
HALl } 
GSTV 
GSTV + + + + 
HALl + + + + 
aGST + + + + 
aHA + + + + 
HAL2~ 
GSTV~ 
GSTV + + + + 
HAL3 + + + + 
aGST + + + + 
aHA + + + + 
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HAL3~ 
Figure 4.2.6.4. Co-immunoprecipitations of GSTV with 
pcDNAIHAL domain constructs. B95a cells were infected with 
vTF7-3 and transfected with the desired constructs (as indicated); one day 
post transfection. cells were labelled with PSS] amino acids for one hour and 
lysed with 1 % NP40. Samples of lysates were immunoextJacted with the 
appropriate antibody (see above) and immunoprecipitated proteins were 
analysed on 8% acrylamide Laemmli gels. 
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Met Glu Met Gly Leu Ile Ser Glu Glu Asp Leu Ala Met 
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Figure 4.2.6.5. Sequence analysis of the c-Myc tag inserted at the amino terminus of the V protein. 
The primers ordered for the generation of the c-Myc tagged V construct (cmyefor and cmycrev) were designed to insert a small 
spacer amino acid at the end of the c-Myc sequence (highlighted in blue) before the start of the V open reading frame. This was 
designed to be a glycine residue, but due to the mis-synthesis of the primer(s) the sequence reads GCC (alanine) instead of GGC 
(g lycine), as highlighted by the red box. This error in the primer sequence was not in a critical region of sequence, so neither the 
reading frame of the construct, nor the c-Myc tag were affected. 
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Triton X-I 00 before labelling with antibody. Cells were labelled using either 
9EIO, a monoclonal mouse a-c-Myc antibody (Santa Cruz Biotechnology) or a 
monoclonal rat a-c-Myc antibody (Serotec) (figure 4.2.6.6). Clear expression of 
c-MycV was observed. 
However, it was not possible to immunoprecipitate c-MycV using 9EI O. It was 
confirmed by immunoprecipitation that the pGem/c-MycV was expressing the V 
protein as lysate of cells transfected with pGem/c-MycV immunoextracted with 
U32 (a-V antibody) pulled down the V protein (see figure 4.2.6.7). The problem 
was therefore with the a-c-Myc antibody being utilised. Due to time constraints, 
celllysates transfected with pGem/c-Myc V were immunoextracted using 1 J-ll of 
each of the following a-c-Myc antibodies simultaneously; A-14 (rabbit a-c-Myc, 
Santa Cruz Biotechnology), 9EI 0 and rat a-c-Myc. As a control, cell lysate 
transfected with pGem/c-MycV was also immunoextracted, using 9ElO. Using 
the combination of the three antibodies raised against the c-Myc epitope, c-MycV 
was shown to be immunoprecipitated from cells transiently transfected with 
pGem/c-MycV (figure 4.2.6.8). 
It should now have been possible to determine if V interacts with the first 
conserved domain ofL. To do this A549 cells were co-transfected with a 
combination of either pcDNNHAL and pGem/c-MycV, or with pcDNNHALl 
and pGem/c-MycV, along with the appropriate controls of the singly transfected 
plasmids, in addition to untransfected cells. However, whenever pGem/c-MycV 
was co-transfected with either pcDNAlHAL or pcDNAlHALl, the level of 
protein expression, particularly of c-MycV, was seen to be reduced (figure 
4.2.6.9). To see if this problem was specific for c-MycV and HAL or HALl, all 
plasmids which were previously transfected singly as controls were now co-
transfected with a null plasmid (pcDNA3), so that the same amount of DNA was 
being transfected in all cases. These experiments showed that, when transfected 
with any other plasmid, the expression of c-MycV was almost eliminated (figure 
4.2.6.10). The same experiments were performed using separate CsCI maxi-
127 
Chapter 4- Mapping of P, C & V Binding Domains on L 
Mouse a c-Myc Rat a c-Myc 
Figure 4.2.6.6. Immunofluorescence confocal 
microscopy of cells transfected with pGem/c-MycV. B95a 
cells were infected with vTF7-3 and transfected with pGem/c-MycV. 
One day post transfection, cells were fixed and permeabilised with 0.1 % 
Triton X-l00 before staining with antibody. Cells were reacted with 
either mouse a-c-Myc (9EI0, Santa Cruz Biotechnology), at a dilution 
of 1110 and the primary antibody visualised with Alexa Fluor 488 a-
mouse IgG, at a dilution of 11200 (A), or with rat a-c-Myc (Serotec), at 
a dilution of 11200 and the primary antibody visualised with Alexa Fluor 
488 a-rat IgG, at a dilution of 11200 (D). B and E show nuclei of cells 
counter-stained using DAPI and overlay of the stains used is shown in C 
and F. 
pGEM/c-MycV 
66 kDa 
c-MycV ----+ 
46 kDa 
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a P/V a c-Myc 
+ + 
2 3 4 
Figure 4.2.6.7. Verification of V protein 
expression from pGem/c-MycV. B9Sa cells we re 
infected with vTF7-3 and transfected with SI-I.g of pGem/c-
MycY; one day post transfection, the cells were labe lled 
with [35S] amino ac ids for one hour and lysed with 1% 
NP40. Cell Iysates were then treated with either O.SIlI of 
U32 (mouse a-PlY monoclonal antibody) (track I and 2) 
or with I III 9E 10 (mou e a-c-Myc monoclonal antibody, 
Santa Cruz Biotechnology) (tracks 3 and 4) and 
immunoprecipitated proteins were anal ysed on 8% 
acrylamide Laemmli gels, alongside [1 4C] labell ed 
molecular weight markers (M). Track 1= 51-1g pGem/c-
MycY, U32, 2= untransfected ce ll lysate, U32 , 3= SI-I g 
pGem/c-MycV, 9E l 0 and 4= untransfected ceilly ate, 
9EIO. 
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9El0 mi xture 
pGEMlc-MycV + + 
M 1 2 3 4 
66 kDa 
+- c-M ycY 
46 kDa 
Figure 4.2.6.8. Immunoprecipitation of c-MycV 
protein expression from pGem/c-MycV using a 
combination of anti-c-Myc antibodies. A549 cell s were 
infected with vTF7-3 and transfected with 5!!g o fpGem/c-MycY; one 
day post transfection, the cell s were labelled with [35S] amino acids for 
one hour and lysed with 1% NP40. Celllysates were then treated with 
either 2111 o f a previously tested aliquot of9E 10 (mouse a-c-Myc 
monoclonal antibody, Santa Cruz Biotechnology) (tracks I and 2) or 
with I!!I of each of9E 10 (mouse a -c-Myc monoclonal antibody, Santa 
Cruz Biotechnology), A-1 4 (rabbit a -c-Myc antibody, Santa Cruz 
Biotechnology) and rat a-c-Myc antibody (Serotec) (tracks 3 and 4) 
and immunoprecipi tated proteins were analysed on 8% acrylamide 
Laemmli ge ls, alongside [1 4C] labelled molecular weight marker (M). 
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c-MycV + + + + 
HAL + + + + 
a c-Myc + + + + 
aHA + + + + 
HAL -. 
c-MycV -. 
c-MycV + + + + 
HALl + + + + 
a c-Myc + + + + 
aHA + + + + 
HALI-' 
c-MycV -. 
Figure 4.2.6.9. Co-transfection with pGemlc-MycV 
reduces levels of c-MycV expression. A549 cells were 
infected with vTF7-3 and transfected with the desired consbucts (as 
indicated); one day post transfection, cells were labelled with PSS] 
amino acids for one hour and lysed with 1 % NP40. Samples of 
lysates were immunoextracted with either 1 Jll rat anti-HA (Roche) or 
a mixture of anti-c-Myc antibodies (1J.1l of each of9ElO, mouse a-
c-Myc (Santa Cruz Biotechnology), A-14 (rabbit a-c-Myc (Santa 
Cruz Biotechnology) and rat a-c-Myc (Serotec)),as indicated above, 
and immunoprecipitated proteins were analysed on 8% acrylamide 
Laernmli gels. 
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c-MycV + + + + 
HAL + + + 
Null + + + 
ac-Myc + + + + 
aHA + + + + 
HAL ----. 
c-MycV ----. 
c-MycV + + + + 
HALl + + + 
Null + + + 
ac-Myc + + + + 
aHA + + + + 
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Figure 4.2.6.10. Co-transfection with a null plasmid 
virtually eliminates c-MycV expression. A549 cells were 
infected with vTF7-3 and transfected with the desired constructs (as 
indicated); one day post transfection, cells were labelled with PSS] 
amino acids for one hour and lysed with 1 % NP40. Samples of 
lysates were immunoextracted with either IJ!l rat anti-HA (Roche) or 
a mixture of anti-c-Myc antibodies (1J1l of each of9ElO, mouse a-
c-Myc (Santa Cruz Biotechnology), A-14 (rabbit a-c-Myc (Santa 
Cruz Biotechnology) and rat a-c-Myc (Serotec»,as indicated above, 
and immunoprecipitated proteins were analysed on 8% acrylamide 
Laemmli gels. 
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preps prepared from two different clones of the pGemlc-MycV construct, but no 
difference was observed in the expression of c-MycV. Due to time constraints 
the problem of whether or not V interacts with HALl remains unsolved. Work is 
currently in progress investigating this area of my PhD project using Qiagen 
midi-preps ofpGem/c-MycV (previous work has indicated that Qiagen midi-
preps may result in a higher level of transient protein expression when compared 
to CsCI maxi-preps), in addition to using another recently made construct which 
expresses a V protein which has a 6-HIS tag at its amino-tenninus. It is hoped 
that one of these avenues will allow us to detennine if V and HALl interact by 
co-immunoprecipitation. 
While these co-ip studies were being perfonned, the yeast two-hybrid system 
(Y2HS) was utilised to further characterise the P, C and V binding sites on L. 
4.2.7 Preparation of Further L Domain Mutants for Finer Mapping of 
P, C and V Binding Sites 
The Y2HS was chosen as a suitable system to further characterise the sequences 
of L required for interaction with each ofthe P, C and V proteins. At the time 
this work was started the Y2HS had been functioning as expected and it was 
thought that, when compared to co-ip analysis ofprotein:protein interactions, the 
Y2HS would require less "hands on time", which was a critical factor at this 
stage of the research. 
To enable more exact identification of the sequences of L interacting with P, C 
and V, a panel of carboxy-tenninal domain deletions of L was made from an 
existing laboratory yeast plasmid, pAS2/L. Using a combination of naturally 
occurring restriction sites within the L protein and Pfu PCR, L deletion mutants 
were prepared, each starting at the beginning of the L protein (figure 4.2.7.1). 
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Figure 4.2.7.1. Diagrammatic representation of pAS21L carboxy-terminal domain deletions. 
Mutants denoted in black were created using restriction sites naturally occurring in L. Mutants denoted in blue were 
created by amplifying the coding region of interest from pAS2/L, using Pfu peR, and cloning the resulting insert into a 
suitable pAS2 vector. 
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Regions of the L protein covered by each mutant and the method of construction 
can be seen in table 4.2.7.1. All carboxy-terminal domain deletions generated by 
Plu PCR (see table 4.2.7.1) consisted of Neol/SmaI inserts, which were then 
cloned into pAS2 (Neol/SmaI cut). All reactions used the HALl start primer in 
addition to a specific primer designed for each mutant, and pcDNAlHAL was 
used as the template for each reaction performed. Deletion mutants generated by 
restriction enzyme digestion were digested with the enzyme indicated (see table 
4.2.7.1) in addition to digestion with San, prior to treatment with T4 DNA 
polymerase, which blunt-ended the batch of prepared digested plasmid. Addition 
ofT4 DNA ligase was all that was required for a simple re-ligation. 
Further to these carboxy terminal deletion mutants of L, Y2HS constructs were 
made which corresponded to each of the three L domain constructs prepared 
previously for the co-immunoprecipitation studies (see section 4.2.6), Ll 
(pcDNAlHALl), L2 (pcDNAlHAU) and L3 (pcDNAlHAL3). LI was generated 
by digesting pT7blue/HALl with Neol and San, and ligating the resulting insert 
into pAS2 (Neol/San cut). The insert for L2 was produced by digesting 
pcDNAlHAL2 with EeoRI and XmnI and this was then cloned into pGBT9 
(Clontech) (EeoRI/SmaI cut). The insert for the L3 construct was obtained by 
digesting pcDNAlHAL3 with EeoRI and StuI, the resulting insert was then 
cloned into the same batch ofpGBT9 that was used for the production of the L2 
construct. 
In all cases, constructs were sequenced at the 5' and 3' ends for confirmation 
purposes. Each L mutant was then used in the yeast two-hybrid system for the 
analysis of the binding properties of L with each of P, C and V. 
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Clone Region of L Region of L Method of 
Na me covered ( bp) cove red Construction 
(amino acids) 
LI-1 22 1-1 26 1-42 Restric tion digest 
(Bam HI ) 
LI-360 1-336 I- I 12 Restriction digest 
(Acc6S I) 
L1-S00 I-S I9 1-1 73 Pfu pe R 
L I-SOOrev primer 
L1-700 1-699 1-233 Pfo pe R 
L1-700rev primer 
LI-900 1-897 1-299 Pfu PCR 
L 1-900rev primer 
LI- I IOO 1- 1089 1-363 Pfu PCR 
L I- I I OOrev primer 
L1 -1200 1-I IS8 1-386 Re triction d igest 
(£CoNI ) 
L1- 1500 1- 1497 1-499 Pfil PCR 
L 1-1500rev primer 
L1- 1800 1- 1839 1-6 13 Restriction digest 
(SacI l) 
L1 -1 900 1-1 935 1-645 Restriction digest 
(Age l) 
L1-2 100 1-2 11 5 1-705 Restriction digest 
(Sfo l) 
L1-2400 1-2400 1-800 Pfil pe R 
L1-2400rev primer 
L1 -3 100 1-32 13 1- 1071 Restric tion d igest 
(Sma!) 
L1-3640 1-3639 1- 12 13 Re triction d igest 
(AatIl ) 
Table 4.2.7.1. Carboxy-terminal domain deletions of 
full-length L. A panel o f carboxy-terminal domain deletions ofL 
were made us ing a combination of Pf u PC R to generate the codi ng 
regions ofL requ ired and then cl oning the resul ting insert into the yeast 
expression vector pAS2 o r, using un ique naturall y occun'ing restriction 
sites found along the length of L, an exi sti ng full -length L yeast 
construct, pAS2/L, was d igested with a spec ific enzyme, in add ition to 
digesti on with SaIl . Digested preparations o fpAS 2/L we re then blunt-
ended using T4 DNA polymerase and re-ligated u ing T4 DNA ligase. 
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4.2.8 Identification of More Exact Binding Regions on L for P, C 
and V 
Once these L deletions were confirmed by sequence analysis, each of the 
constructs was then co-transformed using AHI09 yeast cells with yeast constructs 
expressing each of P (pACT2/P), C (pACT2/C) and V (pACT2/V). To test for 
autoactivation properties, each mutant was also co-transformed with empty 
pACT2 vector. In all cases 200ng of each plasmid used was transformed and 
interactions were screened for by using two of the three available reporter genes; 
adenine biosynthesis and histidine biosynthesis. If a negative result was obtained 
for either assay, then that particular pairing of constructs was scored as not 
interacting with each another. None of the L deletions generated were found to 
autoactivate when transformed using AH I 09s. 
Co-transformation of each of the carboxy-terminal deletions of L with P revealed 
that the P binding site requires the first 700bp of L (see table 4.2.8.1), mapping to 
between amino acids 1 and 233, which fit with the co-ip ofP and HALl (4.2.6). 
The same batch of L deletions when co-transformed with each of the non-
structural proteins C and V, identified the region of L required for interaction 
with these two proteins lies in the first 11 OObp of L, which is the equivalent to 
somewhere between amino acids 1 and 363 of L (see table 4.2.8.1). This was a 
surprising result as this region of L is well inside the first conserved domain of L. 
Using co-immunoprecipitations it had been revealed that the L binding sites of 
these two proteins lie somewhere in the second of the three conserved domains, 
with no hint of an interaction occurring between HALl and C. The interaction 
between HALl and V remains untested. 
To determine which domain of L each protein bound to within the yeast two-
hybrid system, the yeast L domain mutants (Ll, L2 and L3) were each co-
transformed with P, C and V (data not shown). As indicated from the yeast 
experiments with the carboxy terminal deletions of L, all three viral proteins were 
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RPVL Yeast P C V I 
Mutant 
Ll -1 22b~ X X X 
Ll -360bp X X X 
Ll -500bR X X X 
Ll -700~ .; X X 
Ll -900bR .; X X 
Ll - llOObp .; .; .; 
Ll -1200bR .; .; .; 
Ll - 1500b~ .; .; ., 
Ll -1800bp ., .; ., 
Ll -1900bp .; ., ., 
Ll -2100bp ., ., ., 
Ll -2400bp ., ., ., 
Ll -3100bp .; ., ., 
Ll -3640bR .; ., ., 
Table 4.2.8.1. Interact ion of carboxy-termin al deletions of full-length L with P, C and V in the 
yeast two-hybrid system. Using the yeast two-hybrid system each of the above L deletions were co-trans fonn ed 
wit h each of P, C and V into A H 109 ce lls and interact io ns investigated . Ifa n interaction was scored as positive, then a 
positive result was obtained for beta- galactosidase acti vi ty and adenine biosyn thesis. If one of these assays produced a 
negative resu lt, then the pairing was deemed to yield no interaction. 
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shown to interact with Ll. In addition, no interaction was detected between L2 
and any ofP, C or V. This was another unexpected result, as both C and V were 
expected to interact with L2, based on the co-ip data. On a more positive note 
none of the three proteins were found to interact with L3, which was as expected. 
To confirm that L1 was just not interacting with any protein sequence inserted 
into pACT2, L1 was co-transformed with pACT2N. RPV N is known to not 
interact with RPV L and so no interaction between the two was expected. Co-
transformants were screened for both adenine biosynthesis in addition to histidine 
biosynthesis, as with all the previous pairings. No interaction was detected 
between L1 and N, suggesting that the interaction observed between L1 and both 
C and V is genuine within this system. 
The lack of an interaction between L2 and either C or V was an obvious problem 
in these mapping studies. It remains unknown why the L2 mutant was defective 
within this system. 
Each of the co-transformations described here was performed on three separate 
occasions, with the same results and conclusions being drawn. 
4.2.9 Demonstration of RPV L Self-Association 
Early work during the start of this project involved investigating the possibility of 
an RPV L self-association using the Y2HS. However, despite numerous attempts 
to uncover an L-L interaction, no such interaction was observed within this 
system (data not shown). The results obtained in 4.2.8 suggested that some clear 
interactions (such as C and L2 or V and L2) might not be detected by the Y2HS, 
so co-immunoprecipitation studies were used to look for an L-L interaction. 
Using the vaccinia transient expression system as previously described, pGempol 
(5Jlg) and each of the three HAL domain constructs were co-transfected into 
B95a cells. It was clearly shown that HALl co-immunoprecipitates full-length L, 
. 
revealing that L self-associates through interaction with the first of the three 
conserved domains (see figure 4.2.9.1). Unfortunately the reverse of this co-ip 
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HALl + + 
L + + 
aHA + + + 
220 kDa ~L 
97.4 kDa 
66 kDa ~ HALl 
HAL2 + + 
L + + 
aliA + + + 
220 kDa 
~ HAL2 
97.4 kDa 
HAL3 + + 
L + + 
aliA + + + 
220 kDa 
97.4 kDa 
66 kDa 
~ HAL3 
46 kDa 
Figure 4.2.9.1. Co-immunoprecipitations of L with 
pcDNA/HAL domain constructs. 8 95a ce ll s were infected with 
vTF7-3 and trans fected with the de ired constructs (a indicated); one day 
post tran fec ti on, cells we re labell ed wi th [35S] amino acids for one hour and 
lysed wi th 1% NP40. Samples of lysates we re immunoextracted with I~ll 
monoclonal rat a-HA antibody (Roche) and immunoprecipitated protein 
were analysed on 8% ac rylamide Lae mmli gels, alongs ide [1 4C] labell ed 
molecular weight ma rker (the fir t track on each ge l). 
140 
Chapter 4- Mapping ofP, C & V Binding Domains on L 
could not be demonstrated due to the fact that the only antibody available against 
the L protein, MB41, is unsuitable for immunoprecipitations as it generates a lot 
of background. To confirm this interaction, a further full-length L construct 
needs to be designed which is tagged with an epitope such as the c-Myc epitope, 
so that two commercially available antibodies may be used in the same 
experiment. 
Initially it was thought that L also interacted with HAL2, as a protein similar to 
L was co-immunoprecipitated with HAL2 (figure 4.2.9.1). However, on closer 
inspection and subsequent sets of transfections and immunoprecipitations, it was 
revealed that this band, which was thought to be L, in fact migrates faster than 
full-length L. This band was found in all extracted lysates produced from cells 
which were co-transfected with pcDNAlHAL2 and pGempol. It was not seen in 
lysates where pGempol was co-transfected with either HALl or HAL3. These 
data would be explained if the vaccinia vTF7-3 used in this transient expression 
system is producing this extra band, possibly by recombination ofpcDNA/HAL2 
and pGempol, indicating that these two plasmids share sequence that is 
particularly susceptible to recombination. 
4.3 Discussion 
Co-immunoprecipitation studies were used as a method with which to further 
characterise known protein:protein interactions of the rinderpest L protein. 
Before any immunoprecipitations could be performed it was necessary to make 
new protein expressing constructs in the pcDNA vector. Expression ofthe P and 
N constructs was easily optimised, but good levels of Land C protein expression 
were difficult to obtain. Expression levels of L were extremely low when driven 
by the CMV promoter, but when the T7 promoter was used a good level of L 
protein expression was seen. Attempts to increase the level of protein expression 
included the utilisation of known chemical stimulators of the CMV promoter, in 
addition to a commercially available plasmid, pAdVAntage, which acts to 
increase the levels of transient protein expression in transfected mammalian cells. 
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In an effort to achieve expression of the C protein, several combinations of lysis 
buffers and protease inhibitors were tried without success, even when expression 
was driven from the CMV promoter. Previous work in the laboratory had shown 
that when C protein expression was performed using the vaccinia T7/T7 promoter 
system, the protein ~as found in a predominantly degraded form, which is why 
the CMV promoter was initially used for this work. However, a change of cell 
line resulted in good expression of C, even when driven off the T7 promoter 
using Vaccinia T7, which also eliminated the problem of poor L expression. 
During the course of these studies it was noticed that co-expression of RPV N 
with pcDNAlHAL resulted in an increase in the level of HAL protein expressed 
from transiently transfected cells. The precise reason for this remains unclear. It 
was shown that N is not exerting this effect on HAL expression by stabilising the 
HAL protein. N could however be stimulating plasmid uptake to the nucleus, or 
acting to upregulate transcription levels within the transfected cell. Further work 
could include investigating whether or not this effect ofN on protein expression 
is specific to HAL. Preliminary data has indicated that N also boosts the level of 
P protein expression (data not shown). It would be interesting to see if this was 
an effect confined to members of the genus Morbillivirus, or ifRPV N could act 
to increase the level of protein expression from a totally unrelated virus, such as 
African swine fever virus (ASFV). 
To confirm the previously established interactions of L with P, C and V 
(Sweetman et al., 2001), co-immunoprecipitations were performed with full-
length L and each ofP, C and V. Each of these three interactions were 
confirmed, although a GST-tagged version of the V protein had to be used, as a 
pcDNA construct expressing the V construct failed to co-ip full length L within 
this system. The most likely explanation for this unexpected observation is that 
the anti-V antibody, which was being used for the immunoextractions of cell 
lysates transfected with pcDNAIV, was displacing the L protein. Due to the large 
size of the L protein, it was first decided to determine with which of the three 
conserved domains ofthe L protein P, C and V interact. To facilitate this, three 
initial domain mutants of L were designe'd and constructed, HALl, HAL2 and 
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HAL3. Each of these three constructs contained one of the conserved domains, 
as determined by McIlhatton and co-workers (1997) (McIlhatton et al., 1997), 
and the appropriate hinge region(s). 
Using co-immunoprecipitation studies P was found to interact with the first 
conserved domain of the L protein, whilst the two non-structural proteins, C and 
V, were found to interact with the second of the three conserved domains of L. 
Using the Y2HS, further deletion mutants of L were investigated for their binding 
properties with the viral proteins P, C and V. These yeast studies should have 
confirmed the preliminary binding site data obtained by co-immunoprecipitations 
(section 4.2.6). Experiments using the Y2HS confirmed that P binds to the first 
conserved domain of L, as identified by co-immunoprecipitation. However, 
unlike the co-immunoprecipitation data, which identified C and V as interacting 
with HAL2, the second conserved domain of L, the Y2HS showed that C and V 
both interact with the L1 yeast mutant and not with L2. One explanation for 
these data might be the existence of a secondary binding site for these two non-
structural proteins within the first conserved domain of the L protein, somewhere 
between amino acids 1 and 363 (and therefore distinct from the P binding 
domain). 
It is difficult to explain why the C-L2 and V-L2 interactions were not picked up 
within this system. It could be due to the fact that one or both of the proteins are 
being mis-folded, or that they are not being taken to the yeast nucleus, which as 
mentioned in chapter three, is a requirement for the functionality of the Y2HS. 
The problems encountered with the L2 yeast construct failing to show an 
interaction with either C or V, together with the fact that both the C and V L 
binding sites were mapped to a region within the first domain of L suggest that 
the Y2HS is not a reliable system with which to map protein:protein interactions. 
The Y2HS is known in some cases to not detect previously characterised 
protein:protein interactions. An example of this is that an interaction between 
RPV Nand P was never shown in the Y2HS, despite numerous attempts 
(Sweetman, 2000), although this interaction is necessary for the formation of 
viral nucleocapsid complexes. 
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The accessory proteins C and V both appear to have an additional L binding site, 
somewhere in the first 11 OObp of L. This interaction was picked up by the Y2HS 
only and could indicate that this interaction is weak. The Y2HS is known to be 
very sensitive and is capable of detecting both weak and transient interactions. 
Co-ips on the other hand are known to detect physiologically relevant 
protein:protein interactions, and it is acknowledged that low affinity or transient 
protein:protein interactions may not be detected. It is therefore possible that the 
interactions seen in the Y2HS, between LI-II 00 and C and V are either artefacts 
of the highly artificial nature of the system, or evidence of a secondary L 
interaction site for these two proteins. 
As it was recently shown that the L protein of Se V oligomerises (Smallwood et 
al., 2002), an RPV L-L interaction was investigated. To determine if such an 
interaction exists for the rinderpest L protein, a combination of the Y2HS and co-
immunoprecipitation studies were performed. Once again conflicting results 
were obtained from these two systems. The Y2HS failed to provide any evidence 
for an L-L interaction (data not shown), whilst clear co-immunoprecipitation of L 
with HALl was observed. As previously mentioned, it is more likely that the 
interaction seen by co-immunoprecipitation is genuine, rather than the negative 
result obtained with the Y2HS. Further work now needs to be carried out to 
further map the binding region for this L-L self-association. 
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Chapter Five 
Identification of interactions of RPV L with Host Cell Proteins using 
the Yeast Two-Hybrid System (Y2HS) 
5.1 Introduction 
To enable the identification of novel host cell proteins that interact with the L protein 
of rinderpest virus, the yeast two-hybrid system was utilised. The Y2HS, originally 
developed nearly fifteen years ago by Fields and Song (Fields & Song, 1989), has 
been widely used to identify novel protein:protein interactions, in addition to 
enabling the further characterisation of known interactions between proteins. The 
Y2HS allows the identification of novel protein binding partners of a known protein 
by the screening of expression libraries and it is this function which was to be 
exploited in this part of my PhD project. This system should therefore allow a large 
number of host cell proteins to be screened for an interaction with L in a short period 
of time. 
The functionality of the Y2HS relies on the fact that transcriptional activators can be 
separated into discrete regions corresponding to DNA-binding domains and 
transcriptional activation domains (Brent & Ptashne, 1985, Hope & Struhl, 1986). 
To assess protein:protein interactions, the Y2HS uses two protein fusions, which are 
each expressed from a separate plasmid vector, and which are co-expressed in a 
suitable host strain of yeast containing inducible reporter genes. The protein of 
interest, the "bait" protein, is encoded as a fusion to a DNA-binding domain, and for 
the purpose of these studies the RPV L protein is the bait. The "prey" protein, on the 
other hand, is fused to a transcriptional activation domain and in this case the "prey" 
corresponds to proteins encoded by the porcine macrophage eDNA library. If an 
interaction occurs between the bait and the prey, then the transcriptional activator 
will be reconstituted, leading to the transcription of the reporter genes present within 
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the host strain, thereby generating a phenotypic signal. Reporter gene products can 
be easily assayed on the basis of nutritional requirements of the transformed yeast 
cells, or on the basis of a colour change, such as that scored in a beta-galactosidase 
activity assay. 
At the onset ofthis work the Y2HS was thought to be a reliable and robust system 
with which to study protein:protein interactions. However, during a late stage of the 
screening process, problems became apparent with this system. 
5.2 Results 
5.2.1 Performing Large-Scale Library Screen 
Initial experiments with the Y2HS were performed using the Y 190 strain of yeast 
cells, which had previously been used in the laboratory (Sweetman et al., 2001) 
however, this particular stock of yeast cells started to exhibit the unusual 
characteristic of growing very slowly. This resulted in the purchase of a more recent 
yeast strain from Clontech, the AHI09 strain of yeast. AH109's are considered to be 
a superior strain of yeast when compared to the Y190's, as it has three selectable 
markers, one more than the YI90's. More importantly, each of the three reporter 
genes are under the control of different GAU-inducible promoters, thereby 
theoretically eliminating virtually all false positives specific to the promoter element 
in the GAU system (James et al., 1996). It was therefore expected that the number 
of false positives obtained with this library screen would be dramatically reduced, 
from an early stage of the screening process. However, before a library screen could 
be performed, the transformation efficiency had to be optimised for AH 109's, as a 
high number of transform ants are necessary for a successful library screen. To 
optimise the transformation efficiency, a known interactor of L was used (C) and 
varying quantities of plasmid DNA were co-transformed. Either SOng, lOOng, 
20Ong, 300ng or SOOng of each of the two plasm ids being co-transformed was 
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utilised. Clontech recommend that 100ng of plasmid be used for each 
transformation. However, due to the large size of L, the transformation efficiency of 
pAS21L alone was found to be significantly lower than that of any other pAS2 
construct which contained the coding sequence for a protein considerably smaller 
than L, for example pAS2/C (data not shown). Following optimisation it was 
decided that 200ng of each plasmid being co-transformed would be utilised for 
small-scale transformations, this figure was then adjusted according to the scale of 
the transformation being undertaken. 
As the transformation efficiency had been optimised, a full-scale library screen could 
now be performed (as in section 2.4.3), see figure 5.2.1.1. The L protein was 
provided by the existing laboratory pAS2/L construct (Sweetman et aT., 200 I), as 
used in chapter four. The porcine macrophage eDNA library was a kind gift from 
Dr. L. Dixon (Department of Molecular Biology, Institute for Animal Health, 
Pirbright, Surrey, UK), and stocks were grown as in section 2.4.1. For the library 
screen approximately Img of the porcine macrophage cDNA library was used along 
with 600llg of pAS2/L. 
Initial co-transformants were screened for cells positive for the HIS3 gene product 
(histidine biosynthesis), as described in section 2.4.2. After five days the 
transformation yield of the library screen was calculated to be 2.6 x 105, meaning 
that 260,000 clones of the library had been screened. After ten days the number of 
putative L interactors obtained from the library screen was 57. Each of these 57 
colonies was picked with a sterile PIO tip and used to inoculate 201l} ofSC-L-T 
liquid medium and 5111 of this was used to inoculate each of two SC-L-T grids, and 
an SC-L-T -Ade grid. The grids referred to here are just agar plates each with a grid 
drawn on the back. Each square of the grid was inoculated with a single colony, 
therefore allowing a large number of colonies to be screened at anyone time. Two 
SC-L-T grids were required as one acted as a master plate containing all colonies 
under selection for both ,interacting plasmids, and also to confirm the presence of two 
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cDNA library 
~ C~~:~f~~~~:on ~ 
Incubare at 30·C for 10 days l 
Colonies screened by H is+ selection 
l 
~-gal and adenine biosynthe sis assays 
l 
Isolate plasm ids, confirm interaction with RPV L in the 
Y2HS, characterise clones by PCR and sequence analysis 
l 
Verification oftrue positives using confocal 
microscopy and immunoprecipitation analysis 
Figure 5.2.1.1. Diagrammatic representation of a library 
screen using RPV L as the "bait" protein. AH 109 yeast ce lls we re 
co-transformed w ith pAS21L and a porc ine macrophage cDNA libra ry. 
Trans fo rm ants were plated out on minimal aga r lacking hi stidine and in cuooted 
for a per iod o f I 0 days at 30"C. Resultin g coloni es we re then cultured and 
furth er scree ned using bo th adenine biosyn thesis and be ta-galac tos idase assays 
as indica tors ofa func ti onal interac ti on. Tfthe libra ry c lones isolated prov ided 
pos iti ve scores un de r a ll three se lectable reporte r genes tested, th en they were 
taken thro ugh to the nex t stage of th e c ree nin g process. Prey plasmids were 
then isolated and put back into the Y2HS to co nfirm an interac tion with L. 
cDNAs of pos iti ve plasm ids were th en c haracteri sed by PC R and sequence 
analys is. To determin e if a genuine interaction w ith RPV L occurs outs ide o f 
the yeas t two-h ybrid system, o th er methods were employed. 
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plasmids; the second of the SC-L-T grids was used for the beta-galactosidase assay 
which was performed at a later stage. The SC-L-T-Ade grid was to select for 
transformed cells positive for the ADE2 gene product (required for adenine 
biosynthesis) and was considered to be the most stringent selection assay available in 
determining a true interaction between L and the isolated library clone. After an 
incubation period of24 hours, all 57 colonies had re-grown on both SC-L-T grids, as 
expected. One of the inoculated SC-L-T grids was then used for beta-galactosidase 
assays (as described in section 2.4.4, for results see table 5.2.1.1). Colonies that 
turned blue after an incubation period as long as overnight were still scored as 
positive, due to the fact that the negative controls remained unchanged in colour. In 
addition, growth on the SC-L-T -Adc grids was scored after 24hrs, 48hrs and 72hrs 
(see table 5.2.1.1). Only colonies positive for all three reporter genes tested were 
taken through to the next stage of the screening process. Therefore at this stage, 12 
colonies were eliminated as they scored a negative result for either adenine 
biosynthesis or beta-galactosidase activity. The remaining 45 colonies were then 
divided into 4 groups based on the growth characteristics displayed, which served to 
indicate the relative strength of the interactions (see table 5.2.1.11). It is generally 
acknowledged that the stronger an interaction is, the stronger a positive result 
obtained under screening conditions will be. The results, when taken in this context, 
looked promising as the majority of the putative L interactors exhibited a strong 
beta-galactosidase activity score in addition to strong growth under adenine 
biosynthesis selection. 
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Clone SC-L-T r eo rowth SC-L-T-Ade Beta-oalactosidase ac thity 
I ., ., ., ., ., ., ., ., ., 
2 ., ., ., ., ., ., ., ., 
3 ., ., ., ., ., ., ., ., ., ., ., 
4 ., ., ., ., ., ., ., ., ., ., ., 
5 ., ., ., ., ., ., ., ., ., ., ., 
6 ., ., ., X ., 
7 ., ., ., ., ., ., ., ., ., 
8 ., ., ., ., ., ., ., ., ., ., ., 
9 ., ., ., ., ., ., ., 101 ..; ~ ..; 
10 ., ., ., ., ., ., ., ., ., 
I I ., ., ., ., ., ., X 
12 ., ., ., ., ., ., ., 
13 ., ., ., ., ., ., 
14 ., ., ., ., ., ., ., ., ., ., ., 
15 ., ., ., ., ., ., ., ., 
16 ., ., ., X ., ., ., ., 
17 ., ., ., ., ., ., ., ., 
18 ., ., ., ., ., ., ., 
19 ., ., ., ., ., ., ., ., ., 
20 ., ." ., ., ., ., ., ., ., ., ., 
21 ., ." ., ., ., ., ., 
22 ., ." ., ., ., ., ., ., 
23 ., ., ., ., ., ., X 
24 ., ." ., ." ., ." ., ., 
25 ., ." ., ., ., ., ., ., ." ., 
26 ., ." ., ., ., ., ., ., ., ., 
27 ." ., ., ., ., ., ., ." ., ., ." 
28 ." ." ., X X 
29 ." ." ." ." ., ." ., ." ." ." 
30 ." ." ." ." ., ." ." ., ." 
31 ." ." ., ." ." ." ." ." ." ." ., 
32 ." ." ., ." ." ." X 
33 ." ." ." ." ." ." X 
34 ." ." ., ." ." ." ., ." ." ." ." 
35 ." ." ., ., ." ." ." ., ." ." 
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Clone SC-L-T reg r owth SC-L-T-Ade Beta-ga lactos idase activit)' 
36 '" '" '" '" X 
37 '" '" '" '" '" '" X 
38 '" '" '" '" '" '" '" '" 
39 '" '" '" X X 
40 '" '" '" X '" 
4 1 '" '" '" '" '" '" '" '" 
42 '" '" '" '" '" '" '" 
43 '" '" '" '" '" '" '" '" '" '" '" 
44 '" '" '" '" '" '" '" '" '" '" 
45 '" '" '" X '" 
46 '" '" '" '" '" '" '" '" '" '" '" 
47 '" '" '" '" '" '" '" '" '" '" '" 
48 '" '" '" '" '" '" '" '" '" '" '" 
49 '" '" '" '" '" '" '" '" '" '" '" 
50 '" '" '" '" '" '" '" '" '" 
5 1 '" '" '" '" '" '" '" '" '" '" 
52 '" '" '" '" '" '" '" '" '" '" '" 
53 '" '" '" '" '" '" '" '" '" '" 
54 '" '" '" '" '" '" '" '" 
55 '" '" '" '" '" '" '" '" 
56 '" '" '" '" '" '" '" '" '" '" '" 
57 '" '" '" '" '" '" '" '" '" 
Table 5.2.1.1. Growth characteristics of isolated 
library clones. Co- tra nsfo rrn ants se lec ted for by hi stidin e 
biosynthes is were furth er sc reened by re-c ultur in g co lo nies o n 
media ma inta ining the se lection for bo th plasmids (SC-L-T). 
Result ing co loni es were th en assayed for both adenin e biosynthe is 
(SC-L-T-Ade) and p -ga lac tos idaseac tiv ity. SC- L-T and SC-L-T-
Ade key: '" '" '" indicates strong growth after 24hrs, '" '" grow th 
a fter 48hrs and '" strong g rowth after 72 hrs, X no grow th at 
72hrs. Beta-ga lactos idase acti vity key: '" '" '" '" '" blu e co lora tio n 
after 2hrs. '" '" '" '" blueafter 3hrs. '" '" '" bluea fter 5hrs. '" '" 
blue a ft er 7hrs, '" blue a ft er ove rnight incubati on. 
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Group Adenine J3-galactosidasc Number of 
I 
2 
3 
4 
biosynthesis activity positive clones 
" " " " " 
Blue within 3hrs 25 
" " " " 
Blue within 5hrs 8 
" " 
Blue within 7hrs 9 
" 
Blue after 3 
overnight 
incubation 
Table 5.2.1.11. Positive library clones divided into 
four individual groups based on growth 
characteristics. (Which may indica te th e re lative trength or 
the interac ti on between th e isolated library c lone and RPYL). 
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5.2.2 Recovery of Putative L Interactors 
To facilitate the retrieval of possible L interactors, yeast plasmid DNA was isolated 
from yeast cultures. Colonies cultured on SC-L-T agar were picked with a sterile 
PI0 tip and used to inoculate 5ml SC-L liquid medium and incubated for 3-5 days at 
30°C on an orbital shaker set at 250rpm. SC-L (synthetic complete medium lacking 
leucine) medium was used to culture the isolated library plasmid as this maintained 
selection for only the library plasmid, which contains the LEU2 gene. Yeast plasmid 
DNA was then extracted using a combination of either acid washed glass beads and 
phenol chloroform (as in section 2.4.5) or the "Yeastmaker" yeast plasmid isolation 
kit (Clontech, as in section 2.4.6). To confirm the successful extraction of yeast 
plasmid DNA from the cultures, plasmid inserts were amplified using Taq PCR (as 
in section 2.2.1.2) with primers (pACT23' and pACT25'), specific for the yeast 
library plasmid, pACT2 (see appendix 3 for primer sequences). When PCR products 
were analysed on agarose gels, it was noted that several of the isolated colony 
cultures contained more than one library plasm id (figure 5.2.2.1). Despite three 
separate attempts, from three separate cultures, no PCR product was ever isolated 
from library clones 5, 9, 17,21,22,26,27,31 or 56, taking the number of putative L 
interactors obtained from the library screen down to 36 (see table 5.2.2.1). However, 
due to the fact that some of the cultures contained more than one isolated library 
plasmid, the number of plasm ids requiring confirmation rose to a total of 46 clones. 
The presence of multiple library plasmids in a single culture is not uncommon at this 
stage of a library screen. 
Once the presence of a library insert was confirmed in each DNA preparation, it was 
necessary to transform the yeast plasmid DNA into bacteria to permit cloning of the 
library plasmid and identification by DNA sequence analysis. To enable isolation of 
the library plasmid it is widely thought that E. coli strains carrying a leuB gene 
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Isolated lib rary clone 
M 32 33 34 35 36 37 38 39 40 4 1 42 43 
Figure 5.2.2.1. Examples of Taq p e R products 
generated from isolated positive yeast pl asmids from a 
yeast-two hybrid system library screen. Sampl es o f Taq 
PCR produ cts genera ted from iso lated yeast plasmid DN A were 
analysed on 0.8% agarose ge ls in TB E buffer alongside 1 OObp ladder 
molecular weight markers (M, Roche). 11 was noted that several o f the 
D A preparati ons contained more than one yeast plasmid , for 
example clones 33 , 34, 37 and 38. 
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Clone Taq PCR product Clone Taq PCR product 
size (bp) s ize (bp) 
IT - 900 35 250 
IB - 650 38T 1100 
2 - 400 38B - 700 
3 250 41 1050 
4 500 42 200 
7 1000 43 800 
8 200 44 200 
10 - 450-500 46T 300 
12 - 1050 46B 200 
13 1200 47T 300 
14 200 47B 200 
15 650 48 200 
18T - 1100 49 250 
18B ~950 SOT 600 
19T 700 SOB 500 
19B 200 SIT 1900 
20 200 SIB 800 
24 200 52T 1901 
25 200 53 250 
29 200 54T 1150 
30 500 54B 850 
34T 800 55 - 550 
34B 500 57 11 80 
Table 5.2.2.1. Size of Taq peR products amplified from 
isolated positive yeast library plasm ids from a yeast 
two-hybrid system library scree n. Cultures th at were found 
to contain more than one plasmid resulted in the clones be ing named 
as fo llows : th e numberofthe clone was su ffixed with either a T (e .g. 
34T ) or a B (e .g. 34B). The T refers to th e larger o f the two products 
produced by PC R, whereas the B denotes the sma ller product 
amplified from anyone yeast clone. 
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mutation are required. This is due to the fact that the library plasmid, pACT2, 
contains the LEU2 gene which complements the leuB6 mutation seen in E. coli 
strains such as HB 101 and Ke8. This is important, as it was the prey that is being 
selected and not the bait (RPV L). It is also generally accepted that yeast plasmid 
DNA requires electroporation for successful transformation to occur. Taking this 
information into account, competent HBIOls (a kind gift from L. Goatley, 
Department of Molecular Biology, Institute for Animal Health, Pirbright, Surrey, 
UK) and DH5as (used as a positive transformation control), were used for 
electroporation (as in section 2.2.11). However, no transformants were obtained. To 
determine if home-made electrocompetent cells were at fault, commercially available 
electrocompetent Ke8 cells (Clontech) were next tried. However a change of cell 
line did not alter the outcome and no electroporation was successful. 
Attempts were next made to transform the isolated yeast plasmid DNA using 
chemically competent HBIOI and Ke8 cells (cells prepared as in section 2.2.7, 
transformations as in section 2.2.9). Despite several efforts this approach remained 
unsuccessful, due to the low level of transformation obtained with these cells using 
our standard method of making competent cells. It was then decided to try 
transforming chemically competent DH5a.'s (as in sections 2.2.7 and 2.2.8) which do 
not solely select the library plasmid. It was therefore feared that the majority of 
transformants recovered would consist of the "bait" L protein only. For each 
transformation using the DH5a.'s, 2JlI of isolated yeast plasmid DNA was used and 
final transformation mixes were plated out on the usual LBI Amp plates and 
incubated overnight at 37°C. This method proved to be reasonably successful with 
approximately 50% of the transformants containing the prey plasmid. Although 
transformation efficiency did vary considerably between yeast plasmid DNA 
samples, this variability is most likely due to the crude DNA preparations being 
used. Once this transformation difficulty was overcome, the majority of putative L 
interactor plasm ids were retrieved. Out of the remaining 46 isolated library clones, I 
was unable to recover 9 using this system (clones 3, 7,8, 10,29, 47T, 47B, 48 and 
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49). Due to time constraints and the large number of clones that were recovered, 
these samples were stored as -70°C glycerol stocks. The final 37 recovered library 
clones were all grown up and CsCI maxi-preps were made for each one (as in section 
2.2.14). CsCI DNA preparations were necessary as maxi-preps purified using 
Qiagen columns were found not to function in the Y2HS during earlier studies as 
part ofthis project (data not shown). 
5.2.3 Identification and Classification of L Interactors 
The majority ofthe isolated putative L interactors were sequenced and this was done 
using either sample from PCR products, or sample from DNA maxi-preps of 
recovered library plasmids. Isolated library clones were sequenced by either T7 
polymerase sequencing (as described in section 2.2.15.1) or by cycle sequencing (as 
in section 2.2.15.2). In all cases the ACT25' primer was used (for primer sequence 
see appendix 3). 
Once obtained, nucleotide sequences were submitted to an NCBI BLAST search to 
identify the putative L interacting partner (see table 5.2.3.1). As a result of the 
sequence analysis, many of the remaining clones were theoretically eliminated due to 
published literature on common false positives found using yeast library screens 
(http://chaos.fccc.edu/researchilabs/golemis/main false.html accessed on 27/11/2002 
at 12:37pm, http://chaos.fccc.edu/research/labs/golemis/Tablel.html, accessed on 
27/1112002 at 12:4Ipm). According to the data compiled by that laboratory, ferritin, 
cytochrome oxidase C (COX proteins) and zinc-finger proteins are amongst those 
which most commonly occur as false positives when performing yeast two-hybrid 
system library screens. The following clones were therefore considered to be 
probable false positives at this stage; clones 19T, 34T, 38B, 41 (this protein has a 
zinc-fmger domain), 52 and 57. Clones 4, 14,20,24,30, 34B, 5IT and 5IB were 
also considered to be probable false positives as they were all identified to be either 
GAL4 gene sequences or parts of cloning vectors. 
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Clone Identity Clone Identity I 
IT lmuse thymus cDN A 35 hwmn striatin 
IB no significant li'3tches 38T hunnn helicase mRN A 
2 no significant li'3tches 388 hunnn cox VI lb mRNA 
3 no significant nntches 41 dorfin-double ringfinger protein 
4 Drosophila GALA gene 42 hwnan ARX protein mRN A 
12 hwmn cDNA clone HEP08253 43 pig platelet binding protein 
13 hlD11l1n cDN A 44 short porcine type I IFN related protein 
14 pACT2 MCS 46T no significant li'3tches 
15 human DN A sequence from RP 11-54A4 468 no significant matches 
18T Nwnerous porcine c10nes 50T sheep beta actin 
18B no signijicant li'3tches 508 no significant matches 
19T cox subunit VIlb 51T S. cereviyiae GALA Gene 
198 no signijicant matches 518 GALA ACTivation domain 
20 pACT2 MCS 52 cox subunit VIlb 
24 pHELLSGA TE cloning vector 53 Sequence 21 from patent WOO208456 
25 no significant lnatches 54T Hwmn hexokinasell mRNA 
30 GALA ACTivation DOli'3in 54B sequence 81 from patent W0021 0453 
34T bovine/pig ferritin heavy chain 55 hlD11l1n TRAF6 binding protein 
34B S. cerevisiae GAIA gene _ 57 hwmn co)(}I proteinlhornologue 
Table 5.2.3.1. Identification of the remaining putative L interactors as determined by DNA 
sequencing. Library clones were sequenced using either T7 polymerase sequencing or cycle sequencing. Sequences obtained 
were submitted to a nucleotide NCB I blast search; the match with thc highest score for each clone is shown. In some instances no 
significant matches were found on the databases searched. Highlighted clones were not taken through to the next stage. 
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5.2.4 Determination of "True" Interactors within the Y2HS 
All recovered yeast plasmids were put back into the yeast two-hybrid system to not 
only confirm an interaction with RPV L in yeast. but to also check the library clones 
for auto-activation properties. Each library plasmid (20Ong) was therefore co-
transformed with pAS2/L and, to test for auto-activation properties, each library 
plasmid was also co-transformed with empty pAS2 vector. In addition, the 
specificity of the interaction of each library clone with L was tested by co-
transformation with pAS2/C. All interactions were screened using the three separate 
reporter genes of AHI09s. The result obtained for each co-transformation was 
reproduced on three separate occasions. The majority of clones were found to either· 
no longer interact with L when put back into the Y2HS, or be auto-activators (see 
table 5.2.4.1). 
Library clones shown to be non-auto-activators and which failed to interact with L 
when put back into the Y2HS are difficult to explain. Experiments were set up on 
two separate occasions using fresh stocks of AHI09 cells, but the results obtained 
were the same. In all cases the positive control pairing ofpAS2/L and pACT2/C 
continued to work, although the strength to the interaction, as measured by the speed 
of colony growth on SC-L-T-Ade media, was found to be erratic. All colonies 
containing both Land C should have provided a positive result, yet this was not seen. 
Co-transformants isolated from SC-L-T plates were found to only provide a positive 
result in either adenine biosynthesis or beta-galactosidase activity about 50% of the 
time. It had been noticed that the AH109s grew at unreliable rates when cultured for 
any period of time; as a result experiments were set up using both Y190s and 
AH 1 09s in duplicate. Results obtained were inconclusive, as the positive control of 
pAS2IL and pACT2/C proved to be unreliable in the reporter assays. 
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Clone Auto-activator? Interaction '\1th L? Clone Auto-activator? Interaction '\1th L? 
IT yes N/A 38T no no 
IB yes N/A 38B no no 
2 yes N/A 4 1 no no 
4 yes N/A 42 yes N/A 
12 no yes 43 yes N/A 
13 no yes 44 no no 
14 yes N/A 46T no no 
15 no no 46B no no 
18T no no 50T no no 
18B no no 50B no no 
19T no no SIT yes N/A 
19B no no SIB no no 
20 Not tested Not tested S2T yes N/A 
24 Not tested Not tested 52 no no 
25 no no 53 no no 
30 yes N/A 54T yes N/A 
34T yes N/A 54B no no 
34B no no 55 yes N/A 
35 no yes 57 yes N/A 
--_ . -
-
Table 5.2.4.1. Yeast two-hybrid system analysis of the specificity and auto-activation 
properties of recovered putative L interactors. Recovered library clones were tested for auto-activation 
properties in addition to confinning an interaction with L within the yeast two-hybrid system. Highlighted clones were 
confinned to interact with L and found not to auto-activate. 
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Despite these problems, three library plasmids, clones 12, 13 and 35, were identified 
as interacting with L and were therefore taken through to the next stage of anal ysis. 
Sequence analysis of the clones (table 5.2.3.1), identified only clone 35 as a known 
protein; it was shown to be 92% similar to the human striatin protein after an NCBI 
BLAST nucleotide search (see figure 5.2.4.1 for sequence alignment). Striatin was 
also confirmed to be expressed from clone 35, in the correct reading frame (see 
figure 5.2.4.2). To date little is known about the host cell protein striatin. It is 
however known that striatin is a highly conserved intracellular protein which is 
mostly membrane associated. Striatin is mainly expressed in the central nervous 
system (Castets et ai., 1996). The interaction between Land striatin was further 
characterised. 
5.2.5 Investigating the Interaction of L with Striatin Using Co-
Immunoprecipitation Studies 
Co-immunoprecipitation studies were performed as a method with which to 
characterise the potential interaction of Land striatin in a system outside of the 
Y2HS. To determine if Leo-ips full length striatin, a construct was produced by 
manipulating the construct pSVLHAStriatin (a kind gift from Francis Castets, FRE 
9041, CNRS, 31 Chemin Joseph Aiguier, Universite de la Mediterranee, Marseille, 
13402 Marseille Cedex 20, France), which contains the rat striatin ORF. 
pSVLHAStriatin was digested with Ncol and BamHI to produce a full length striatin 
insert, which was then ligated into pGST(NcoVBamHI cut) to produce pGST/striatin. 
The resulting construct was confirmed by sequence analysis and expression verified 
by immunofluorescence (data not shown). It was decided to use GST as a way to 
detect the striatin protein as it had been previously shown that full-length L does not 
interact with GST (Sweetman et al., 2001) and it was demonstrated in section 4.2.6 
that none of the three pcDNAlHAL constructs interact with GST. Using A549 cells, 
pGST/striatin and pcDNAlHAL were transfected either singly or together, in 
duplicate, and the proteins expressed using the vaccinia T7/T7 expression system (as 
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>gi145072821ref1NM 003162 . 11 Homo sapiens striatin, calmodulin binding protein (STRN) , mRNA 
Length = 2790 
Score = 319 bits (161), Expect 
Identities = 209/225 (92%) 
Strand = Plus / Plus 
4e-84 
Query: 324 agcccagtacagcctcccgggaatcctgcacttccttcagcacgagtgggcccgcttcga 383 
111111111111 11111111 11111111111111 11111111111111111111111 
Sbjct: 141 agcccagtacagtctcccggggatcctgcacttcctgcagcacgagtgggcccgcttcga 200 
Query : 384 agtggagagagcccagtgggaagtagagcgggcggagctgcaggctcagattgccttcct 443 
11111111111111 1 11 1 11 II 1111111111111 1 111111 111111111111 11 
Sbjct : 201 ggtggagagagcccagtgggaggtggagcgggcggagctgcaggcccagattgccttcct 260 
Query : 444 tcagggggacaggaaaggtcaagaaaatttgaagaaggatcttgtgaggcggatcaaaat 503 
11111 II 11111 II 111111111111111111111111111111 1111111111 
Sbjct : 261 gcagggagaaaggaagggccaagaaaatttgaagaaggatcttgtgaggaggatcaaaat 320 
Query: 504 gctggagtgtgctctcaaacaggaaagagccaaataccacaagtt 548 
I I I I II I I I II II I II II I I II II I I I I I I I I I III I I I I I I 
Sbjct : 321 gttggagtatgctcttaaacaggaaagagccaaataccacaagtt 365 
Figure 5.2.4.1. NCBI blast search res ult for library clone 35. The sequence obtained for 
pACT2/clone35 was submitted to an NCB! blast nucleotide search. Here the Query sequence is that of 
pACT2/clone35 and the subject (Sbjct) sequence is the sequence identified as a match from the BLAST 
search. 
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>gi167556861ref1NP 035630.11 striatin, calmodul in binding protein [Hus musculus] 
gi I 17368003 I sp 10551061 STRN ImUSE Str iat in 
gi128283011ernb1CAAl1545 . 11 striatin [Hus musculus] 
Length = 780 
Score = 166 bits (419 ) , Expect = 5e-40 
I dentities 85/120 (70%), Positives = 87/120 (72 %) 
Frame = +1 
Query : 193 HDEQAGPGVFF SNNHPGASXXXXXXXXXXXXXXXXXXXXXXXXXXQYSLPGI LHFL QHELJ 372 
HDEQAGPGVFFSNNHPGA QYSLPGILHFLQHELJ 
Sbjct : 1 HDEQAGPGVFFSNNHPGAGGAKGLGPLAEAAAP.GDGAP.AAGAARAQYSLPGILHF LQHELJ 60 
Query : 3 73 ARFEVE1:AQLJEVERAELQAQIAFLQGD1:KGQENLKKDLV1:RIKHLECALKQE1:AKYHKFE 552 
ARFEVE AQLJEVERAELQAQIAFLQG+ KGQENLKKDLV RIKHLE ALKQE AKYHK + 
Sbjct : 61 ARFEVERAQLJEVERAELQAQIAFLQGERKGQENLKKDLVRRIKMLEYALKQERAKYHKLK 120 
Figure 5.2.4.2. Striatin is expressed from the isolated pACT2 library clone 35. In addition to screening the 
DNA sequence of library clones, the expressed open reading frame of the pACT2 constructs was calculated and the trans lated 
protein sequence submitted to an NCB! protein search. Clone 35 again match ed striatin (note that the BLAST search engine 
automatica ll y replaces repetitive sequences with runs of X). The query sequence is the sequence obtained for pACT2/c!one35 
and the subj ect sequence is the sequence retrieved using the BLAST search . 
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in section 2.2.17). One day post transfection, transfected cells were labelled with 
C5S] amino acids and lysed. Celllysates were then harvested and immunoextracted 
with either rabbit anti-GST antibody (MB38), or rat anti-HA antibody (Roche). 
GST/striatin was shown to co-ip full length L (figure 5.2.5.1) and this result was 
shown on three separate occasions. However it was not possible on any of these 
occasions to show HAL co-immunoprecipitating full length GST/striatin due to the 
presence of background bands migrating at the same location as GST/striatin in cells 
transfected with pcDNAlHAL and immunoextracted with rat anti-HA antibody. By 
demonstrating GST/striatin co-immunoprecipitating L, the interaction between the 
two proteins was proven to be genuine and not an artefact of the Y2HS. 
The region of L with which striatin interacts was narrowed down by co-transfecting 
pGST/striatin with each of three HAL domain constructs used in section 4.2.6. 
Again, each plasmid construct (pcDNAlHALl, 2 or 3) was either transfected alone 
or with pGST/striatin into A549 cells using the vaccinia T71T7 expression system (as 
in section 2.2.17). GST/striatin was shown only to co-ip HAL2 (figure 5.2.5.2), 
indicating that striatin may interact with L in a similar region to that of the two non-
structural proteins C and V. Once again this interaction was reproducible, 
confirming that striatin interacts with the second conserved domain of L. 
In an attempt to further map the striatin binding site on the L protein, the panel of 
pAS21L carboxy-terminal domain deletions as used in section 4.2.8 were each co-
transformed with pACT2/clone 35 using AH 1 09 cells and 200ng of each plasmid. As 
described previously interactions were screened using HIS3 and ADE2 reporter 
genes. Using the Y2HS, striatin was shown to bind to L in a region including the 
first 900 and 11 OObp of L. This demonstrates that the striatin binding site resides 
somewhere between base pairs 1 and 1100 of L which is the equivalent to 
somewhere between amino acids 1 and 363 (see table 5.2.5.1). Striatin was also 
shown to interact with the yeast construct Lt, but not L2 or L3. This mimicked the 
data obtained for both the C and V proteins in chapter 4. Once again the data 
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GST/striatin - + + + + 
HAL + + + + 
aGST + + + + 
aHA + + + + 
M 2 3 4 5 6 7 8 
220kDa 
Figure 5.2.5.1. Co-immuDoprecipitatioD of 
pGST/striatin with pcDNAIHAL. A549 cells were infected 
with vTF7-3 and transfected with the desired constructs; one day post 
transfection, cells were labelled with PSS] amino acids for one hour 
and lysed with 1 % NP40. Samples of lysates were immunoextracted 
with t~ of the appropriate antibody and immunoprecipitated proteins 
were analysed on an 8% acrylamide LaemmJi gel, alongside [l4C] 
labelled molecular weight markers (M). Track t= pGST/striatin, a-
GST, 2= pGST/striatin and pcDNAIHAL, a-GST, 3= pcDNAIHAL, 
a-GST, 4= pcDNAIHAL, a-HA, 5= pcDNAIHAL and pGST/striatin, 
a-HA, 6= pGST/striatin, a-HA, 7= untransfected cells, a-GST, 8= 
untransfected cells, a-HA. 
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GST/striatin + + + + 
HALl + + + + 
aGST + + + + 
aHA + + + + 
GST/striatin --+ 
HALl--+ 
GST/striatin + + + + 
HAL2 + + + + 
aGST + + + + 
aHA + + + + 
GST/striatin --+ 
BALl --+ 
GST/striatin + + + + 
HAL3 + + + + 
aGST + + + + 
aHA + + + + 
GST/striatin --+ 
Figure 5.2.5.2. Co-immunoprecipitations of 
pGST/striatin with pcDNAIHAL domain constructs. 
A549 cells were infected with vTF7-3 and transfected with the desired 
constructs (as indicated); one day post traosfection, cells were labelled 
with PSS] amino acids for one hour and lysed with 1 % NP40. 
Samples of lysates were immunoextracted with the appropriate 
antibody (see above) and immunoprecipitated proteins were analysed 
on 8% acrylamide Laemmli gels. 
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RPVL Yeast Striatin 
Mutant 
Ll-1 22bp X 
Ll -360bp X 
Ll-SOObp X 
Ll-700bp X 
Ll-900bp X 
LI-lIOObp 
" Ll-1 200bp 
" Ll-lSOObp 
" Ll-1 800bp 
" Ll-1 900bp 
" Ll-2100bp 
" Ll-2400bp 
" Ll-3100bp 
" Ll-3640bp 
" 
Table 5.2.5.1. Interaction of carboxy-termin al 
domain de letions of full-le ngt h L w ith striatin in the 
yeast two-h ybrid system. Using the yeas t two-h ybr id 
system each of the above L deleti ons we re co-trans fo rm ed wi th 
stra itin into AH 109 ce lls and interac t ions in vest igated. If a n 
inte raction was sco red as pos itive, th en a pos iti ve result was 
obta ined fo r both beta-ga lac tosidase ac tivity and adenine 
biosy n th es is. If e ithe r o f th ese assays produced a nega ti ve result, 
then th e pa ir ing was deemed to y ie ld no interac tion. 
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obtained with the Y2HS contradicted that obtained with the (possibly more reliable) 
data obtained with co-ips. 
5.2.6 Investigating the Interaction of L with Striatin Using Confocal 
Microscopy 
To determine if striatin and L co-localise in transiently transfected cells, GST/striatin 
and HAL were expressed either singly or together in A549 cells using the vaccinia 
T71T7 expression system (as in section 2.2.17). When cells were transfected with 
pcDNAlHAL alone a diffuse cytoplasmic distribution of the protein was seen, with 
aggregates ofL forming in the cytoplasm and perinuclear regions of the cell (figure 
5.2.6.1). When GST/striatin was expressed alone, it was found at the outer edge of 
the cell, with a low level of cytoplasmic labelling, as is the normal cellular 
distribution of striatin (figure 5.2.6.2). When the two proteins were co-expressed in 
the same cell co-localisation was not seen on a large scale in cells where there was a 
low level of expression of the two proteins (see figure 5.2.6.3), yet the cellular 
distribution of the two proteins was clearly altered. The GST/striatin protein was no 
longer found almost exclusively around the perimeter ofthe cell, but had adopted an 
almost diffuse cytoplasmic distribution. In addition, the aggregates of L which were 
seen when HAL was expressed alone were no longer visible. However, in cells 
where high levels of protein expression were seen, the two proteins could clearly be 
seen to co-localise (figure 5.2.6.4). These effects were seen in all cells which were 
co-transfected with the two plasm ids expressing the constructs of interest, and co-
localisation was only seen in those cells where the levels of protein expression were 
high. To demonstrate that it was the striatin protein itself, and not the GST tag that 
was having these effects on the HAL protein, an identical experiment was performed 
using pGST in place ofpGST/striatin. When pGST was transfected alone, 
expression ofGST was not confined to the outer edge of the cell as was seen for 
pOST/striatin, instead OST was shown to be universally distributed throughout the 
cell, with low levels of protein expressed in the nucleus (figure 5.2.6.5). Moreover, 
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Figure 5.2.6.1. Immunofluorescence microscopy of cells 
transfected with pcDNAIHAL. A549 cells were infected with 
vTF7-3 and transfected with pcDNAIHAL. One day post transfection, 
cells were fixed. and perrneabilised with 0.1% Triton X-tOO before 
staining with antibody. Cells were reacted with rat a-HA (at 1/300, 
Roche) and the primary antibody visualised with Alexa Fluor 488 a-rat 
JgG (at tl2oo, A&D). B and E show nuclei of cells counter-stained using 
DAPI and overlay of the stains used is shown in c&F. 
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Figure 5.2.6.2. Immunofluorescence microscopy of cells 
transfeded with pGST/striatin. A549 cells were infected with 
vTF7-3 and transfected with pGST/striatin. One day post transfection, 
cells were fixed, and penneabilised with 0.1 % Triton X-I 00 before 
staining with antibody. Cells were reacted with rabbit a-GST (MB38, at 
11400) and the primary antibody visualised with Alexa Fluor 568 a-rabbit 
IgG (at 11200, A&D). Band E show nuclei of cells counter-stained using 
DAPI and overlay of the stains used is shown in c&F. 
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Figure 5.2.6.3. Immunofluorescence microscopy of cells co-
transfected with pcDNAlHAL and pGST/striatin. A549 cells were 
infected with vTF7-3 and co-transfected with pcDNAIHAL and pGST/striatin. One day 
post transfection, cells were fixed, and permeabilised with 0.1 % Triton X-I 00 before 
staining with antibody. Cells were reacted with rat a-HA (at 11300, Roche), and the 
primary antibody visualised with Alexa Fluor 488 a-rat IgG (at 11200, A&D), and with 
rabbit a-GST (MB38, at 1/400), and the primary antibody visualised with Alexa Fluor 
568 a-rabbit IgG (at 11200, B&E). C and F show overlay of the stains used (nuclei of 
cells counter-stained using DAPI). 
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Figure 5.2.6.4. Immunofluorescence microscopy of cells co-
transfected with pcDNAIHAL and pGST/striatin. A549 cells were 
infected with vTF7-3 and co-transfected with pcDNAlHAL and pGST/striatin. 
One day post transfection, cells were fixed, and permeabilised with O. I % Triton 
x-tOO before staining with antibody. Cells were reacted with rat (X-HA (at 
11300, Roche), and the primary antibody visualised with Alexa Fluor 488 (X-rat 
IgG (at 11200, A&D), and with rabbit (X-GST (MB38, at 11400), and the primary 
antibody visualised with Alexa Fluor 568 (X-rabbit IgG (at 11200, B&E). C and F 
show overlay of the stains used (nuclei of cells counter-stained using DAPI). 
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Figure 5.2.6.5. Immunofluorescence microscopy of cells 
transfected with pGST. A549 cells were infected with vTF7-3 and 
transfected with pGST. One day post transfection, cells were flXed, and 
permeabilised with 0.\% Triton X-tOO before staining with antibody. 
Cells were reacted with rabbit (X-GST (MB38, at \/400) and the primary 
antibody visualised with Alexa Fluor 568 (X-rabbit JgG (at 11200, A&D). 
B&E show nuclei of cells counter-stained using DAPI and overlay of the 
stains used is shown in c&F. 
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when the two proteins (GST and HAL) were co-expressed there was no alteration of 
the cellular distribution of either protein and no evidence of co-localisation was seen 
(figure 5.2.6.6). These data clearly demonstrate that the cellular distribution of both 
GST/striatin and HAL is altered when the two proteins are co-expressed. In addition 
the two proteins have been shown to co-localise in cells where the level of protein 
expression is high. All the images shown in figures 5.2.6.1 through to figure 5.2.6.6 
were taken using a confocal microscope, using sequential scanning. These results 
have been reproduced on two separate occasions. 
5.3 Discussion 
A large-scale library screen was performed using a porcine macrophage eDNA 
library and RPV L as the "bait" protein. From this library screen 46 possible L 
interactors were obtained and the majority of prey plasm ids were recovered using 
DH5as. After recovery plasmids were sequenced for identification purposes and 
then put back into the Y2HS to confirm an interaction with L and check for auto-
activation. A large proportion of the remaining library clones was found to either 
auto-activate, or to no longer interact with the L protein in this system. The reason 
for this remains unclear; it could be that the initial preparation ofpAS2/L which was 
used for the library screen contained a contaminant, or that the stock of AHI09s used 
contained a mutation. To try and eliminate the yeast cells as the cause of these 
observations, fresh batches of AH I 09 were co-transformed with the library plasm ids 
and pAS2/L, however the majority of library plasmids still failed to interact with L. 
The same positive control is always used for the co-transformations, that ofpAS2/L 
and pACT2/C. It was found that this positive control only produces a positive result 
under the ADE2 reporter gene -50% of the time using the stock of AH 1 09 cells we 
had. The AHI09 strain of yeast has therefore been shown to be unreliable in nature 
and not as useful as expected with regards to eliminating the majority of false 
positives. It was hoped that by using this strain of S. cerevisiae that the number of 
false positives encountered when performing the library screen would be limited due 
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Figure 5.2.6.6. Immunofluorescence microscopy of cells co-
transfected with pcDNAfHAL and pGST. A549 cells were infected with 
vTF7-3 and co-transfected with pcDNAIHAL and pGST. One day post transfection, 
cells were fixed, and permeabilised with 0.1 % Triton X-I 00 before staining with 
antibody. Cells were reacted with rat <x-HA (at 11300, Roche), and the primary antibody 
visualised with Alexa Fluor 488 <x-rat IgG (at 11200, A&D), and with rabbit <x-GST 
(MB38, at 11400), and the primary antibody visualised with Alexa Fluor 568 <x-rabbit 
IgG (at 11200, B&E). C&F show overlay of the stains used (nuclei of cells counter-
stained using DAPI). 
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to the fact that the strain possesses three reporter genes which are all under the 
control of different GAU-inducible promoters. However, in actual fact it was found 
that a very high level of false positives relative to previous screens carried out in 
other laboratories at the Institute of Animal Health using Y190s were obtained. 
Despite the problems with auto-activators and clones that were found to no longer 
interact with the L protein, three clones were shown to interact with Land 
demonstrated to not auto-activate. One of these clones was sequenced and shown to 
be 92% similar to the human striatin protein. Due to time constraints it was decided 
to only take this protein through to the next stage. A construct expressing full-length 
striatin was a generous gift from Francis Castets and this construct was manipulated 
to produce a striatin construct that was GST-tagged. This construct was then used in 
co-immunoprecipitation studies with pcDNAlHAL and each of the three 
pcDNAlHAL domain constructs as used in chapter 4. An interaction betwecn Land 
striatin was confirmed outside of the Y2HS as GST/striatin was shown to co-ip full-
length L. Moreover, the binding site of striatin on L was shown to be located 
somewhere in the second conserved domain of the L protein as GST/striatin co-
immunoprecipitated HAL2, but not HALl or HAL3. Striatin was shown by Y2HS 
analysis to interact with L somewhere in the first 11 OObp of L, the equivalent to 
between amino acids 1 and 363; striatin was also shown to interact with the yeast 
construct Ll, but an interaction with L2 or L3 was not detected. The same results 
were obtained for the two non-structural proteins C and V in chapter 4, where the 
data obtained using co-ips contradict the data obtained with the Y2HS. 
Confocal microscopy was next utilised and it was dcmonstrated that in cells with 
high levels of expression ofGST/striatin and HAL, co-localisation of the two 
proteins was seen. Even in co-transfected cells where levels of protein expression 
are too low to demonstrate co-localisation, the cellular distribution of each of the two 
proteins was shown to be altered when compared to the cellular distribution when 
each one is expressed alone. Clear evidence was therefore obtained for a novel 
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interaction between a host cellular protein and RPV L. The possible role(s) of an L-
striatin interaction in the viral life cycle are considered in the final discussion 
(chapter 7). 
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Chapter Six 
Interaction of RPV L with Host Cell Proteins known to Interact 
with Polymerases of other members of the order ~fononegavirales 
6.1 Introduction 
Several host cell proteins are known to interact with viral proteins from members 
of the order Mononegavirales, for example the L protein ofVSV (Indiana 
serotype) associates with translation elongation factor-l a. (Das et 01., 1998), 
while the L proteins of both MeV and VSV interact with tubulin (Moyer et 01., 
1990, Moyer et 01., 1986). Furthermore, the amino terminal domain of the 
phosphoproteins of two lyssaviruses, rabies virus and Mokola virus, was recently 
found to interact with the dynein light chain, LC8 (Jacob et 01., 2000). 
The dynein light chain, LC8, is a small protein with extremely high sequence 
conservation and is a component of both cytoplasmic dynein and myosin-V, an 
actin-based motor. Cytoplasmic dynein, a microtubule-associated motor protein 
complex, is involved in numerous motile events including retrograde movement 
of organelles along microtubules, nuclear migration, axonal transport and mitotic 
spindle alignment, as reviewed by Janmey, 1998 (Janmey, 1998), and references 
therein. 
A number of diverse cellular and viral proteins that interact with LC8 have now 
been identified and two distinct types of LC8 binding motifs have been 
characterised (Rodriguez-Crespo et 01., 2001). The neuronal nitric oxide 
synthetase (nNOS) and several other proteins use the binding sequence, 
"MKDTGIQV" (Liang et 01., 1999), while the apoptosis regulator, bim, amongst 
others, uses the binding motif "SCDKSTQT" (Puthalakath et 01., 1999). An 
nNOS-type motif was identified in the lyssavirus P protein that mediates the 
interaction of P and LC8 (Poisson et 01., 200 I). Following sequence analysis, a 
putative LC8 binding motif was identified within the L protein of rinderpest virus 
(see figure 6.1.1). This theoretical LC8 binding motif appears to be conserved 
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amongst the L proteins of the genus Morbillivirus, indicating that if an interaction 
does occur between Land LC8, it may play an important role within the viral life 
cycle. Only the DXXXQ part of the motif is conserved to a lesser extent 
throughout the paramyxoviruses as a whole. This part of the motifis not enough 
for LC8-binding, as it does not contain other critical residues from the nNOS and 
bim motifs. 
As I am interested in identifying host cell proteins with which rinderpest virus 
interacts, it was decided to investigate whether translation elongation factor-l a, 
a component of a group of soluble proteins that function in the chain elongation 
process during polypeptide synthesis at the ribosome, or LC8 interacted with the 
L subunit ofthe rinderpest polymerase, using the yeast two-hybrid system. 
6.2 Results 
6.2.1 Preparation of Yeast Two-Hybrid System Constructs 
Yeast constructs were made to express translation elongation factor- 1 (EF-l) 
subunits a, ~ and 'Y from the yeast expression vector, pACT2. EF-I subunits a 
and ~ were cut from existing laboratory pT7blue clones using SalI and EcoRI and 
ligated to pACT2 (XhoI/EcoRI cut). EF-l subunit 'Ywas excised from another 
existing pT7blue clone using XmaI and SalI and inserted into pACT2 (XmaI/XhoI 
cut). Resulting pACT2 constructs were then sequenced to confirm correct 
insertion and reading frames of each of the EF-l subunits. 
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6.2.2 Investigation of Interactions with Translation Elongation 
Factor- l(aBy) 
Two hundred ng ofpAS2/L with each ofpACT2/EF-1a, pACT2/EF-1 (3 and 
pACT2/EF-1 ywere co-transformed using either competent Y190 yeast cells or 
competent AH1 09 yeast cells, as in section 2.4.2. As a positive control, pAS2/L 
was co-transformed with pACT2/C and 200ng of each plasmid used. To check 
for autoactivation properties each of the three pACT2/EF-I constructs were co-
transformed with empty pAS2 vector. Co-transformants were selected for by 
plating out on minimal medium lacking leucine and tryptophan. Resulting 
colonies derived from the Y190 transformations were then picked and assayed for 
histidine biosynthesis in addition to beta-galactosidase activity, whilst colonies 
derived from the AHI 09 transformations were assayed for both histidine and 
adenine biosynthesis on the relevant selection plates. Only the positive control of 
pAS2/L and pACT2/C grew under either of the selection conditions and provided 
a positive beta-galactosidase result. In addition, none of the three pACT2/EF-l 
constructs were found to autoactivate. 
To confirm that the pACT2 constructs were expressing the EF-l subunits, 200ng 
of each of the three constructs was transformed using either AH 109 cells or Y 190 
ceIls (as in section 2.4.2) and each transformation mix plated out on SC-L plates 
and incubated at 30°C to select cells transformed with the pACT2 plasmid. A 
single colony was then picked and used to inoculate liquid cultures. After 2-3 
days protein samples were harvested (as in section 2.3.5) and expression tested by 
Western blot analysis, as in section 2.3.3. It was demonstrated that only 
pACT2/EF-1yexpressed a fusion protein of the expected size (-63 kDa) (see 
figure 6.2.2.1). pACT2/EF-1a and pACT2/EF-1(3 were expected to express 
fusion proteins of -63 kDa and ~26.8 kDa respectively, yet no proteins of this 
size were detected. The same results were obtained for both strains of yeast 
tested (data not shown) and a varying amount of expression was seen between 
isolated colonies. 
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Figure 6.2.2.1. Western blot analysis of EF-l subunit 
expression by protein samples derived from 
transformed AH109 yeast celllysates. Prepared protein 
sampl es from AH I 09 yea t celll ysates transronned with th e 
construct of interest were run on 10% Lae rnrnli D -PAG - ge l , 
alongside prestained protein broad range marker (New England 
Biolabs). After running, the gel wa tran ferred to membrane and 
probed llsing rat a- HA-Perox idase linked antibody (Roche) at 
I 11000. Tracks 1&2 = pACT2 - F- I a , tracks 3&4 = pA T2fEF- 1 ~ 
and tracks 5&6 = pACT2fEF- 1 'Y, where each track repre ent 
individual clones. Note: replicate clone howed considerable 
vari ation in protein expression. 
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It was thus concluded that RPV L does not interact with the translation elongation 
factor-l 'Y subunit within this system. However an interaction between Land EF-
1 ex or EF-l ~ may still be possible due to the lack of protein expression from 
pACT2/EF-lex and pACT2/EF-l~ in transformed yeast cells. 
6.2.3 Investigation of an Interaction Between Land Dynein Le8 
The Y2HS was used as a method with which to search for a possible interaction 
between Land LC8. A yeast plasmid construct expressing LC8, pACT2/LC8, 
was a kind gift from Dr. L. Dixon (Department of Molecular Biology, Institute 
for Animal Health, Pirbright, Surrey, UK) and enabled the rapid progression of 
this work. Using AHI09 yeast cells, 200ng ofpAS2/L and pACT2/LC8 were co-
transformed, in addition to a positive control pairing ofpAS2/L and pACT2/C (as 
in section 2.4.2). Previous work using the pACT2/LC8 construct had revealed 
that it did not autoactivate in Y190 cells, but the construct was nonetheless tested 
for autoactivation properties in AHI09 cells. pACT2/LC8 was shown not to 
autoactivate in AHI 09s, by co-transforming 200ng of the plasmid together with 
200ng of empty pAS2 vector. Double transformants were selected for using 
minimal agar lacking leucine and tryptophan and an L-LC8 interaction confirmed 
by selection for adenine biosynthesis and histidine biosynthesis, in addition to 
demonstrable J3-galactosidase activity, as assayed in section 2.4.4. As a novel 
interaction had been found within this system, it was necessary to confirm the 
interaction in a system outside of the Y2HS. This was to verify that the 
interaction was genuine and not an artefact of the Y2HS. The Y2HS is known to 
throw up spurious interactions that cannot be corroborated with other systems. 
To confirm the interaction between Land LC8, co-immunoprecipitation studies 
and co-localisation studies using immunofluorescence were employed. 
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6.2.4 Co-Immunoprecipitation Studies of Land Dynein LC8 
Before this work could be undertaken, it was first necessary to set up a gel system 
to enable LC8 to be resolved. This is due to the fact that LC8 is such a small 
protein (despite its name, LC8 is actually a 10 kDa protein). The tricine buffer 
system as described by Schagger and von Jagow (Schagger & von Jagow, 1987) 
was utilised as it has been shown to have superior resolution for proteins 
<20 kDa. The ability to detect LC8 was first tested by Western blot. Vero cell 
lysates were prepared by resuspending 106 cells in I OOJ..lI of SDS loading buffer 
and incubating at either 90°C or 40°C for thirty minutes. A series of cell lysate 
samples were run on a 10% acrylamide tricine gel (as in section 2.3.2.2) and 
analysed by Western blot (as in section 2.3.3); using this system it was possible to 
detect LC8 (figure 6.2.4.1). The normal denaturation temperature (90°C) was 
found to be superior to the temperature used by Schagger and von Jagow (40°C) 
(Schagger & von Jagow, 1987), as can be seen in figure 6.2.4.1. 
As it was possible to resolve LC8 by Western blot it was decided to try 
demonstrating pcDNNHAL bringing down LC8 using this system. 
Immunoprecipitated HAL was analysed by 10% acrylamide tricine gels and 
Western blot, using the monoclonal mouse a-PIN antibody used in the successful 
Western blot. However, possibly due to the fact that only a small amount of HA-
tagged L is produced in transfected cells (probably due to its size), no LC8 was 
detected in the HAL fraction (see figure 6.2.4.2). The same experiments were 
performed with pcDNAlHAL1, -/HAL2 and -!HAL3, but again no LC8 was 
detected (data not shown). 
Since it was possible that the Western blot was not sensitive enough to detect co-
precipitated LC8, direct co-immunoprecipitation studies of metabolically labelled 
proteins were next performed. Again, cells transfected with pcDNAlHAL were 
used and lysates examined for evidence that LC8 co-precipitated with the full 
length L (HAL). However, possibly due to the low levels of LC8 present in 
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Figure 6.2.4.1. Detection of Le8 by Western blot. 
Vero ce lll ysa tes were p repared by the centrifuga tio n of I x 106 
try psinised cells a t 500 rpm fo r fo ur minutes. The ell pe lle t wa 
resuspended in I OO~ I SDS load ing buffe r and incubat.ed a t e ither 
90°C (tr acks 2 and 3) or 40° ( track 4 and 5) for thirty m inutes. 
Either 5 ~1 ( tracks 2 and 4) or 20~ I (tracks 3 and 5) of sample wa 
loaded o nto a 10% tli c ine gel , a longs ide 5 ~1 of pre ta ined protein 
broad ra nge marker (New - ng land Bio labs) and 5~ g o f ra t 
ce rebrwn b ra in lysa te (provided \vi th th e a-PI anti b dy), as a 
pos iti ve contro l (trac k I). Af te r runnin g the ge l under condit.ion 
described by S hagge r and vo n Jagow ( 1987) , th e ge l was 
transfe rred to m emb ra ne and probed using m ou e monoc lona l a-
PI N at 1/1 000 (BD Transdu c ti o n Laboratorie ) and w ith a-mo use 
Ig- HRP lin ked who le anti body fTom sheep a t 1110 OOO( mersham 
Pharmac ia Bio tech). 
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Figure 6.2.4.2. Analysis of immunoprecipitated HAL 
by Western blot using anti-LC8 antibody. Ly ate fro m 
Vero cells tra nsfec ted with pcDNA / HA L wa immunoex tracted u ing 
rat monocl onal anti -HA anti body (Roche) and imm unoprec ipi ta ted 
proteins analysed on 10% acrylami de tri c ine ge ls. Ei ther 10111 (tra k 
2) or 20111 (u'ack 3) of sampl e was loaded onto the ge l along ide 5111 o f 
prestained protein broad range marker (New ng land Bio lab ) and 
51lg of rat cerebrum brain lysate (prov ided with the a-PI antibody) , 
as a pos itive co ntrol (track I ). After running the gel unde r conditions 
desc ribed by Schagger and von Jagow ( 1987) , the ge l was tra n fer red 
to membrane and probed us ing mouse monoclo nal a-PI at 1/1000 
and wi th a -mouse Ig-HRP linked w hole antibody from heep 
(Amersham Pharmacia Biotech). 
186 
Chapter 6- L and Host Cell Protein Interactions 
Vero cells, A549 cells and B95a cells, the natural LCS present in these cell types 
could not be detected when labelled and immunoprecipitated using either the 
mouse monoclonal a-PIN antibody, or a rabbit a-LCS antibody (a kind gift from 
Dr. Stephen M. King, Department of Biochemistry, University of Connecticut 
Health Centre, Farmington, Connecticut, 06030-3305, USA) (data not shown). 
An a-PIN antibody was utilised for the detection of LCS, as LCS is also referred 
to as PIN (protein inhibitor ofnNOS - neuronal nitric oxide synthase). A 
construct was therefore generated that expressed LC8 from a T7 promoter; since 
there was only a small quantity of rabbit a-LCS antibody available, a 6-HIS 
tagged LC8 construct was designed, enabling the use of commercially available 
anti-6-HIS antibodies. The LCS construct with a C-terminaI6-HIS tag was 
produced by amplifying the LC8 coding region from pACT2/LC8 using Pfu 
polymerase PCR and the LC8hisfor and LC8hisrev primers (see appendix 3). 
The resulting PCR product was cloned into pT7blue, excised by digestion with 
EcoRI and San and cloned into peDNA3 (EcoRIIXhoI cut). To confirm correct 
insertion ofthe 6-HIS tag and the LC8 coding sequence, the resulting pcDNA3 
construct was sequenced. 
To confirm expression of LCS from the peDNA/LCS/HIS construct and to ensure 
that the 6-HIS tag was functional, A549 cells were transfeeted using 2Jlg or 5Jlg 
amounts of plasmid DNA, as in section 2.2.17. One day post transfection, the 
cells were fixed, permeabilised and stained using a mouse monoclonal a-6-HIS 
antibody (Sigma) and the rabbit polyclonal a-LC8 antibody. As expected, a 
higher transfection efficiency was seen in cells transfected with the 5J.lg amount 
of plasmid DNA than with cells transfected with the lower amount of DNA. The 
immunofluorescence confirmed the expression of LCS from peDNA/LC8/HIS 
and the 6-HIS tag was shown to be fully functional (figure 6.2.4.3). 
Despite the production ofpcDNAlLCSIHIS, the levels of LC8 remained 
undetectable by immunoprecipitation within transiently transfected cells, even 
when other transfected constructs expressed proteins which were detected from 
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Figure 6.2.4.3. Immunofluorescence microscopy of cells 
transfected with pcDNAlLC8I1llS. A549 cells were infected 
with vTF7-3 and transfected with pcDNAlLC8IHlS. One day post 
transfection, cells were fixed, and permeabilised with 0.1 % Triton X-I 00 
before staining with antibody. Cells were reacted with either rabbit a-
LC8 (at 1110, a kind gift from S. King), and the primary antibody 
visualised with Alexa Fluor 568 a-rabbit IgG (at 11200, A), or with 
mouse a-6 HIS (at 11100, Sigma), and the primary antibody visualised 
with Alexa Fluor 488 a-mouse IgG (at 11200, B). C shows nuclei of cells 
counter-stained using DAPI and overlay of the stains used is shown in D. 
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the same batch oftransfections, see figure 6.2.4.4, where HAL is efficiently 
expressed from pcDNAlHAL. LCS/HIS should migrate at approximately 
11 kDa, and as can be clearly seen in figure 6.2.4.4, no protein of this size was 
detected in cells transfectcd with pcDNAlLC8IHIS, even when the gel was 
greatly overexposed. In addition to the usual NP40 lysis buffer, a high salt lysis 
buffer was also tried, where the concentration ofNaCI was increased from the 
usual O.15M to O.5M. This lysis buffer breaks open the nucleus and improves the 
dissociation of cytoskeletal proteins, which may have improved the solubility of 
LC8. However, the change in lysis buffer salt concentration did not alter the fact 
that LC8 was undetectable. The failure to detect LC8 in Iysates of radio labelled 
transfected cells could be due to there not being enough methionine/cysteine 
residues in this small protein. LC8 (esS] labelled) could not be detected by 
immunoprecipitation from labelled cells, even though LCS was being 
immunoprecipitated, as shown by subsequent Western blot of the 
immunoprecipitated material with anti-LCS antibody (M. D. Baron, personal 
communication) . 
6.2.5 Immunofluorescence Studies on the Interaction of Land 
Dynein Le8 
One possible explanation for the L-LCS interaction being observed in the yeast 
two-hybrid system, but not in co-immunoprecipitation, would be if the interaction 
is transient or unstable under the conditions ofimmunoprecipitation. Such an 
interaction, however, should lead to significant co-localisation of the two proteins 
when co-expressed in cells. To clarify if an interaction between Land LCS does 
in fact exist, co-localisation studies were performed using constructs expressing L 
and LC8. pcDNAlHAL and pcDNAlLCSIHIS (5Jlg of each) were transiently 
transfected into B95a and A549 cells, as in section 2.2.17. One day post 
transfection the cells were fixed and labelled with rabbit a-HA (Santa Cruz 
Biotechnology) and mouse a-6-HIS (Sigma). In the majority of transiently 
transfected cells of either cell type, no co-localisation was observed between 
these two proteins (see figure 6.2.5.1); however, in a few transfected cells of both 
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Figure 6.2.4.4. Failure to immunoprecipitate LCS/HIS from 
cells transfeeted with either peDNA/LCS/H IS alone, or 
peDNA/LCS/HIS eo-transfeeted with peDNA/HAL, despite 
the immunoprecipitation of HAL. 895a ce ll s were infected Witll 
vTF7-3 and transfec ted Witll ei ther pcDNAIL C8/HIS onl y (track I and 6), 
or pcDNAlHAL only (tracks 3 and 4), or both constl1l ct were co-tran fec ted 
(tracks 2 and 5); one day post transfection, ce ll s were labe lled w ith [35 ] 
amino acids for one hour and lysed with 1% NP40. Track 7 and 8 represent 
non-trans fecled (no DNA) control cell Iysates. Samples of Iy ate were 
immunoextracted with eitller mouse 0.-6 HIS monoclonal antibody (Sigma) 
(tracks 1,2, 3 and 7), or rat a.-HA monoclonal antibody (Roche) (tracks 4,5, 
6 and 8) and immunoprecipitated proteins analysed on both 8% acrylamide 
Laemmli ge ls and 10% acry lamide Tricine gels. Panel A shows an 
overnight exposure of tll e 8% Laemmli gel, panel 8 an ovemight ex po ure 
of the 10% Tricine gel and panel C a 10 day expo ure of tll e 10% Tri cine 
gel. 
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A549 B95A 
Figure 6.2.5.1. Immunofluorescence microscopy of cells co-
transfected with pcDNAIHAL and pcDNAfLC8I1DS. A549 cells 
(A, B and C) or B95a cells (D, E and F) were infected with vTF7-3 and co-
transfected with pcDNNHAL and pcDNAlLC8Il-DS. One day post transfection, 
cells were fixed, and permeabilised with 0.1 % Triton X-IOO before staining with 
antibody. Cells were reacted with either rabbit a-HA (at 11200, Santa Cruz 
Biotechnology), and the primary antibody visualised with Alexa Fluor 568 a-
rabbit IgG (at 1/200, A&D), or with mouse a-6 IDS (at 1/100, Sigma), and the 
primary antibody visualised with Alexa Fluor 488 a-mouse IgG (at 11200, B&E). 
C and F show overlay of the stains used (nuclei of cells counter-stained using 
DAPI). 
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cell types, it did appear as though Land LCS did in fact co-localise (see figure 
6.2.5.2). It is not clear why apparent co-localisation was seen in these cells, but 
not in others. It may indicate an interaction that depends on cell cycle state, or it 
may be that the rare co-localisation seen was an artefact. 
Although it is unlikely that L interacts with dynein LCS, it was observed in the 
course of the studies that in RPV infected cells not only were the levels of LCS 
increased, but that LCS was also re-organised within infected cells (M. D. Baron, 
personal communication). It is possible that another component ofthe viral 
nucleocapsid may be interacting with either LCS or another component of the 
dynein complex, thus accounting for the re-organisation of LCS seen in RPV 
infected cells. To investigate if this was the case, A549 cells were transfected 
using pcDNA constructs expressing N, P or C, together with the 
pcDNA/LCS/HIS construct. From these studies using confocal microscopy it 
was clear that LCS did not interact with N, as N was shown to form aggregates 
and did not share a cellular distribution with LeS/HIS (data not shown). It was 
impossible to determine if LCS interacted with either P (figure 6.2.5.3) or C 
(figure 6.2.5.4) by this technique; the apparent co-localisation (yellow in 
overlays) is due to the extensive diffuse cytoplasmic distribution seen with each 
of these proteins. 
6.3 Discussion 
Recent work with VSV has shown that the L protein subunit of the polymerase 
interacts with EF-1 a. for its activity (Das et ol., 1995). Using the Y2HS, such an 
interaction was explored with the RPV L protein. Despite numerous attempts to 
identify an interaction between L and the EF-1 subunits, no such interaction 
between these proteins was seen. When the expression of fusion proteins from 
each of the pACT2 constructs made was tested, it was found that only 
pACT2/EF-1'Yexpressed a fusion protein of the expected size. It was therefore 
only possib Ie to cone lude that RPV L does not interact with EF -1 'Y within the 
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Figure 6.2.5.2. Immunofluorescence microscopy of 
cells co-transfected with pcDNAIHAL and 
pcDNAlLC8I1DS. A549 cells were infected with vTF7-3 and co-
transfected with pcDNAIHAL and pcDNAlLC8/lllS. One day post 
transfection, cells were fixed, and permeabilised with 0.1% Triton X-
100 before staining with antibody. Cells were reacted with either 
rabbit a-HA (at 11200, Santa Cruz Biotechnology), and the primary 
antibody visualised with Alexa Fluor 568 a-rabbit IgG (at 11200, A), 
or with mouse a-6 HIS (at 11100, Sigma), and the primary antibody 
visualised with Alexa Fluor 488 a-mouse IgG (at 11200, B). C shows 
nuclei of cells counter-stained using DAPI and 0 shows an overlay of 
the stains used. 
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Figure 6.2.5.3. Immunofluorescence microscopy of cells 
co-transfected with pcDNAfP and pcDNAfLC8I1DS. A549 
cells were infected with vTF7-3 and co-transfected with pcDNAIP and 
pcDNAfLC8IHlS. One day post transfection, cells were fixed, and 
permeabilised with 0.1% Triton X-IOO before staining with antibody. 
Cells were reacted with either rabbit a-RPVP, and the primary antibody 
visualised with Alexa Fluor 568 a-rabbit IgG (A), or with mouse a-6 HIS 
(Sigma), and the primary antibody visualised with Alexa Fluor 488 a-
mouse IgG (B). C shows nuclei of cells counter-stained using DAPI and 
D shows an overlay of the stains used. 
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Figure 6.2.5.4. Immunofluorescence microscopy of 
cells co-transfected with pcDNAlC and 
pcDNAfLC8IH1S. A549 cells were infected with vTF7-3 and 
co-transfected with pcDNAIC and pcDNAlLC8IHIS. One day post 
transfection, cells were fixed, and penneabilised with 0.1 % Triton 
X-IOO before staining with antibody. CeUs were reacted with either 
rabbit a-RPVC (MB38), and the primary antibody visualised with 
Alexa Fluor 568 a-rabbit IgG (A), or with mouse a-6 HlS (Sigma), 
and the primary antibody visualised with Alexa Fluor 488 a-mouse 
IgG (B). C shows nuclei of cells counter-stained using DAPI and D 
shows an overlay of the stains used. 
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Y2HS. Each of the EF-I subunits should now be cloned into pcDNA and an 
interaction with L investigated using co-immunoprecipitation. 
More interestingly, further studies using the Y2HS revealed a direct interaction 
between RPV Land LC8. However attempts to confirm this interaction outside 
ofthe Y2HS resulted in no such interaction being observed. This was despite the 
fact that the interaction was observed on numerous occasions within the Y2HS 
and was selected for using all the available reporter genes. 
Co-immunoprecipitations were utilised but LC8 failed to co-ip L and vice versa. 
Initially it was thought that this lack of co-ip was due to the low levels of LC8 
present in the B95a cells and Vero cells, which were used for this work. To get 
around this problem a construct was made which expressed a 6-HIS tagged 
version of LC8 from a T7 promoter. Despite boosted levels of LC8 expression in 
transfected cells, no direct interaction between the two proteins of interest could 
be confirmed, because labelled LC8/HIS was never detected by 
immunoprecipitation from transfected celllysates. The a-6-HIS antibody was 
known to be functional as it had previously been used successfully in the 
laboratory for immunoprecipitation studies, and it was unlikely that the antibody 
had deteriorated as it was used in the same time period for accompanying 
immunofluorescence studies, where it was shown to be fully functional. The co-
immunoprecipitation data therefore failed to confirm the observations seen with 
the yeast two-hybrid system, but this was largely due to problems with the 
labelling and detection of LC8. It would be useful to use purified LC8 protein, as 
was used to study the interaction of this protein with the African swine fever 
virus (ASFV) protein p54 (Alonso et al., 2001). 
Confocal microscopy was next used and again the evidence was inconclusive as 
to an interaction between Land LC8. In a population of A549 cells transfccted 
with Land LC8 there did appear to be co-localisation between the two expressed 
proteins, but only in a small proportion of the total cell number. These data, 
together with those obtained from the co-immunoprecipitation studies outlined in 
section 6.2.4, would indicate that there is little evidence to suggest that a genuine 
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interaction exists between Land LC8, leading to the conclusion that the 
interaction found in the Y2HS may either be an artefact of the system within 
which it was found, or that it may be a weak or transient interaction which will be 
difficult to confirm. 
As it had been shown that LC8 is re-organised in RPV infected cells, in addition 
to there being more LC8 present in RPV infected cells, it was decided to test if 
any of the other viral proteins present in the nucleocapsid complex co-localised 
with LC8 in transfected cells. Using confocal microscopy the N protein was 
shown not to co-localise with LC8. However, P and C could not be eliminated as 
they each share a diffuse cytoplasmic distribution with LC8. This remains an 
interesting area to be investigated further. 
It has been proposed that the interaction of viral capsid proteins with the LC8 
dynein light chain may be a common virus event (Poisson et at., 2001). Many 
viruses are now known to interact with LC8 for intracellular movement of viral 
components along microtubules during virus infection, including the ASFV 
protein p54 (Alonso et at., 2001). More recently several viral proteins from a 
wide variety of families have been shown to bind LC8 by a pepscan technique 
(Martinez-Moreno et at., 2003). These proteins include the attachment protein of 
RSV, the polymerase protein of vaccinia virus, two herpes simplex virus proteins 
and a human coxsackievirus capsid protein, providing evidence that the hijacking 
of the dynein motor complex by viruses could be a common virus event. 
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Chapter Seven 
Discussion and Future Work 
The L proteins ofparamyxoviruses are known to interact with the P protein to 
form the functionally active RNA dependent RNA polymerase complex 
(Hamaguchi et al., 1983) and recently the L protein of rinderpest virus was 
demonstrated to interact with the two non-structural proteins (C and V), in 
addition to P (Sweetman et al., 2001). One of the major aims ofthis study was to 
map the region of the L protein to which each of these three viral proteins binds. 
Initial attempts to determine the sequences of L which interact with the P, C and 
V proteins were performed using the Promega Checkmate MTHS. However, this 
system was shown to be unsuitable as the majority of constructs generated using 
RPV coding sequence failed to localise to the nuclei of transfected cells; nuclear 
localisation of protein encoding constructs is essential for the functionality of the 
MTHS, so that the reporter gene may be transcribed. Using the MTHS, it was 
however possible to further investigate a putative C-C interaction, previously 
seen in the Y2HS but not directly in any other system (Sweetman et al., 2001). 
Such an interaction was not confirmed using the MTHS. This does not mean that 
this C-C interaction does not occur, it may just be that is unable to be detected 
within this system. There are several possible reasons for the MTHS not 
detecting a genuine interaction, including the proteins being investigated not 
being correctly folded within this system or interactions being blocked as a result 
of steric hindrance. 
To study the domain of L that interacts with the P, C and V proteins, co-
immunoprecipitation studies were utilised. P and C were both shown to co-ip full 
length L. The V protein, however, failed to co-ip L yet, when expressed as a 
GST fusion, an L-V interaction was confirmed. A possible explanation for this 
result is that the monoclonal anti-V antibody (U32), which was being used to 
immunoprecipitate V, was in some way displacing the L protein. Previous work 
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had shown that L does not interact with GST (Sweetman et 01., 2001) an 
observation that was reconfirmed in these studies. 
Using co-immunoprecipitation studies it was demonstrated that the P protein co-
immunoprecipitates HALl. That is, P interacts with the first of the three 
conserved domains of the L protein, as defined by McIlhatton and co-workers 
(McIlhatton et 01., 1997). In an effort to further characterise the L binding site for 
the P protein, a series of L deletions were generated to enable binding studies to 
be performed using the Y2HS (as in section 4.2.7 and 4.2.8). Using the Y2HS, it 
was confirmed that the P protein binds to the first conserved domain of the L 
protein. The P binding region, or at least an essential part of that binding region, 
was further mapped to sequence found in the first 700bp of L, corresponding to 
amino acids 1-233. Amino-terminal deletions are still required to define the 
precise boundary of the P-binding domain. 
The P-L binding data obtained during the course of these studies ties in with the 
literature published to date as, like the RPV P protein, the P proteins of MeV 
(Horikami et 01., 1994), SV5 (Parks, 1994), hPIV-3 (Malur et 01.,2002) and SeV 
(Chandrika et 01., 1995, Horikami et 01., 1997) are all known to interact with the 
amino-terminal domain of the L protein. The binding site for MeV P has been 
mapped to the first 408 amino acids of L (Horikami et 01., 1994), that of SV5 has 
been mapped to the N-terminal1247 amino acids ofL (Parks, 1994), for hPIV-3 
the first 15 amino acids of L are required (Malur et 01.,2002) and for SeV the P 
binding site has been shown to reside within the first 350 amino acids of L 
(Holmes & Moyer, 2002). For the rhabdoviruses VSV and rabies virus, on the 
other hand, the carboxy-terminal domain of L is required for interaction with P 
(Canter & Perrault, 1996, Chenik et 01., 1998). For RPV, the region of L 
sequence required for P binding confirms the difference seen in the binding 
properties of the L-P interaction between members of the rhabdoviridae family 
and members of the sub-family paramyxovirinae. 
In contrast to the co-ip data obtained for P, each of the two non-structural 
proteins, C and V were shown to co-ip HAL2, demonstrating an interaction with 
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the central conserved domain of the L protein. At this stage however, it was not 
possible to rule out that the V protein does not also interact with HALl since the 
GST tagged form of the V protein migrated at exactly the same position as the 
HALl protein on Laemmli gels. To determine if V interacts with HALl, a c-Myc 
tagged version of V was made, enabling the V protein to migrate at a faster rate 
than the HALl protein when analysed on Laemmli gels. However, it was found 
that when the c-Myc tagged V construct was co-transfected with another plasmid, 
the level of c-Myc V expression was dramatically reduced. Expression levels of 
this construct at this time are too poor to determine if HALl and V interact. This 
work is ongoing and due to time constraints could not be completed in time for 
inclusion in this thesis. 
When the L binding characteristics of C and V were further investigated using the 
Y2HS, conflicting data were produced. Using the Y2HS, the C and V proteins 
were both shown to interact with the first conserved domain of the L protein and 
not the second domain of L, as was identified using co-ip studies (section 4.2.6). 
The C and V proteins were implied to interact with L somewhere between amino 
acids 1 and 363, which is well within the first conserved domain of the L protein. 
Taken together, these results may therefore suggest that the two non-structural 
proteins have an additional binding site within in the first conserved domain of 
the L protein that is distinct from the P binding sequence. No interactions were 
detected between either C or V and the domain 2 L construct using the Y2HS, 
which was surprising given the clear interaction demonstrated by co-ip between 
C and V and the second domain of L. At the start of this work, it was thought 
that the P and V proteins might bind to the same region of L as a result of the 
shared domain between P and V. However, this was shown not to be the case by 
both co-ip and the Y2HS. To date little is known about the regions of L required 
for C and V binding. It is however known that the amino-terminal half of Se V L 
contains the C binding site (Holmes & Moyer, 2002). Despite the fact that the C 
proteins ofRPV and SeV are very dissimilar, it remains possible that each may 
bind to the same domain of L. 
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This part of the project is ongoing and further work will involve the confirmation 
of the P, C and V binding sites on L. To do this both amino- and carboxy-
terminal deletions of the L protein will be made, resulting in constructs which can 
be utilised for protein expression in eukaryotic cells, and thus enable the use of 
co-ips for the remainder of these protein binding studies. Such constructs will 
determine whether the regions of L sequence identified by the Y2HS, or those 
sequences identified by co-ip studies so far, are required for L-P, L-C and L-V 
interactions. The existing panel of L deletions that were generated for the 
production of the constructs utilised for the Y2HS studies will be used for the 
generation of the deletions required for co-ip studies. Further Domain 2 L 
deletions will also need to be synthesised to ascertain which region of domain 2 is 
necessary for interaction with each of the non-structural proteins, C and V. 
In addition to mapping the domains required for the interaction of L with P, C 
and V, co-immunoprecipitations were also used to reveal that the L protein of 
RPV interacts with itself. It was demonstrated that the region of L sequence 
required for self-association resides within the first conserved domain of the L 
protein, as full-length L was shown to co-ip HAll. Further work now needs to 
be carried out to map the binding region for this novel RPV interaction. This 
work will be performed using the L deletions, which are currently being prepared 
for use in co-immunoprecipitations to further characterise the P, C and V binding 
sites on L. The L protein of Se V was recently demonstrated to form an oligomer 
in the polymerase complex (Smallwood el al., 2002b). The region ofSeV L 
required for this self-association has now been mapped to somewhere in the first 
174 amino acids of the L protein (Cevik el al., 2003). It has also been shown 
with SeV that pairs of different mutant L proteins, each defective for RNA 
synthesis, can be co-expressed to restore viral RNA synthesis on an added 
template, by complementing each other, providing further evidence that the L-L 
interaction is of functional importance (Smallwood el al., 2002b). Furthermore, 
analysis of RNA-dependent RNA polymerase structures and predicted secondary 
structures of positive strand RNA viruses has revealed the conservation of a 
unique region at the amino terminus of the polymerase, which is thought to be 
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involved in oligomerisation, as reviewed by O'Reilly and Kao (O'Reilly & Kao, 
1998). 
Like the RPV L self-association, the oligomerisation ofSeV L is now known to 
be independent of the P protein (Cevik et al., 2003). Furthermore, it has been 
proposed that for Se V, the L protein self associates, forming an oligomer, prior to 
binding the P protein (Cevik et al., 2003) as, in the case ofSeV, P functions to 
stabilise the L protein (Smallwood et al., 1994). This would therefore mean that 
the minimal constitution of the polymerase complex would be L2:PlI, as SeV P 
has been shown to be a tetramer (Tarbouriech et al., 2000a, Tarbouriech ei al., 
2000b). RNA polymerase proteins of the positive sense RNA viruses, poliovirus 
(Hobson et al., 2001, Pata et al., 1995) and hepatitis C virus (Qin et al., 2002, 
Wang et al., 2002) are also known to require oligomerisation for functionality. 
It is of interest to note that neither of the two hinge regions of L, as proposed by 
McIlhatton and co-workers (McIlhatton et al., 1997), appear to be required for 
either the oligomerisation of L, or for the interaction of L with P, C or V. These 
studies may therefore provide evidence to support the claims that these two 
regions of sequence, which share less identity with related viruses than the three 
domains of highly conserved sequence, may function to mediate the optimal co-
operation between each of the three conserved domains, in addition to mediating 
the conformation of L required for binding to some of its functional partners. 
Recent research with MeV has indicated that only the first ofthe two proposed 
hinge regions has either spatial or size constraints for its functionality. This is 
due to the fact that the c-Myc tag could be inserted into the second hinge region 
of MeV L without affecting the function of the polymerase (and it was 
subsequently shown that even with the insertion of the green fluorescent protein 
(GFP) ORF at this site in L, the polymerase remained functional, although 
polymerase activity was shown to have reduced by over 40% (Duprex et al., 
2002). However, not even the insertion of the epitope tag c-Myc was tolerated 
in the first of the two hinge regions (Duprex et al., 2002), indicating that only the 
second of the two hinge regions is completely flexible. These findings, together 
with the fact that domain 3 has been shown to be unnecessary for L 
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oligomerisation, or for P, C or V binding, may suggest that the third conserved 
domain of the L protein can be spatially re-orientated with respect to the other 
two domains. The fact that the first hinge region was unable to tolerate an 
increase in size, together with the C and V binding data, may suggest that the C 
and V proteins have complex L binding sites which span the first and second 
domains ofL. Any disruption to the spatial arrangement of these domains may 
abolish C-L or V-L interactions. Despite the fact that domain 3 of L has been 
shown to be unnecessary for the self-interaction of L, or the binding ofP, C or V, 
it has been demonstrated for SeV that the C-terminal region of L is essential for 
both viral transcription and replication (Smallwood et 01., 2002a). 
Using a minigenome system and an experimental approach similar to that used by 
Duprex and co-workers (2002), parallel observations with RPV L would be 
possible. It would be interesting to determine if the L proteins of MeV and RPV 
are comparable with respect to the functional spatial requirement of each domain. 
It has, indeed, already been found that RPV L, like MeV L remains functional in 
vitro after the insertion of the GFP ORF into the second of the two hinge regions 
(D. Brown, personal communication). One major difference between the L 
proteins of MeV and RPV, which share a high level of sequence conservation, is 
already known; as unlike RPV L, MeV L requires co-expression with MeV P for 
stability (Horikami et 01., 1994). 
Another major aim of this project was to determine if the L protein ofRPV 
interacts with host cellular proteins. The Y2HS was used to enable a porcine 
macrophage eDNA library to be screened for proteins that may interact with L. 
After an enormous amount of effort and time, a novel interaction between Land 
the host cell protein, striatin, was confirmed, not only in the Y2HS, the system 
within which the interaction was isolated, but also confirmed by co-
immunoprecipitation studies and confocal microscopy. Furthermore, it was 
demonstrated that striatin, when expressed as a GST fusion, co-ips HAL2, that is, 
it interacts with the second of the three conserved domains of the L protein. 
Using the Y2HS, it was shown that striatin binds L in a similar way to that of the 
non-structural proteins, C and V, somewhere in the first 363 amino acids of L, 
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indicating that striatin may also have an additional binding site located in the first 
conserved domain of L. However, like the P, C and V binding sites, the 
interacting sequences of L with striatin need to be confirmed. Co-
immunoprecipitation studies will be performed using the same batch of L 
deletions, which are currently being cloned for use in the identification of the 
exact sequences of L required for self-association, in addition to interaction with 
P, C and V. 
After a recent literature search it would appear that this is the first described 
interaction of a viral protein with striatin. Unfortunately, little is known is about 
this protein. However, striatin is known to be a highly conserved intracellular 
protein of780 amino acids (86,225 kDa), belonging to the family ofWD-repeat 
proteins (Castets et 01., 1996, Moqrich et 01., 1998), containing 8 WD-repeats at 
its carboxy- terminal domain (Castets et 01., 1996), although recent analysis has 
suggested that striatin may only possess 7 WD-repeats (Castets et 01.,2000). The 
large family ofWD-repeat proteins constitutes a group of proteins that are 
specific to eukaryotes, are regulatory in function though none are known to 
possess enzymatic activity (Neer et 01., 1994). WD proteins are so-called due to 
the fact that they consist of between four and eight copies of a highly conserved 
unit - the WD-repeat, which is commonly found to start with the amino acids 
Gly-His (GH), followed by a core that varies in length from 23 amino acids to 41 
amino acids and ends with the amino acids Trp-Asp (WD), each WD-repeat 
being separated by short variable sequences (Neer et 01., 1994). 
Striatin is known to be expressed almost exclusively in the CNS, with the brain 
striatum being the richest source of this protein (Castets et 01., 1996), although 
striatin has also been found in kidney and placenta samples (Moqrich et 01., 
1998), in addition to the lungs and spleen (Castets et 01., 2000). As a striatin 
clone was found in the porcine macrophage library used in this study it can be 
concluded that striatin is expressed in macrophages. The distribution of striatin 
therefore encompasses the main tissue targets ofRPV which is lymphotrophic 
and epitheliotrophic. Striatin has been demonstrated, by subcellular fractionation, 
to be a mostly membrane-associated protein (Castets et 01., 1996). Striatin is 
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known to bind calmodulin in a calcium-dependent manner and was the first WD-
repeat protein identified to bind calmodulin (eastets et 01., 1996). This 
interaction is known to be mediated by amino acids 149 to 166 of striatin, 
revealing that it is not the WD-repeats of this protein that are necessary for this 
interaction (Bartoli et 01., 1998). It is thought that striatin acts as both a calcium 
dependent signalling protein and as a scaffolding protein (Bartoli et 01., 1998, 
eastets et 01., 1996, eastets et 01.,2000). Striatin is known to interact with the 
host cell proteins phocein, a protein that is thought to playa role in membrane 
traffic and membrane budding reactions (Baillat et 01., 2002) and caveolin-l, an 
integral membrane protein that is a main component of caveolae, the specialised 
domains of rafts (Gaillard et 01.,2001). Furthermore, striatin is known to 
associate with protein phosphatase 2A, a vital serine/threonine protein 
phosphatase found in all eukaryotic cells (Moreno et 01.,2000). More recently, 
striatin was also shown to associate with mMOB1, a mammalian homologue of 
the MOB yeast protein (Moreno et 01., 2001). It has been proposed that striatin 
may interact with PP2A and mMOBI to regulate interactions of, or re-organise, 
the cytoskeleton and membrane structures (Moreno et 01., 2001). Although the 
precise function of striatin remains unknown, the fact that its sequence is 
conserved throughout the animal kingdom, even down to Drosophila and 
Caernorhabditis elegans, suggests that the function of striatin is basic and well-
conserved (Moqrich et 01., 1998). 
From the literature available it is possible to postulate why L may be interacting 
with striatin. L may be interacting with striatin when it is complexed with 
phocein, in order to "piggy back" a ride from the cytoplasm to the cell membrane 
where viral assembly may then occur. The striatin may then dissociate from its 
complex with phocein and form a new association with caveolin-l as a 
mechanism with which to anchor itself onto the membrane structure. MeV is 
already known to assemble on lipid rafts and it is known that F glycoprotein is 
targeted to the rafts independently of the other viral proteins (Manie et 01.,2000, 
Vincent et al., 2000). Furthermore, the pneumovirus RSV assembles on the host 
cell surface membrane in areas rich with caveolin-l, which is known to be 
incorporated into mature RSV particles during virus assembly; however, 
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caveolin-l was found not to associate with the viral nucleocapsids (Brown et al., 
2002a, Brown et al., 2002b, McCurdy & Graham, 2003). This may indicate the 
presence of intermediary proteins, which may act as a bridge between RSV 
proteins and caveolin-l. Another interesting prospect is that L may be interacting 
with striatin in order to regulate the activity of PP2A, which may function to 
dephosphorylate RPV P, thereby regulating the levels of RNA synthesis. 
In addition to a cDNA library screen, direct protein:protein interactions of L with 
host cell proteins known to interact with compone!lts of the polymerase complex 
of members of the order Mononegavirales were also investigated. These 
included the three subunits of translation elongation factor- 1 (EF-l aI(3/y), as the 
L protein ofVSV is known to interact with the EF-l a subunit for its activity 
(Das et al., 1998). Using the Y2HS, no such interaction was demonstrated for the 
L protein of RPV, with the EF-l y subunit. Analysis of the EF-I a and (3 yeast 
plasmid constructs used for the investigation of an interaction with L revealed 
that the EF-l a and (3 subunits were not expressed in transformed yeast cells from 
the constructs made. It is therefore still possible that an interaction like that 
demonstrated for VSV L may still exist for RPV L. To confirm this, it would 
now appear that the method of choice would be co-ip analysis. The EF-l 
subunits could be cloned into a suitable expression vector and once expression 
was confirmed in mammalian cells, immunoprecipitations could be performed to 
determine if L interacts with EF-I aI(3/y. 
Due to the fact that the phosphoprotein component of the RNA-dependent 
polymerase complex of rabies virus and Mokola virus was recently found to 
interact with the dynein light chain, LC8 (Jacob et al., 2000), an interaction 
between LC8 and RPV L was searched for using the Y2HS. A direct interaction 
between these two proteins was demonstrated within the Y2HS, but to date this 
has yet to be confirmed in a system outside ofthe Y2HS. Some evidence was 
obtained using confocal microscopy that would suggest these two proteins may 
co-localise in a small number of co-transfected cells. Additionally, in RPV 
infected cells, the levels of LC8 are known to have increased when compared to 
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non-infected cells and LC8 is also shown to be re-organised in RPV infected cells 
(M. Baron, personal communication). These data would suggest that a 
component of the viral nucleocapsid is exerting these effects on LC8. Further 
investigation into the mechanism of LC8 reorganisation seen in cells during RPV 
infection is required. Preliminary confocal microscopy findings have indicated 
that the N protein is not responsible (data not shown). However, it was not 
possible to rule out the involvement of the P, C or L proteins. 
It is entirely plausible that L is interacting with LC8 in order to transport itself 
and other components of the viral nucleocapsid from the host cell plasma 
membrane to the cytoplasm where RPV is known to replicate. Several viruses 
are already known to utilise dynein for the transport of viral capsids including, 
adenovirus (Suomalainen et al., 1999), herpes simplex virus type 1 (Dohner et 
al., 2002, Ye et al., 2000), African swine fever virus (Alonso et al., 2001), canine 
parvovirus (CPY) (Suikkanen et al., 2003). For hPIV-3 (Bose et al., 2001) and 
rotaviruses (Nejmeddine et al., 2000) it is known that the microtubules are used 
for transport, but it remains unclear whether they target a component of the 
dynein motor complex. Taken together, it would appear that the interaction of 
viral capsid proteins with the dynein motor complex might be a common 
exploitation of the host cell machinery by viruses. 
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Appendix 1- Media, solutions and reagents 
1.1 Bacterial culture media and reagents 
Ampicillin (Sigma) 
Standard anhydrous form (sodium salt) made up using 50% ethanol to a stock 
concentration of 100mglml. Store at -20°e. 
1.2 Buffers and Reagents used for peR 
lOmM dNTP Mix 
5 J-ll 100mM dA TP 
5J-ll100mM dTTP 
5J-ll100mM dCTP 
5J-ll100mM dGTP 
Make up to 50J-ll with distilled deionised water. 
1.3 DNA sequencing with T7 polymerase 
Short sequencing termination mixes 
'A' short mix 
'C' short mix 
840J-lM each of dCTP, dGTP and dTTP; 93.5 J-lM 
dATP; 14J-lM ddATP; 40mM Tris-HCL (pH 7.6) 
and 50mM NaCl. 
840J-lM each of dATP, dGTP and dTTP; 93.5 J-lM 
dCTP; 17JlM ddCTP; 40mM Tris-HCL (pH 7.6) 
and 50mM NaCl. 
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'G' short mix 840J.lM each of dATP, dCTP and dTIP; 93.5 J.lM 
dGTP; 14J.lM ddGTP; 40mM Tris-HCL (pH 7.6) 
and 50mM NaCI. 
'T' short mix 840J.lM each of dATP, dCTP and dGTP; 93.5 JlM 
dTTP; 14JlM ddTIP; 40mM Tris-HCL (pH 7.6) 
and 50mM NaCI. 
1.4 Buffers and reagents used for yeast two-hybrid analysis 
Terrific Broth Base 
48g Tryptone 
96g Yeast extract 
pH to 7.0 
Add 16ml glycerol and make up to 3.6 litres with double distilled water and 
autoclave to sterilise. 
Terrific Broth Buffer 
11.5g Di-hydrogen potassium phosphate 
62.7 g Di-potassium hydrogen phosphate 
pH to 7.0 
Make up to 500ml with double distilled water and autoclave to sterilise. 
Drop out amino acids (10X) (DOAA) (without histidine, tryptophan or 
leucine) 
300mg isoleucine 
1.5g valine 
200mg adenine hemisulphate salt 
200mg arginine 
300mg lysine HCL 
200mg methionine 
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300mg tyrosine 
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Make up to } litre with double distilled water and autoclave in lOOml volumes to 
sterilise. 
Drop out amino acids (1 OX) (DOAA) (without adenine) 
As above, but minus adenine hemisulphate salt. 
Stock amino acids (1 OOX) 
200mg Histidine HCL in lOOml 
} g leucine in 100ml 
200mg tryptophan in 100ml 
Filter sterilise or autoclave and store at 4°C. 
Synthetic complete plates minus tryptophan (SC-T plates) 
170ml molten YNB agar 
20ml} OX nOAA 
I Om140% dextrose 
2ml histidine 
2mlleucine 
Synthetic complete plates minus tryptophan and leucine (SC-T -L plates) 
170ml molten YNB agar 
20ml lOX nOAA 
I Om140% dextrose 
2ml histidine 
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Synthetic complete plates minus tryptophan, leucine and adenine (SC-T-L-
Ade plates) 
170ml molten YNB agar 
20mllOX nOAA (without adenine) 
1 Om140% dextrose 
2ml histidine 
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~ 
Antibodv Target Antibody Tvpe Source 
MB2 RPV N: peptides based on N carboxy term inus Rabbit PAb (Baron et al., 1999) 
MB18 RPV P: single carboxy terminal peptide ofP Rabbit PAb (Baron & Barrett, 1997) 
MB38 RPV C and GST: GSTIC protein fusion Rabbit PAb (Baron & Barrett 2000) 
a.-V2 RPV V: against MeV V Rabbit PAb D. Briedis (Wardrop & Briedis, 1991) 
C39 RPYN Mouse Mab Fleming & Barrett unpublished 
MB41 RPV L: GST fusion of carbo~yterminal third of L Rabbit PAb (Sweetman et al., 200 I) 
a.-HA HA tag Rat Mab Roche 
2-1 RPYP Mouse MAb Dr. Sugiyama (Sugiyama et al., 1989) 
U32 RPYPN Mouse MAb Dr. Sugiyama (Sugiyama et al., 1989) 
9EI0 c-Myc tag Mouse MAb Santa Cruz Biotechnology 
a.-c-Myc c-Myc tag Rat MAb Serotec 
A-14 c-Myc tag Rabbit PAb Santa Cruz Biotechnology 
a.-PIN LC8 Mouse MAb BO Trandsuction Laboratories 
a.-LC8 LC8 Rabbit PAb S. King, University of Connecticut USA 
a-6-HIS poly HIS tag MouseMAb Sigma 
a.-HA HA tag Rabbit PAb Santa Cruz Biotechn9IQgy 
Appendix 2: A list of all primary antibodies utilised during this project. PAb= polyclonal antibody and 
MAb=monoclonal antibody. 
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Appendix 3- Primer Sequences 
3.1 Primers designed for the generation of MTHS constructs 
Primer Name 
KatNstart 
KatNend 
KatLstart 
KatLend 
KatCstart 
KatCend 
KatPNstart 
KatPend 
KatVend 
Primer Sequence (5' - 3') 
TCTCTACGCGTAAATGGCTTCTCTCTTGA 
CTCTTGCGGCCGCTCAGTTGAGAATATCCTTGT 
TATCTCGTCGACCCATGGACTCCCTCTCA 
TCTCGCGGCCGCCAGTTGCAGAATCACTCC 
TCTCTACGCGTCCATGTCAACAAAGGCCTG 
TCTCGCGGCCGCCTTCTACTGTTTCAACATC 
ACCGTACGCGTAGATGGCAGAGGAGCAAG 
TCTCGCGGCCGCCTAGTTCTTTAGAATTTTGACC 
TCTCGCGGCCGCTCAATGTTACTCTGGGATAT 
3.2 Primers designed to insert a new SalI site downstream of Lin 
pGempola 
Primer Name 
KatLl 
KatL2 
Primer Sequence (5'-3') 
CGTCGACAGGCC 
TGTCGACGGGCC 
3.3 Overlapping primers designed to re-introduce a NotI site into 
pcDNAlHA 
Primer Name 
HAinsl 
HAins2 
Primer Sequence (5'-3') 
AATTCGATATCGCGGCCGC 
TCGAGCGGCCGCGATATCG 
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3.4 Primers designed for the generation of pc DNA/HAL domain 
constructs 
Primer Name Primer Sequence (5'-3') 
HALlSmrt ATATGCGGCCGCCATGGACTCCCTCTCAGT 
HALl End TTATGTCGACTCATATCTGATCGGGGCCAC 
HAL2Smrt ATATGCGGCCGCTGCTAAGACTTTCTCCTCCAAG 
HAL2End ATATGTCGACTCAATTGCTTATGTGCATATCAG 
HAL3Smrt ATATGCGGCCGCTCTAACTGTAACAGATCC 
Lend TCTCGCGGCCGCCAGTTGCAGAATCACTCC 
3.5 Primer designed for the generation of the newstartC pcDNA 
construct 
Primer Name Primer Sequence (5'-3') 
NewCstart2 CAGCAGAATTCACCATGGGGTCAACAAAGGCCTG--
GAAT 
3.6 Primers designed for the insertion of a 6-HIS tag into 
pcDNA/LC8 
Primer Name Primer Sequence (5'-3') 
lc8hisrev CCCCGAGTCGACTTAATGATGATGATGATGATGA--
CCAGATTTGAACAGAAG 
lc8hisfor CCCCTAGAATTCACCATGTGTGACCGAAAG 
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3.7 Primers designed for the insertion ofa c-Myc tag into pcGem/V 
Primer Name Primer Sequence (5'-3') 
Vrnycfur AATTATGGAACAAAAACTCATCTCAGAAGAGGAT--
CTGGGCATG 
Vrnycrev CATGCCCAGATCCTCTTCTGAGATGAGTTTTTGT--
TCCAT 
3.8 Primers designed for the generation ofpAS2/L deletion mutants 
Primer Name 
Ll-500rev 
Ll-700rev 
Ll-900rev 
Ll-IIOOrev 
Ll-1500rev 
Ll-2400rev 
Primer Sequence (5'-3') 
ATATCCCGGGTTATGTCTTGATCGTGAACCAG 
ATAACCCGGGTTAGATATCACAGTACATCAACAC 
ATATCCCGGGTTATAATTCTGTTGTTACATCTCTCA 
ATATCCCGGGTTAGATTGCCTCAAGCCTGGG 
ATATCCCGGGTTAATCGACTAGCCTCCGTGAA 
TTATCCCGGGTTATGTCACGCGTGCAGCTTC 
3.9 Universal M13 sequencing primers 
Primer Name 
Forward 
Reverse 
Primer Sequence (5'-3') 
GTAAAACGACGGCCAGT 
CAGGAAACAGCTATGAC 
3.10 pcDNA sequencing primers 
Primer Name 
T7prornoter 
SP6prornoter 
Primer Sequence (5'-3') 
TTAATACGACTCACTATAGGG 
AGCATTTAGGTGACACTATA 
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3.11 NewstartC pcDNA sequencing primer 
Primer Name Primer Sequence (5'-3') 
KATcprla TCTGGGGAGGAGATGAGG 
3.12 pACT2 sequencing primers 
Primer Name Primer Sequence (5'-3') 
act25' CTATTCGATGATGAAGATACCCCACCAAACCC 
act23' GAAGTGAACTTGCGGGGTTTTTCAGTATCTACG 
pACT25'A AGAGATCTGTATGGCTTAC 
pACT23'A ATAGATCTCTCGAGCTCG 
pACT23'B GATGTATAAATGAAAGAA 
3.13 pAS2 sequencing primers 
Primer Name 
pas2rseq 
pAS2F 
pAS2R 
Primer Sequence (5'-3') 
CATGCCGGTAGAGGTGTGGTCA 
GACTGTATCGCCGGTATTGCAA 
ATTCGCCCGGAATTAGCTTGG 
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Appendix 4 
Appendix 4- Plasmid Maps 
The relative positions of all major features of plasm ids are shown. For clarity, the 
size of features in the maps are not shown to sca le. 
4.1 MTHS pACT and pBIND Plasmid Maps 
Intron 
) ~ PTI 
Syntheti c p~ 
Signal 
Synthetic ~ 
Signal 
pACT Vector 
(5566bp) 
--, 
P Y40 
P CMV J Intron 
pBIND Vector 
(6360bp) 
hGH Intron fo~ 
Renilla gene 
--, 
P Y40 
~ LS 
VPI6 Fu 
MCR 
SV40 pA 
Signal 
LS 
MCR 
ion Protein 
Bamlll 
Sail 
Acc l 
Mlul 
Eco RV 
Xba l 
BstZ I 
Notl 
Acc65 I 
Kpn l 
t n 
ion Protein 
BamHI 
Sail 
Acc l 
Mill I 
EcoRV 
Xba l 
BstZ I 
Notl 
Acc65 I 
Kpn l 
t n 
KEY: PCMY= CMV immedi ate-earl y promoter, PT7= T7 R A polymerase promoter, 
PSY40= SV40 early promoter, T3= T3 RN polymerase promoter, pA= 
polyadenylalion signal, AmpR= ampicillin re i lance gene, NeoR= neomycin 
resistance gene. 
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4.2 pcDNAlHAINac Plasmid Map 
This plasmid, a derivative ofpcDNA3 (Invitrogen) , was used in the construction 
ofpcDNN HAL and the pcDNA/HAL domain mutants. 
HATag 
pcDNAfHAINac Nac ORF 
SV40 pA 
KEY: P CMY= CMV immediate-early promoter, PT7= T7 RNA polymerase promoter, 
F I ori= phage FI origin of replication, V40 0';= SV40 origin of replication , pA = 
polyadenylati on, AmpR= ampicillin re istance gene, eoR= neomycin resi stance 
gene. 
4.3 pcDNAlHAL and HAL Domain Construct Plasmid Maps 
SV40 pA 
pcDNAfHAL 
orlHALl 
orlHAL2 
or HAL3 
RPV L ORF 
or 
L 1/2/3 inserts 
KEY: P CMY= CMV immediate-early promoter, PT7= T7 R polymera e promoter, 
FI ori= phage F l origin of replication , SV40 ori= V40 origin of replicati on, pA= 
polyadenylation , AmpR= ampicillin resistance gene, eoR= neomycin re istance 
gene. 
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4.4 pcDNAINIP/V or C Plasmid Map 
These p\asmids are all derivatives ofpcDNA3.1 (Invitrogen) . 
pc DN AlNfPl V 
ore 
SV40 pA 
NeoR 
RPV N/ PN 
or C ORF 
Appendi x 4 
KEY: P CMY= CMV immediate-early prom oter, PT7= T7 RNA polymerase promoter, 
PSY40= S V40 early promoter, FI = T3 RNA polymerase promoter, pA= 
polyadenylati on, AmpR= ampicillin resistance gene, NeoR= neomycin resistance 
gene. 
4.5 pGST Plasmid Map 
Pn + 
AmpR 
pGST BamHI 
I 
t P SP6 
KEY: PT7= T7 RNA polymerase promoter, PSP6=SP6 promoter AmpR= ampici llin 
resistance gene, F I ori= phage F I origin of replication. 
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4.6 pGSTN Plasmid Map 
pGSTN 
(-4700bp) Nco I 
Appendix 4 
RPV VORF 
KEY : Pn = T7 RNA polymerase promoter, PSP6= SP6 promoter, AmpR= ampic illin 
resistance gene, F I ori= phage F I origi n of replication. 
4.7 pGemlc-MycV Plasmid Map 
pGem/c-MycV 
RPV V ORF 
KEY: Pn= T7 RNA polymerase promoter, PSP6= SP6 promoter, AmpR= ampicillin 
resis tance gene, FI ori= phage FI origin of replication. 
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4.8 pGST/striatin Plasmid Map 
Amp R 
pGST Istriati n 
Rat striatin 
ORF 
Appendi x 4 
KEY: Pn= T7 RNA polym erase promoter, PSP6= SP6 promoter, AmpR= ampicillin 
resistance gene, FI ori= ph age FI ori gi n of replication. 
4.9 pcDNAlLC8/HIS Plasmid Map 
PCMV 
LC80RF 
pcDNAlLCS/lllS 
6-HIS Tag 
SV40 pA 
NeoR 
KEY : P CMV= CMV immedi ate-early promoter, PT7= T7 R A polymerase promoter, 
FI ori= phage F I origin of replication, SV40 ori = V40 origin of replicati on, pA= 
polyadenylation, AmpR= ampicillin resistance gene, NeoR= neo myc in resistance 
gene. 
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